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ABSTRACT 
 Thiamine (vitamin B1) is an essential cofactor for all organisms. Humans 
primarily acquire thiamine through their diet and thiamine deficiencies have adverse 
neurological effects. However, the role gut microbes play in modulating thiamine 
availability is poorly understood. In addition, little is known about how thiamine, the 
Bacteroidetes ability to biosynthesize and transport thiamine, or  the regulation of 
biosynthesis and transport impacts the stability of microbial gut communities and human 
health as a whole.  
To investigate the role thiamine plays in the gut we leveraged in silico analyses of 
gut microbial species to determine prominent strategies utilized to attain thiamine. In 
addition, we have identified the genetic content and operon structure of thiamine 
transport and biosynthesis across the prominent gut phylum, Bacteroidetes.  Along with 
the bioinformatic methods, RNAseq revealed differential responses to exogenous 
thiamine by three abundant Bacteroides species. This is highlighted by the  global down-
regulation of thiamine and amino acid biosynthesis, central, and purine metabolism when 
thiamine was present in Bacteroides thetaiotaomicron. In contrast Bacteroides uniformis 
and vulgatus show a much more reserved transcriptomic response to exogenous thiamine.  
In order to build upon these data, we leveraged genetic mutants of thiamine 
biosynthesis and transport loci in B. thetaiotaomicron. These analyses determined both 
systems were critical for growth in thiamine-deficient medium. The defect in the double 
transport mutant suggests an uncharacterized feedback mechanism between thiamine 
transport and biosynthesis in B. thetaiotaomicron. Along with the phenotypic analysis of 
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thiamine acquisition operons in B. thetaiotaomicron we investigated how these deletions 
impacted its fitness in thiamine deplete and replete conditions.  
Building on the phenotypic analysis in B. thetaiotaomicron we turned our 
attention to the conserved regulatory TPP riboswitches preceding thiamine biosynthesis 
and transport genes in B. thetaiotaomicron, B. uniformis, and B. vulgatus utilizing 
transcriptional and translational reporter assays. These assays have shown a clear 
regulatory hierarchy between thiamine biosynthesis and transport pathways. In addition, 
trends in TPP riboswitch distance from their predicted regulon points to the mechanism 
of regulation (transcriptional or translational) and warrants further investigation.  
Together, these data show that thiamine acquisition mechanisms and their 
regulation are critical to physiology and fitness among the Bacteroidetes. In addition 
future work may provide insight into modeling how other gut microbes respond to the 
shifting availability of thiamine in the gut and how to therapeutically alter the gut 
microbiota from a dysbiotic state to a non-disease state. 
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CHAPTER 1: INTRODUCTION 
Thiamine and the microbiome: a crossroads of human health and disease: 
Before scientists had shifted their attention to the microbiome in order to explain 
human ailments, vitamin deficiencies and human nutrition were widely studied due to the 
profound impact these topics had on human health. Deficiencies in key vitamins were 
shown to cause diseases such as scurvy, rickets, osteoporosis, neurodegenerative 
disorders, anemia, infertility, and a multitude of other physiological disorders in humans 
(16, 24, 28, 52, 95, 100).  In addition to the role of vitamins in human health, many other 
vitamin related topics have garnered interest by the scientific community. These topics 
include the synthesis and  transport of vitamins in many organisms. Another topic 
consists of characterizing vitamin requirements of metabolic processes and how they 
change in different organisms. The studies of vitamins in the microbial world have often 
led to a better understanding of metabolism and antibiotic discovery (11, 98, 109, 113).  
Vitamin B1, thiamine, has been investigated since the early 1900s and yielded 
fascinating results. Thiamine has been shown to be crucial in neurodegenerative disorders 
such as Wernicke-Korsakoff syndrome, and beriberi (56, 73). In addition, the 
dysregulation of thiamine metabolism has been shown to be a biomarker for Alzheimer's 
disease (73, 100). Thiamine levels have also been linked to other diseases such as cancer, 
diabetes, irritable bowel disease (IBD), and obesity (68, 74, 99). Thiamine has been 
extensively studied and shown to be important in human physiology. In addition, Vitamin 
B1 has been studied in model microbial organisms, e.g. Escherichia coli, Salmonella 
enterica, and Bacillus subtilis. The study of thiamine in these microbes has led to key 
insights into how thiamine is synthesized and transported (60, 87, 135). Characterization 
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of thiamine acquisition has led to the discovery of a highly conserved, RNA-based, 
regulatory mechanism that controls the acquisition of thiamine (135). 
Another area of research that relates to human health is the study of the human 
gut microbiome. The gut microbiome consists of the bacteria, fungi, archaea, and viruses 
that colonize the human gastrointestinal tract (121). Utilizing clinical samples and germ-
free mouse models, researchers have linked the gut microbiome to diseases such as 
diabetes, obesity, cancer, IBD, and Alzheimer's (14, 25, 81,125, 136). These diseases are 
typically attributed to a disruption of the normal gut flora. The perturbations of these 
communities (dysbiosis) have been attributed to host diet, genetics, antibiotic treatments, 
and environmental factors (29, 40, 62, 102, 123). As of yet, only correlative studies exist 
for how dysbiotic states are affected and impact human health. The absence of 
mechanistic knowledge about the gut microbiota highlights the need to understand how 
the gut microbiome changes and impacts human health. Gaining a mechanistic 
understanding of the gut microbiome will teach us how to therapeutically alter the 
microbiome via prebiotics, probiotics, fecal microbiota transplants, and phage therapies. 
The studies of how vitamins and the microbes that colonize the human 
gastrointestinal tract continue to progress separately, but the gaps between these two 
topics of research are beginning to blur. The advent of multi-omic approaches have 
shown that the gut microbiome is a dynamic system. Continuing work will lead to an 
understanding of the competition that permeates the gut, and the role competition plays in 
human health and disease. To date, these studies cast a wide net but little is known about 
mechanism of how a single metabolite, like thiamine, can impact a microbial community 
or individual gut species.  
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This work attempts to interrogate the role that thiamine and the microbiome play 
in human health by reviewing (i) literature on thiamine and the roles that thiamine plays. 
We also investigated (ii) how thiamine is acquired and (iii) current microbiome research. 
All of these topics were reviewed in an attempt to (iv) highlight the role both the gut 
microbiome and thiamine have in specific human diseases. 
 
 
The role of thiamine: 
Thiamine 
 Thiamine, while naturally occurring, was first synthesized in 1936 (66). Around 
this time thiamine was also recognized for the ability to treat beriberi. Ever since, 
thiamine has yielded a complex and rewarding body of research. Thiamine consists of 
two ring structures, a pyrimidine ring (2,5-dimethyl-6-aminopyrimidine) linked together 
by a carbon bridge to a thiazolium ring (4-methyl-5-hydroxyethyl thiazole) (FIG 1.1A). 
Thiamine is primarily acquired through dietary means in humans (66). Thankfully, 
thiamine is abundant in dietary staples such as rice, meat, beans, and wheat (66). In 
contrast to humans, microbes such as Salmonella, Escherichia coli, and Bacillus posses 
the ability to synthesize thiamine de novo (6, 88, 107). Thiamine in a phosphate free form 
(FIG 1.1A) does not possess an immediate biological role. However free thiamine is 
physiologically important, as certain transporters in humans, yeast, and microbes can 
only import the free form of thiamine (23, 37, 43, 99). 
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Thiamine monophosphate 
 Thiamine monophosphate (TMP) (FIG 1.1B) has not been found to serve any 
particular biological role. Unlike free thiamine, TMP does not allow for transport through 
certain transporters. Transport of TMP is less efficient or all together blocked by the 
phosphate group. In addition, TMP does not serve the role of a cofactor like the 
diphosphorylated form of thiamine. However, TMP does make up an appreciable 
percentage (5-15%) of a cells internal thiamine pool (5, 23). TMP is also detectable in 
human blood serum (90). Together these data show, that despite no defined biological 
purpose, TMP is an important intermediate between thiamine and thiamine 
pyrophosphate (TPP). TMP  is also a flux point in the de novo biosynthesis of TPP. In 




Across all domains of life TPP is an essential cofactor. TPP (FIG 1.1C) is 
primarily utilized in decarboxylation reactions. TPP is required, in central metabolism, 
for the synthesis of Acetyl-CoA and α-ketoglutarate (72). In addition, the pentose 
phosphate shunt employs a transketolase enzyme that requires TPP to be active (17). TPP 
also catalyzes the synthesis of branched-chain amino acids (leucine, isoleucine, and 
valine) through decarboxylation (67). TPP is also a cofactor in many other processes that 
were not covered above.  
 While pyrophosphorylation of thiamine is required to perform catalytic functions; 
the pyrophosphate is not involved in the decarboxylation reaction. TPP catalyzes 
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reactions by carrying a charge on the thiazolium ring of thiamine pyrophosphate. The 
thiazolium ring contains a tetravalent nitrogen that acts as an electron sink to allow for 
the formation of a carbanion (26, 105). This carbanion then attacks a carbonyl group of 
the substrate. In addition, the thiazolium ring forms a double bond between TPP and the 
carbonyl group of the substrate. This is done by rolling electrons from the substrate onto 
the tetravalent nitrogen. The carbonyl group is then broken from the substrate by 
reversing the double bond and regenerating the cofactor (26, 82, 105) (FIG 1.2). 
 
Thiamine triphosphate 
 Thiamine triphosphate (TTP) (FIG 1.1D) was originally thought to only serve a 
biological role in vertebrates. In vertebrates, TTP activates anion channels in 
neuroblastoma cells (10). TTP also phosphorylates specific proteins involved in nicotinic 
acetylcholine binding (83). More recent studies have found detectable levels of TTP 
fungi, plants, bacteria, and invertebrates (71). The presence of TTP across all of these 
organisms suggests that it may play a larger role than originally believed. Further work 
has shown that in bacteria, specifically E. coli, TTP acts as a signaling molecule. In E. 
coli TTP creates a regulatory phosphate cascade that down regulates metabolism in 
response to amino acid starvation (44). 
In addition to studies striving to identify the biological purposes of TTP, 
considerable time has be spent on how TTP is generated. As of yet, no dedicated protein 
to generate this molecule has been identified in any organism. Early studies in mammals 
found that TTP was created by adenyl kinase 1. This reaction is not the primary function 
of adenyl kinase 1, but nutrient starvation may decrease the level of the primary substrate. 
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Reduced levels of the primary adenyl kinase 1 substrate may allow for TPP to be 
converted to TTP (42). In bacteria, TTP is generated by ATP synthase in response to 
metabolic stress and amino acid starvation (45). Similar to vertebrates TTP generation is 
not the primary function of ATP synthase. In both vertebrates and bacteria, TTP can only 
be generated by metabolic enzymes when the primary substrate is in low abundance. The 
fact that TTP generation can only occur as a secondary function lends strength to the 
argument that it acts as a starvation response signal. 
 
Synthetic thiamine analogs 
 In addition to the thiamine species highlighted above, scientists have created a 
multitude of synthetic thiamine analogs. These synthetic analogs were created to act as a 
more bioavailable version of thiamine to combat thiamine deficiencies. In addition, many 
of these analogs were also found to be promising antimicrobial and chemotherapeutic 
compounds. The first synthetic thiamine analog, allithiamine (FIG 1.1E), was created in 
1965 in Japan. Allithiamine was created by synthesizing a disulfide bridge between 
thiamine and a hydroxyethyl group. This compound was synthesized to be a more 
bioavailable version of thiamine to combat beriberi (66). In the years since 1965, many 
other compounds such as oxythiamine, amprolium, pyrithiamine, and benfotiamine (FIG 
1.1F-I) have been synthesized. All of these compounds were synthesized for similar 
reasons as allithiamine. In addition to the intended purpose, these synthetic compounds 
have all been shown to down regulate thiamine biosynthesis and transport in pathogens. 
This down regulation creates a bacteriostatic effect by impairing the dissociation of these 
compounds from a highly conserved regulatory mechanism (33). In addition, these 
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compounds have also been used in the treatment of cancer (129). These compounds take 
advantage of a cancer cells immense thiamine requirements to act as a therapeutic. The 
synthetic thiamine analogs compete with thiamine for the active sites of metabolic 
enzymes in a cancer cell slowing the uncontrolled growth. 
 
 
Thiamine acquisition and biosynthesis: 
Transport 
 Due to the essentiality of thiamine pyrophosphate, many organisms transport 
some version of thiamine. The transport of TPP, TMP, thiamine, and thiamine precursors 
are important; especially when the fact that many organisms lack the ability to 
biosynthesize thiamine de novo is considered. Across all three domains there is a 
diversity of thiamine, TPP, and thiamine precursor transporters. Most of these 
transporters have a high affinity for the substrate. These high affinity thiamine 
transporters allow for organisms to acquire the essential cofactor when environmental 
concentrations are low. 
 In humans transport is especially important, because humans cannot synthesize 
thiamine. Humans can only change the phosphorylation state thiamine, typically 
converting free thiamine to TPP (1, 100). To this end, thiamine must be acquired through 
dietary means in humans. The majority of thiamine is absorbed in the upper 
gastrointestinal tract (1, 79, 100), but thiamine transporters are found throughout the 
gastrointestinal tract. The presence of distal gut thiamine transporters suggests that 
significant levels of thiamine must be present across the gastrointestinal tract (79, 115). 
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The dietary thiamine available throughout the gastrointestinal tract is absorbed by 
humans and microbes alike.  
The first characterized thiamine transporters in humans are members of the solute 
carrier protein super family (SLC). Specifically, these transporters are encoded by the 
genes SLC19A2 and SLC19A3. These genes encode thiamine transport protein 1 and 2 
respectively (72). While both transporters are ~48% identical to one another at the amino 
acid level; they have been shown to be expressed differentially across the human body. In 
addition, SLC19A2 and SLC19A3 have different apparent kinetics for importing free 
thiamine (34). SLC19A2 is commonly found to be expressed in skeletal muscle 
throughout the human body.  In addition, SLC19A2 has an apparent Km of 2.5 µM for 
free thiamine transport. In contrast, SLC19A3 encodes the primary thiamine transporter 
found in the upper intestinal tract. It possess an affinity for thiamine in in low nanomolar 
concentrations. This shows that thiamine transporter 2 is the high affinity thiamine 
transporter in the gut (49). The apparent kinetics of these proteins are likely beneficial for 
the specific regions they are expressed. Both proteins utilize an ion exchange mechanism 
that harnesses a concentration gradient to import free thiamine. This mechanism is 
similar to the one utilized by energy coupling factor (ECF) transporters found in bacteria. 
Among ECF transporters, free thiamine is pyrophosphorylated to the active form of TPP 
as it is imported (39). In addition to the two previously characterized free thiamine 
transporters, a human TPP transporter has also been identified (79). This transporter 
(SLC44A4, hTPPT) is exclusively expressed in the colon. SLC44A4 is believed to solely 
transport microbially derived TPP, but little else is known about it (79). Humans can also 
acquire free thiamine through spontaneous diffusion or nonspecific transport when the 
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concentration of free thiamine is greater than 2 µM (48, 101). This phenomena has also 
been shown to be true in microbes that have had their thiamine transporters deleted (23). 
Interestingly, 2 µM is noted to be the highest end of physiological thiamine 
concentrations found in the human gastrointestinal tract (100).  
 Compared to vertebrates, the microbial world has developed a diverse set of 
importers to acquire thiamine, TPP, and its precursors. The microbial thiamine 
transporter most similar to the human thiamine transporters are the ECF-type transporters 
found among Lactobacillus species, ThiT. ThiT was even utilized as a model for the 
crystallization of the human transporters despite sharing less than 20% amino acid 
identity (72, 132). Similar to SLC19A3, ThiT has been characterized to operate in the 
low nanomolar range (76). Another ECF-type thiamine transporter has recently been 
discovered and lightly characterized. This ECF-type thiamine transporter, PnuT, shares a 
striking level of identity with other pyridine nucleotide uptake transporters. PnuT can be 
distinguished from other pnu transporters by the pyrophosphokinase that is typically 
downstream of pnuT. In addition, this pyrophosphokinase is believed to be involved in 
powering the transport of thiamine across the membrane (36, 96). PnuT transporters are 
widely conserved among gut microbes. For many of these microbes PnuT is also the only 
thiamine transporter. PnuT has the ability to transport free thiamine at low nanomolar to 
low micromolar concentrations (23, 43, 54). This high specificity for free thiamine may 
be especially beneficial for competing with the host to acquire thiamine throughout the 
gastrointestinal tract.  
While ECF-type thiamine transporters are common across gut microbes, other 
types of thiamine transporters are much more widely conserved and utilized. These 
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transporters belong to the ABC transporter superfamily, specifically ThiPQ-TbpA in 
Gram negative bacteria and YkoEDC in Gram positive bacteria (9, 55, 63, 133). These 
transporters utilize ATP to power the import of thiamine and the phosphorylated moieties 
of thiamine. ABC-type transporters have the ability to transport TMP and TPP in addition 
to free thiamine (45, 133). The ability to transport the phosphorylated versions of 
thiamine comes from the utilization of ATP to power transport. This is in contrast to the 
how ECF-transporters power transport e.g. harnessing gradients or the phosphorylation of 
free thiamine. ATP dependent thiamine transporters transport all three varieties  of 
thiamine with similar apparent Kms to the microbial ECF-type transporters (ThiT and 
PnuT). Studies have shown ABC thiamine transporters having a functional range between 
low nanomolar and low micromolar concentrations of thiamine (133). 
 In addition to the numerous thiamine, TMP, and TPP transporters there are 
additional microbial transporters that can transport thiamine precursors such as 2,5-
dimethyl-6-aminopyrimidine (HMP-P) that make up part of the ring structure in thiamine 
(36, 97). Transporters such as ThiXYZ, CytX, and ThiW have all be characterized to 
transport thiamine precursors (4, 99, 101). Thiamine precursor transporters are associated 
with a loss of synthetic genes for the specific molecule they now import (4, 33, 68). This 




 While humans lack the ability to biosynthesize thiamine de novo, many organisms 
possess this ability. Often times biosynthesis exists in addition to common transport 
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pathways. Perhaps the best studied versions of de novo thiamine biosynthesis are the 
pathways found in E. coli and B. subtilis. To this end, thiamine biosynthesis typically 
consists of the same steps carried out by a different suite of enzymes.  
 Thiamine biosynthesis is a bifurcated pathway in which the two major precursors, 
pyrimidine ring (HMP-P) and thiazole (cThz-P), can be synthesized independently of 
each other (FIG 1.3). The formation of HMP-P is conserved across bacteria in that a 
single enzyme, ThiC (E. coli) or ThiA (B. subtilis), through an uncharacterized 
mechanism will convert 5-aminoimidazole ribonucleotide (AIR) into HMP-P (87, 128, 
138). HMP-P will then be phosphorylated to HMP-PP, in preparation for thiamine 
condensation by ThiD (19).  
The other initial step, synthesizing cThz-P, has a much more diverse series of 
steps between Gram negative and Gram positive bacteria. In Gram negative bacteria, 
ThiS creates a thioester group by mobilizing sulfur from cysteine or another sulfur 
carrying molecule. This thioester group on ThiS is then chaperoned by ThiF to ThiH. 
ThiH then catabolizes tyrosine in order to stabilize the thioester carried by ThiSH. Then 
Dxs will combine pyruvate and glyceraldehyde-3-phosphate to form deoxy-D-xylulose 5-
phosphate (DXP). ThiG will then combine the reactive thioester group synthesized by 
ThiSHF and DXP, synthesized by Dxs, to form the thiazole ring (cThz-P) (91). In Gram 
positive bacteria, ThiH is replaced by ThiO. ThiO in contrast to ThiH utilizes glycine 
instead of tyrosine (7). In addition to the ability to biosynthesize thiazole de novo, many 
bacteria also possess the thiazole recycling enzyme, ThiK (Gram positive) or ThiM 
(Gram negative). These enzymes can phosphorylate and convert thiazole from alternative 
sources into cThz-P (110). These two ring structures are then condensed together by ThiE 
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or YjbQ creating TMP (3, 110). TMP is then phosphorylated to the active TPP form by 
the TMP kinase, ThiL (134). 
 In addition to these complex pathways performed by bacteria, there is also a 
thiamine synthesis pathway in yeast. This pathway is still bifurcated similar to the 
bacterial mechanism. In contrast, HMP-PP synthesis performed by Thi5D, instead of 
ThiCD. Thi5D utilizes histidine and pyridoxal in place of AIR (119). Likewise, the 
thiazole synthesis suite of genes are replaced by Thi4 in yeast. The thiazole synthesis 
genes of yeast utilize NAD+, cysteine, and glycine in place of the common bacterial 
precursors (75, 117). 
 
Regulation 
 Thiamine biosynthesis and transport genes in all three domains of life are 
regulated by cis-acting RNA regulatory elements (TPP riboswitches) (13, 78, 94,135). 
TPP riboswitches are highly conserved and maintain a pitch-fork like structure. In 
bacterial species, TPP riboswitches occur in the 5’-UTR of gene (135). In contrast, 
eukaryotes have TPP riboswitches in splice junctions (12). In all species these 
riboswitches impact the expression of thiamine acquisition genes. 
In one branch of the pitch-fork like structure of the TPP riboswitch, there is a 
conserved sequence of 5’-UGAGA-3’ that binds the pyrimidine domain of thiamine, 
TMP, and TPP through Watson-Crick base stacking interactions (80, 108). In addition to 
the pyrimidine binding domain, there is a pyrophosphate binding domain in TPP 
riboswitches (FIG 1.4). This pyrophosphate binding domain utilizes the secondary 
structure in coordination with divalent metals, such as magnesium and manganese, to 
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stabilize and bind TPP (108). This pyrophosphate binding domain aids in the sensing of 
thiamine. This domain makes TPP riboswitches 100-fold more likely to bind TPP than 
TMP. The phosphate binding domain also confers a 1,000-fold higher affinity for TPP 
than free thiamine (122).  
 In bacteria, there are two mechanisms by which TPP riboswitches regulate their 
regulon. It is canonically known that TPP riboswitches in Gram negative bacteria 
regulate by ribosomal binding site (RBS) occlusion. This is affected by the stable binding 
of TPP, which creates a conformational change that now blocks the RBS from being 
bound by the ribosome (108) preventing translation. In Gram positive bacteria, TPP 
riboswitches block transcription of their regulon by creating a stem-loop. This stem-loop 
causes the RNA polymerase to fall off, blocking the transcription of thiamine 
biosynthesis and transport genes (135). While these mechanisms are believed to be 
canonical and exclusive to their Gram type; there is an emerging trend of dual acting TPP 
riboswitches that act at the level of both transcription and translation (15). In addition, 
some gut microbes appear to have independent translational and transcriptional acting 
riboswitches (23). 
 In eukaryotes, TPP riboswitches are found near splice sites of thiamine 
biosynthesis genes (yeast) or in transport genes (18). Alternative splicing allows for the 
hiding of splice sites that create different mature thiamine acquisition proteins. When 
thiamine is replete, splicing prevents the maturation of high affinity thiamine transporter 
mRNA. Instead, the TPP bound riboswitch causes the maturation of a lower affinity 
thiamine transporter (18). 
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The microbiome: 
 The human microbiome is defined as the bacteria, fungi, viruses, and archaea that 
colonize the human body. It has also been shown that microbial cells outnumber human 
cells in the human body (127). As an example, bacterial cells can number as high as 1011-
1012 cells/mL in the distal colon (8). In addition, microbially derived transcripts and 
proteins are 1,000-10,000 times more abundant than human derived transcripts and 
proteins (38, 139). There are numerous types of microbiomes across the human body, but 
the most studied microbiome is that of the human gut. The gut microbiome is linked to 
human development, metabolic function, and disease (2, 41, 85, 111). However, most of 
these studies are correlative in nature. While many studies exist, there is a lack of 
mechanistic understanding about how the gastrointestinal microbiota impacts human 
health and disease. The gut microbiome has been extensively reviewed in many places, 
but a brief overview will be provided here. This overview is provided to emphasize the 
impact this biome plays in human development, immune modulation, and metabolic 
modulation.  
 Microbial communities begin impacting human health at the time of birth. This 
symbioses continues through the life of the host. After birth the gastrointestinal tract is 
immediately colonized by Bifidobacteria. This colonization is favored because 
Bifidobacteria are adept at breaking down and utilizing the nutrients of the infants milk-
based diet (22, 116). The gut community then shifts to being dominated by Firmicutes 
and Bacteroidetes when solid food is introduced (35, 57). This “healthy” microbiome and 
its establishment is crucial for the maturation of gut cilia and the immune system (46, 
51). The early development of a “healthy” gut microbiome is important for long term 
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health. However, data shows that later in life interventions can have a positive impact on 
the severity and development of diseases such as diabetes, obesity, and Alzheimer's 
disease (21, 53). Due to the importance of the gut microbiome, identifying mechanisms to 
change the microbiome are of the utmost importance. The most common way gut 
microbiomes are modulated is through the clearing of most microbial species by broad 
spectrum antibiotics (21, 53, 64). This has recently been regarded as detrimental, as it 
routinely opens the intestinal tract up to being colonized by pathogenic bacteria such as 
Clostridium difficile (120). Other strategies, such as changes in diet and fecal microbiota 
transplants, have been utilized as more subtle mechanisms to affect change and improve 
human health (20, 32, 58, 86, 104). 
 The bacterial phyla that typically dominate the human gastrointestinal tract are the 
Firmicutes and Bacteroidetes. The high abundance these phyla have led many to believe 
that both have an immense impact on the health of the human host. Shifts in either 
phylum have been correlated to diseases such as IBD, obesity, and diabetes (14, 29, 84). 
However, little is known about how to selectively and therapeutically change the 
abundances of these phyla. It is hypothesized that altering host diet (e.g. metabolite 




Thiamine, the microbiome, and disease: 
 Both thiamine and the gut microbiome have been linked to human health. 
Imbalances in either variable have been linked to many diseases, such as Alzheimer's, 
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Parkinson's, irritable bowel disease, obesity, and various types of cancer. Unfortunately, 
little consideration has been given to how both coordinately impact the development of 
these diseases. This section attempts to link the role thiamine and the native flora of the 
gastrointestinal tract play in human health. 
  
Alzheimer’s disease 
 Alzheimer’s disease is a neurodegenerative disorder characterized by the 
accumulation of β-amyloid particles, fibrils, and oligomers in the brain. In addition to an 
over accumulation of these particles, they are typically misfolded. This misfolding leads 
to the particles no longer being able to perform their intended biological function (30, 
70). Alzheimer’s disease typically impacts the elderly because this age group has a 
decreased ability to clear the misfolded amyloids (130). To date, there are no recorded 
therapies for Alzheimer’s disease. However, the intrinsic link of the gut microbiota and 
thiamine metabolism in Alzheimer’s disease suggests that both could be modulated as a 
therapy. 
 The gut microbiome is well known for the expression of lipopolysaccharides. 
Consequently, gut microbes also produce many other metabolites, including amyloid 
particles (31, 106). These microbially derived amyloids become increasingly important as 
the host ages and the gut barrier becomes more permeable them. This increased leakiness 
may be caused by dysbiotic states that decrease the amount of short chain fatty acids 
(SCFAs) produced by the gut community. The decrease in SCFAs leads to increases in 
inflammation and permeability of the gut membrane (27). In addition, certain pathogenic 
bacteria have been noted to excrete these amyloid-like particles. The increase in 
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microbially derived amyloids may seed the formation of human amyloids that cause 
Alzheimer’s disease. Many of these pathogenic species can only gain prominence during 
dysbiotic states. Consequently these pathogenic bacteria may be a source of excess 
amyloid particles that lead to the non-clearing accumulation noted in Alzheimer’s disease 
(50, 106). In addition to the pathogenic bacteria that have been associated with pro-
Alzheimer’s disease states, many beneficial microbes have been correlated with an anti-
Alzheimer’s disease state. As an example, the Bacteroidetes have been correlated with 
decreased amyloid particles (112). Other probiotic species, such as the Bifidobacteria, 
have been shown to be protective against amyloid-producing Enterobacteriaceae (131). 
Considering the impact that the microbiota can have in preventing or causing 
Alzheimer’s disease, it has become important to find modulatory therapies of the 
microbiome.  
 In addition to the role the microbiota plays in Alzheimer’s disease, thiamine has 
also been correlated with the pathology of the disease. It has been noticed that patients 
with Alzheimer’s disease have hypometabolism in the brain (103). This hypometabolic 
state has been correlated with decreased thiamine concentrations in the bloodstream. 
Decreased concentrations of thiamine would lead to a down regulation of central 
metabolism, due to the role thiamine plays as a cofactor in this pathway (77). Thiamine 
levels do not correlate to the buildup of amyloid fibers; however the supplementation of 
thiamine or benfotiamine has been associated with the mitigation of Alzheimer’s disease 
symptoms (77, 89). 
 Altering the microbiome and thiamine availability could be used in coordination 
to treat Alzheimer’s disease. Consequently, similar therapies could be utilized to treat 
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other neurodegenerative disorders such as Parkinson’s disease. In addition, thiamine and 
benfotiamine supplementation may have a profound impact on the microbiome and also 
warrants further study.  
 
Diabetes and obesity 
 Diabetes is a metabolic disorder that has both genetic and environmental factors 
that impact its pathology and severity in the host. Type I diabetes is attributed more to 
host genetics; while type II has more of an environmental based origin. Both however are 
immune modulated and have components related to the microbiome. The microbiome can 
initiate an inflammatory response that causes a signaling cascade creating insulin 
sensitivity in the host (47). Obesity is often a precursor to the onset of diabetes. Similarly, 
obesity is linked to the microbiota that inhabits the gastrointestinal tract. Diabetes may be 
mediated by metabolic dysregulation through dysbiosis (65). Thiamine has also been 
implicated in the development of diabetes and obesity. This implication is due to the role 
thiamine plays in the utilization of dietary carbohydrates. Studies of thiamine and the gut 
microbiome suggest that they both play a role in the prevention and treatment of diabetes. 
 The microbiome of the human gastrointestinal tract has been linked to both 
diabetes and obesity by correlating differential abundances of certain types of bacteria 
(61, 124, 126). While research on this topic is on going, it is unknown whether the 
composition of the microbiome or the disease occurs first. Both obesity and diabetes can 
be mitigated by altering the composition of the gut microbiome (114). In obesity, an 
increase in the abundances of Firmicutes species have been correlated with the ability to 
lose weight. In contrast, increases in Bacteroides species have been shown to be 
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detrimental to weight-loss (65, 114). These associations are likely due to the differential 
metabolic aptitudes of each phylum. These aptitudes impact energy utilization and 
storage in the host (126). The utilization of complex carbohydrates by the gut microbiota 
may prevent the host from absorbing and storing the excess energy (59). Diabetes is also 
linked to a change in microbially derived metabolite production. Both diabetes type I and 
II are associated with a decrease in butyrate producing bacteria, such as Faecalibacterium 
prausnitzii (93, 140). Butyrate is a prominent microbially derived SCFA in the gut. 
SCFAs have been shown to create an anti-inflammatory response in the gut. This anti-
inflammatory response may mitigate the inflammation linked to diabetes and other 
autoimmune diseases (69, 93, 140). Both obesity and diabetes are diseases that may be 
managed or prevented by therapeutically altering or supplementing the gut flora. 
  Thiamine availability and plasma levels are associated with the prevention and 
treatment of diabetes and obesity (92, 118, 137). This may be due to excess utilization of 
thiamine by central metabolic enzymes. High expression of these enzymes may prevent 
insulin sensitivity and the accumulation of fat deposits (118). It has also been shown that 
thiamine supplementation can be beneficial to patients already suffering from diabetes or 
obesity (137). Thiamine is beneficial because it allows the breakdown of metabolites, 
such as glucose. This prevents storage and sensitivity to excess glucose in the host (92). 
 Both thiamine supplementation and the alteration of the gut microbiome have 
been shown to be beneficial in the treatment of diabetes and obesity. Therefore, the study 
of how these factors interact with one another could be beneficial to the prevention and 
treatment of diabetes and obesity.  
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Conclusion:  
The microbiome and thiamine are intrinsically linked to human health and 
disease. The gut microbiome is also linked to other diseases such as cancer, inflammatory 
bowel disease, depression, and many more. In turn, thiamine deficiencies are strongly 
correlated to neurodegenerative disorders, cancer, diabetes, and obesity. Conflicting 
reports and studies have made it difficult to state that thiamine or the gut microbiome are 
definitive treatments of any disease. However, the evidence that both play a role warrants 
further investigation into how they impact human health.  
Due to the importance of both thiamine and the microbiome, it is imperative that 
we study how they impact one another. It is likely that the microbiome affects the 
thiamine availability in the host gastrointestinal tract and blood stream. It is also likely 
that thiamine changes the abundances of keystone microbial species in the gut. Studying 
both variables and how they affect one another is crucial in studying the development and 
prevention of many diseases. 
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Figures: 
 
FIG 1.1. Structures of thiamine and various thiamine analogs 
Structures for (A) thiamine, (B) TMP, (C) TPP, (D) TTP, (E)Allithiamine, (F) 
Oxythiamine, (G) Amprolium, (H) Pyrithiamine, and (I) Benfotiamine were obtained via 
pubchem to illustrate differences in structure between these various moieties. (National 
Center for Biotechnology Information. PubChem Compound Database; CID=6202, 
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FIG 1.2. General decarboxylation mechanism utilized by TPP 
Decarboxylation of pyruvate by TPP is used as a model for this reaction. Charge on the 
thiazole ring of TPP carries out a nucleophilic attack on the substrate for decarboxylation 
(pyruvate). This forms a double bond between pyruvate and TPP. Then the bound 
between TPP and the substrate is broken. This regenerates TPP and creates a 




	   	   	  23
 
 
FIG 1.3. General thiamine biosynthesis pathways 
Thiamine biosynthesis pathways that are utilized by microbes and yeast are depicted 
above in a combined manner to show similarities in the pathways. Dedicated thiamine 
biosynthesis genes are highlighted in green. Enzymes required for thiamine biosynthesis, 
but that are not wholly dedicated to the pathway are highlight in blue. EC numbers are 
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FIG 1.4. Representative TPP riboswitch binding of TPP 
Model of the coupling between TPP binding and structural rearrangements in the TPP 
riboswitch. (A) Summary of the contacts observed between the pyrophosphate (blue) and 
pyrimidine (pink) sensor helices, TPP, and the switch region. Watson-Crick base pairs 
are indicated in black, nonstandard base pairs are shown in green, and hydrogen bonds 
are indicated with thin black lines. TPP is schematically drawn in yellow: phosphates, 
triangles; thiazole ring, pentagon; pyrimidine base, hexagon. The Mg2+ ion is shown as a 
red dot. Contacts between nucleotides and magnesium-bound TPP are highlighted in red. 
Red double-lines indicate stacking interactions with the ligand. Base A72, which forms 
the crucial assembly platform, is shown in yellow. (B) Upon TPP binding (1), bulges J2/3 
and J4/5 rearrange, thereby closing the sensor helix clamp and forming new hydrogen 
bonds at the tip of loop L5. The TPP-induced parallel positioning of the sensor helices 
stabilizes the three-way junction with A72 at the core of the interaction platform (2) and 
promotes the formation of the switch helix P1 (3), which turns the riboswitch “off.”  
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FIG 1.4. (cont.) 
Figure and legend taken from: Thore S, Leibundgut M, Ban N. 2006. Structure of the 
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CHAPTER 2: THIAMINE ACQUISITION STRATEGIES IMPACT 
METABOLISM AND COMPETITION IN THE GUT MICROBE BACTEROIDES 
THETAIOTAOMICRON 
Abstract: 
 Thiamine (vitamin B1) is an essential cofactor for all organisms. Humans 
primarily acquire thiamine through their diet and thiamine deficiencies have adverse 
neurological effects. However, the role gut microbes play in modulating thiamine 
availability is poorly understood and little is known about how thiamine impacts the 
stability of microbial gut communities. To investigate thiamine’s role in the gut we 
utilized the model gut microbe, Bacteroides thetaiotaomicron. RNAseq revealed a global 
down-regulation of thiamine and amino acid biosynthesis, glycolysis, and purine 
metabolism when thiamine was present. Using genetic mutants of thiamine biosynthesis 
and transport loci we determined both systems were critical for growth in thiamine-
deficient medium. The defect in the double transport mutant suggests an uncharacterized 
feedback mechanism between thiamine transport and biosynthesis in B. thetaiotaomicron. 
Mutant phenotypes were recapitulated during pairwise competitions, reinforcing the 
importance of encoding versatile thiamine acquisition mechanisms when thiamine 
concentrations are variable. In addition, LC/MS analyses corroborate that exogenous 
thiamine levels affect the internal thiamine pool of B. thetaiotaomicron. Further, we 
computationally examined the ability of other gut microbes to acquire thiamine and 
identified lineage specific differences in thiamine acquisition strategies. Among the 
Bacteroidetes the capacities for both thiamine transport and biosynthesis are common. 




thetaiotaomicron are not only critical for its physiology and fitness but provide the 
opportunity to model how other gut microbes may respond to the shifting availability of 




 Variation in the ability of gut microbes to transport, synthesize, and compete for 
Vitamin B1 (thiamine) is expected to impact the structure and stability of the microbiota 
and ultimately this variation may have both direct and indirect effects on human health. 
Our study identifies the diverse strategies employed by gut Bacteroidetes to acquire 
thiamine. We demonstrate how the presence or absence of thiamine biosynthesis or 
transport dramatically affects the abundance of B. thetaiotaomicron in a competitive 
environment. This study adds further evidence that altering presence or concentrations of 
water-soluble vitamins, such as thiamine, may be an effective method for manipulating 
gut community composition. In turn, targeted thiamine delivery could be used 




Thiamine, a small metabolite vitamin is an essential cofactor in all three domains 
of life. Thiamine is necessary for glycolysis, the tricarboxylic acid (TCA) cycle, branched 
chain amino acid metabolism, and nucleotide metabolism (6). Deficiencies of thiamine in 




beriberi, as well as heart failure, ataxia, and paralysis (14). In humans, thiamine is 
believed to be primarily derived from dietary sources such as protein rich foods as well as 
fortified grains (14) and absorbed throughout the small and large intestines (12). 
However, there is evidence that thiamine availability is modulated by or acquired from 
the dense and diverse microbial communities present in the gastrointestinal tract (12, 18, 
21). 
Competition for and production of small metabolites such as vitamins, amino 
acids, and short chain fatty acids influence the composition (e.g., abundance and types) of 
microbes that inhabit the gastrointestinal tract (4, 5, 27). As such, small metabolites are 
therapeutic candidates for treating diseases associated with radical changes in gut 
microbial community composition such as Alzheimer’s, diabetes, and obesity (10, 37, 
42). Indirect evidence suggests thiamine may influence gut community structure. 
Metagenomic analysis of different aged human cohorts determined that not only did 
overall microbial communities change with age, but also the abundance of microbial 
thiamine biosynthesis genes increased with the age of the host (45). Conversely, in a 
separate study the activity of human intestinal thiamine transporters was observed to 
decrease with age (29).  These observations may indicate a lower requirement for 
thiamine by the host with age or possibly an increase in thiamine availability due to 
microbial production in older individuals. While these correlative data exist, little is 
known mechanistically about how the competition for and production of thiamine 
impacts individual gut microbes like Bacteroides thetaiotaomicron, microbial 




Microbial thiamine biosynthesis is a bifurcated pathway involving the synthesis of 
two precursors that are condensed to form thiamine (15). Microbes that lack complete de 
novo biosynthesis of thiamine often encode partial biosynthetic pathways of the 
precursors thiazole and hydroxymethyl pyrimidine phosphate or simply phosphorylate 
free thiamine into the biologically active form, thiamine pyrophosphate (TPP) (19). 
Organisms that lack or have incomplete biosynthetic pathways require transporters for 
thiamine or its precursors. Humans exclusively transport free thiamine in the proximal 
small intestine as well as in the large intestine (29), while some microbes like Salmonella 
enterica use an ABC transporter to acquire thiamine and its phosphorylated forms (41). 
However, despite our understanding of thiamine biosynthesis and metabolism in humans 
and a limited number of model organisms little is known of thiamine acquisition 
strategies among most beneficial gut microbes.  
Initial comparative genomic analyses of several gut microbes suggested that the 
Bacteroidetes, a phylum that can comprise as much as 50% of the gastrointestinal 
community (3), possesses a canonical thiamine biosynthesis pathway (28). In addition, a 
novel transport system was predicted due to the presence of cis-acting RNA regulatory 
elements preceding the putative transport genes, TPP riboswitches (28). However, limited 
investigation of thiamine acquisition in the Bacteroidetes has been attempted (18). Here, 
we have carried out a bioinformatic analysis of 641 gut associated microbes and 
performed a transcriptomic, genetic, and competitive characterization of the prominent 
gut microbe B. thetaiotaomicron in response to thiamine. In turn, we have characterized 
(i) the effect of thiamine on the transcriptome, (ii) the predicted thiamine biosynthesis 









Global gene expression response of B. thetaiotaomicron to thiamine availability 
B. thetaiotaomicron, a prominent gut microbe, is typical of the Bacteroidetes in its 
thiamine acquisition strategy encoding both TPP riboswitch regulated biosynthesis 
(thiSEGCHF-tenI, BT0653-BT0647), putative outer membrane transporter (OMthi, 
BT2390) and putative inner membrane transporter and thiamine pyrophosphorylase 
(pnuT-tnr3, BT2396-BT2397) operons (28). TPP riboswitches can act at the 
transcriptional or translational level (23) and it is uncertain how they function in the 
Bacteroidetes. To investigate the response of B. thetaiotaomicron to the availability of 
thiamine, strand-specific RNAseq was performed on cultures grown in minimal medium 
supplemented with either 0 or 15 µM thiamine in duplicate. A total of 34,890,999 reads 
were recovered, ranging from approximately 8 million to 9.5 million reads per sample 
that were quality filtered, trimmed, and analyzed with Rockhopper (Table 2.1) (35). Of 
the 4,778 coding sequences in the B. thetaiotaomicron genome, 151 showed ≥ 2-fold 
expression change (q ≤ 0.05). Of the three putative TPP riboswitch regulated operons, the 
biosynthetic operon as a whole was significantly down regulated when thiamine was 
present (FIG 2.1A). No significant differential expression was observed at either of the 
predicted transport operons (FIG 2.1A). This is in striking contrast to the multiple 




strong transcriptional induction when grown in vitamin B12 limiting conditions (4). 
However, this does not rule out their involvement in thiamine transport, particularly as 
the putative inner membrane transporter, PnuT, has been heterologously expressed in E. 
coli and demonstrated to transport thiamine (18). 
In addition to the genes in the biosynthetic operon, 148 other genes were 
differentially expressed due to exogenous thiamine in the environment. In fact, 132 of the 
151 differentially regulated genes were down regulated when 15 µM thiamine was 
present in the medium (FIG 2.1B). Using a gene set enrichment analysis (GSEA) we 
determined if specific pathways are differentially expressed due to thiamine availability 
(34). Significantly down-regulated KEGG pathways in the presence of exogenous 
thiamine were observed in thiamine metabolism, amino acid biosynthesis, purine 
metabolism, the TCA cycle, coenzyme A biosynthesis, and pyruvate metabolism (FDR 
corrected p ≤ 0.001) (FIG 2.1C). This suggests that in the presence of excess exogenous 
thiamine, B. thetaiotaomicron down-regulates transcription of the thiamine biosynthetic 
pathway in order to maintain homeostatic levels of internal thiamine. In addition to this, 
B. thetaiotaomicron also decreases transcription of thiamine dependent pathways such as 
branched chain amino acid biosynthesis, glycolysis, and the citric acid cycle when excess 
thiamine is present. This decreased expression in the presence of excess thiamine is 
counter intuitive to what was expected. Normally, it is expected that expression of 
cofactor dependent enzymes is positively correlated with the concentration of the 
cofactor (e.g., iron) (13). In the case of thiamine in B. thetaiotaomicron we observe the 





Re-analysis of microarray data 
To test for evidence of transcriptional changes in response to thiamine availability 
we re-analyzed existing microarray data from B. thetaiotaomicron growing both in vitro 
and in vivo (33). Briefly, microarrays had been hybridized with total RNA recovered 
from wildtype B. thetaiotaomicron grown to mid-log phase in biological duplicate in 
minimal medium with no thiamine added (8h), in TYG that has excess thiamine (3.5h) or 
from the ceca of two monoassociated gnotobiotic NMRI mice (GSE2231) (33). Raw 
GeneChip data were normalized and model-based expression values (PM-MM model) 
were compared using DNA-Chip Analyzer (v2011.05) as described (33). Mean and 
standard deviations of the normalized expression values were calculated and significantly 
differentially regulated genes were detected with t-test, p < 0.05 using FDR correction. 
 
Genetic analysis of thiamine acquisition genes in B. thetaiotaomicron 
To assess the conditions in which thiamine biosynthesis and uptake are important 
for the growth of B. thetaiotaomicron and validate the role of the predicted transporters in 
thiamine uptake a series of in-frame genetic deletions were generated. We focused on the 
three TPP riboswitch regulated operons, removing the entirety of the downstream 
biosynthetic or putative transport coding sequences. The resulting mutant strains and their 
complements (Table 2.2) were evaluated for their ability to grow under a range of 
exogenous thiamine concentrations. 
Wildtype B. thetaiotaomicron readily grows in media without added thiamine 
(FIG 2.3A) (11), which corresponds with elevated expression of the TPP riboswitch 




major thiamine biosynthetic operon (∆BioThi: BT0653–BT0647) is expected to 
completely inhibit growth in minimal medium without thiamine. Indeed, growth 
inhibition occurs in the ∆BioThi mutant, severely attenuating terminal cell densities (FIG 
2.3A,B). Partial growth of the ∆BioThi mutant is recovered when ≥ 1 nM thiamine is 
supplemented in the medium (FIG 2.3B). The calculated EC50 (the effective 
concentration of thiamine for which the terminal OD600 of the mutant attains 50% of the 
wildtype)(Table 2.3) for the ∆BioThi mutant is 2.8 nM (Confidence Interval of 95%, 
CI95, 1.4 – 5.5 nM) showing that biosynthesis is critical in thiamine deficient 
environments. This growth defect can be complemented when the thiSEGCHF-tenI 
operon and its native promoter are returned to the ∆BioThi mutant in trans (FIG 2.3B) 
alleviating the requirement for exogenous thiamine and returning the EC50 to 0 nM 
thiamine (Table 2.3). Together these data suggest that B. thetaiotaomicron does in fact 
encode thiamine transporters that likely function in the low nanomolar range. This is 
comparable to other characterized thiamine transporters such as ThiPQ-TbpA in 
Salmonella typhimurium (41). 
To determine if the predicted TPP riboswitch regulated inner (pnuT: BT2396) and 
outer (OMthi: BT2390) membrane transporters are responsible for transporting thiamine 
individual transporter deletions were constructed in the wildtype background (∆pnuT, 
∆OMthi). Regardless of the thiamine concentration in the medium, growth of the single 
transporter mutants never significantly varied from wildtype (FIG 2.3B). This result was 
expected, as the thiamine biosynthesis pathway is fully intact. Therefore, to further 
investigate the role of these transporters, double mutants consisting of either the 




Deletion of the biosynthetic operon in conjunction with either the inner 
(∆∆BioThi-pnuT) or outer membrane (∆∆BioThi-OMthi) transporters resulted in mutants 
that required ~10 times more thiamine (1,000 nM) than the ∆BioThi mutant to achieve 
growth equal to the wildtype (FIG 2.3C). The EC50 for the double mutants increased to 
15.8 nM (CI95 8.1 – 31 nM) thiamine for the biosynthesis and outer membrane transporter 
mutant and to 10.9 nM (CI95 9.2 - 13 nM) for the double mutant of biosynthesis and inner 
membrane transporter compared to an EC50 of 2.8 nM (CI95 1.4 – 5.5 nM) in the 
biosynthesis mutant (Table 2.3). Thus, partially disrupting thiamine transport in the 
absence of a complete biosynthetic pathway further attenuates, but does not completely 
abolish thiamine dependent growth. Growth of either of these two mutant backgrounds 
can be fully complemented by restoring the major thiamine biosynthesis operon in trans 
(FIG 2.3C).  
Compared to the individual biosynthesis and transporter mutants, deletion of both 
transporters while the biosynthesis locus is fully intact (∆∆Transport) has a highly 
deleterious effect on growth (FIG 2.3D). This mutant requires at least 10 µM of thiamine 
to achieve wildtype growth and has an EC50 of 30.3 nM (CI95 22.8 – 40.3 nM, Table 2.3). 
To ensure this phenotype was not due to an inability to transport cysteine, the only 
thiamine precursor present in the minimal medium, the double transport mutant was 
grown with an alternate sulfur source. The growth phenotype of the mutant in the 
modified medium was unchanged suggesting that neither transporter is likely involved in 
cysteine transport (see Supplemental Results, FIG 2.4).  
Individual complementation constructs were generated for the inner and outer 




(∆∆Transport ppnuT, ∆∆Transport pOMthi). Although we did not observe full 
complementation by either of the two constructs, they did significantly improve the EC50 
from 30.3 nM (CI95 22.8 – 40.3 nM) in the double transport mutant to 1.9 nM (CI95 0.8 – 
4.4 nM) and 0.1 nM (CI95 0 – 1.9 nM, Table 2.3) in the outer and inner membrane 
transport complement respectively (t-test, p < 0.0001; FIG 2.3D). In addition to single 
transport complements, a double transport complement (∆∆Transport ppnuT+OMthi) was 
made and tested to similar results as the single transport complements. The double 
complement allowed for better fitness at low levels of thiamine achieving >35% of 
wildtype growth at 0 nM added thiamine and greater than 80% of wildtypes growth at 10 
nM (FIG 2.5). It also significantly improved the ∆∆Transport mutants EC50 from 30.3 nM 
to 0.1 nM (CI95 0 – 0.2 nM, Table 2.3). While not uncommon, it is possible that the 
introduction of the complementation vectors in trans were not expressed at the same level 
as the wildtype or are missing key upstream elements preventing the strains from 
growing as well as the wildtype B. thetaiotaomicron. (FIG 2.3D). 
A final triple mutant of all three TPP regulated loci was generated (∆∆∆). This 
strain demonstrated a similar level of growth inhibition as compared to the double 
transport mutant (FIG 2.3D). It required 10 µM of thiamine in the medium to attain 100% 
wildtype growth (EC50 of 51.9 nM CI95 42.4 – 63.6 nM, Table 2.3). It is important to note 
that growth defects only affected the terminal density of the mutants and the doubling 
times remained fairly constant (~2 hrs). Together these data confirm the crucial role these 






Factors affecting the phenotype of the double transport mutant 
To determine if dysregulation of biosynthesis played a role in the severe growth 
phenotype of the double transport mutant RT-qPCR was performed.  Consistent with the 
RNAseq data (FIG 2.1), expression of the major biosynthetic operon in wildtype B. 
thetaiotaomicron is up regulated in thiamine deficient conditions (0 & 100 nM) as 
compared to replete (10,000 nM) (FIG 2.6A,B). In a thiamine-deficient environment 
genes thiC (FIG 2.6A) is 9.2-fold higher expressed in 0nM thiamine as compared to its 
expression in 10,000 nM and 3.3-fold higher as compared to its expression in 100 nM 
thiamine (FIG 2.6A). Similarly the expression of thiS is expressed 2.7-fold to 2-fold 
higher in 0 nM thiamine as compared to 10,000 nM and 100 nM respectively (FIG 2.6B). 
As noted above the ∆∆Transport mutant cannot be cultured in 0 nM thiamine, but thiC 
and thiS expression was determined in 100 and 10,000 nM thiamine. In marked contrast 
with the wildtype, thiC and thiS expression are repressed over 100-fold in media with 100 
nM or 10,000 nM thiamine. These data suggest that transport and biosynthesis are linked 
and likely contribute to the severe growth defect in the ∆∆Transport mutant despite the 
presence of an intact biosynthetic operon. 
In addition, we also performed RT-PCR on tnr3, which is encoded immediately 
downstream of pnuT, to ensure that the generation of the ∆∆Transport mutant did not 
have a polar effect (FIG 2.6C). The expression of tnr3 remains unchanged in wildtype 
and the ∆∆Transport mutant cells regardless of the thiamine concentration tested. Given 






Characterization of transport mutants in response to thiamine precursors 
In order to ascertain whether our transport mutant phenotypes were due to a 
disruption in transport of thiamine precursors instead of complete thiamine molecule. 
Apart from cysteine, none of the other immediate precursors or intermediates for 
thiamine biosynthesis are present in minimal medium. Cysteine is both the reducing 
agent and reduced sulfur source in the medium. Therefore, it is possible that these two 
genes do not transport thiamine, and instead is required for the acquisition of cysteine as 
a precursor to enable thiamine biosynthesis. We note that B. thetaiotaomicron encodes a 
putative alanine, serine, and cysteine transporter (BT1223) and the biosynthetic pathway 
for cysteine (cysE, cysK, cysM). Also, based on the RNAseq results, these cysteine-
associated genes are expressed in cells grown in minimal medium in the presence or 
absence of thiamine HCl. However, if OMthi and pnuT are involved in cysteine transport 
providing an alternative sulfur source to enable de novo biosynthesis of cysteine should 
reverse the apparent thiamine growth defect. Thus, the cysteine in the medium was 
replaced with sodium thioglycolate as a reducing agent and sodium sulfide as the sulfur 
source (FIG 2.4) (33). This change had no effect on the growth of wildtype and the single 
OMthi and pnuT mutants indicating that B. thetaiotaomicron can use sodium sulfide to 
biosynthesize cysteine. Moreover, thiamine dependent phenotypes of the double mutants 
were recapitulated when cysteine was replaced with sodium sulfide as the sulfur source. 
Together these data indicate that neither of the transporters is involved in cysteine 
transport.  
B. thetaiotaomicron thiamine acquisition mutants were also tested to determine if 




performed before thiazole, tyrosine, and GAP were supplemented in the media. Wildtype 
and the single transport mutants grew normally, exhibiting no growth improvement or 
impairment in the presence of these metabolites. In addition, in the absence of thiamine 
none of these metabolites rescued the growth of the double transport mutants at the 
concentrations tested (0 – 10 µM) (FIG 2.4). The failure to rescue the double transport 
mutant suggests B. thetaiotaomicron lacks the ability to import the precursors necessary 
to biosynthesize thiamine or that some other feedback mechanism exists between 
biosynthesis and transport. 
The responses of B. thetaiotaomicron mutants to the phosphorylated thiamine 
moieties were also evaluated for their ability to alter growth phenotypes. B. 
thetaiotaomicron mutants were supplemented with either thiamine monophosphate 
(TMP) or thiamine pyrophosphate (TPP) and grown as before (Table 2.3). Neither TMP, 
nor TPP rescued growth of the mutants to wildtype levels at a concentration below 1 µM, 
which is reflected in the EC50 values of each mutant increasing on either TMP or TPP. 
These data suggest that B. thetaiotaomicron, like other organisms that rely solely on pnuT 
type transporters (e.g. Acinetobacter baumannii and Pseudomonas putida) cannot 
transport phosphorylated thiamine moieties. It is likely that the poor growth is due to the 
presence of dephosphorylated thiamine impurities in commercial TPP and TMP 
preparations.  
 
Consequences of thiamine acquisition on competition 
We investigated the competitive capacities of the B. thetaiotaomicron thiamine 




determine if co-culture increased (competition) or decreased (cross-feeding) the 
individual phenotypes mixed cultures were serially passaged for five days in media with 
0, 10, 100, and 10,000 nM exogenous thiamine and strain abundances were monitored 
through time by qPCR (FIG 2.7, FIG 2.8). The single transport mutants (∆pnuT and 
∆OMthi) successfully coexisted with wildtype B. thetaiotaomicron in every condition 
tested (FIG 2.7A,B). The mutants maintained 60-80% of the population throughout the 
five days of serial passaging. Although the abundance of the mutants fluctuated during 
passaging this was likely due to stochastic effects during the daily inoculations (FIG 2.8). 
Together, these results extend the individual growth findings and show that cells lacking 
either the inner or outer membrane transporters are not at a disadvantage when grown in 
competition with the wildtype strain that encodes both fully intact transporters. 
In contrast, the ∆BioThi mutant was rapidly outcompeted in the absence of 
thiamine, falling to < 0.1% of the population by day five despite initially making up 90% 
of the population. As exogenous thiamine levels were increased the fitness defect was 
alleviated. At 10 nM thiamine, the wildtype dominated the competition by day five. 
However, the ∆BioThi only dropped to 44% of the population. As the concentrations of 
thiamine increased to 100 nM and 10,000 nM, the ∆BioThi mutant showed no fitness 
defect, maintaining ≥ 80% of the population throughout the competition (FIG 2.7C). 
Similarly, ∆∆BioThi-pnuT and ∆∆BioThi-OMthi are dramatically outcompeted in 0 nM 
and 10 nM of added thiamine, to the level that they are not even detectable. As thiamine 
is increased in concentration the abundance of the double biosynthesis and transporter 
mutants stabilize to ~55% of the population for the ∆∆BioThi-OMthi and ~66% of the 




and ∆∆∆ mutants were also interrogated for their competitive abilities. We observed 
severe phenotypes with both mutants in 0, 10, and 100 nM thiamine (FIG 2.7F,G). The 
mutants were rapidly outcompeted by the wildtype within the first three days and driven 
below the level of detection by day 5 (FIG 2.8). Only in 10,000 nM did the ∆∆Transport 
mutant and the ∆∆∆ mutant coexist with the wildtype; maintaining 40% and 80% 
respectively at day five. These results essentially mirror the individual growth data for the 
mutants, and suggest that wildtype B. thetaiotaomicron does not cooperate with or 
facilitate the growth of these mutants, indicating that B. thetaiotaomicron does not appear 
release thiamine to the environment under in vitro growth conditions. 
 
Quantification of cell-associated thiamine  
Intracellular concentrations of thiamine, TMP and TPP were measured after 
wildtype B. thetaiotaomicron cultures were grown in four different concentrations of 
thiamine (0, 10, 100, and 10,000 nM). In all the B. thetaiotaomicron cultures tested the 
cofactor form TPP is the predominant moiety, averaging between 100,000 and 250,000 
molecules per cell (FIG 2.9A) and constituting 70 – 87% of the total thiamine (FIG 
2.9B). Therefore, despite a 10,000x increase in the amount of exogenous thiamine, the 
internal concentration changes no more than 2.5-fold. As such, thiamine moieties appear 
to be maintained within some homeostatic range. However, as exogenous thiamine levels 
increase we did detected marginally significant increases in thiamine and TMP 
concentrations (FIG 2.9A). While TMP maintains 9 – 14% of the thiamine pool in spite 
of its increased concentrations, thiamine itself increases from ~2 to 16% of the total pool 




mechanisms, the same mechanisms responsible for the ability of the ∆∆Transport and 
∆∆∆ mutant to grow in 10,000 nM thiamine. As a result, this excess thiamine may 
impede or exceed the capacity of the thiamine pyrophosphorylase, Tnr3. 
 
Identification of thiamine acquisition genes in gut Bacteroidetes 
To expand upon the knowledge gained from our experiments in B. 
thetaiotaomicron we interrogated 641 genomes from 5 Phyla and 11 Classes of gut 
bacteria for the presence of thiamine-dependent enzymes. Every one of the 641 genomes 
encoded at least one thiamine-dependent enzyme (FIG 2.10A). We then determined the 
route by which these bacteria acquire thiamine by examining their genome’s ability to 
synthesize, transport, or recycle thiamine. Only 48% (307/641) genomes investigated 
have readily identifiable, complete thiamine biosynthesis pathways, implying that many 
gut microbes likely compete with one another and/or the host for this essential cofactor 
(FIG 2.10A). 
All of the gut Bacteroidetes genomes examined exhibit evidence of requiring 
thiamine (n=114). This includes encoding one or more putatively thiamine dependent 
enzymes (𝑥  = 13 ± 2 genes) or a thiamine binding riboswitch (𝑥  = 2 ± 1). As such, 
thiamine biosynthesis and transport genes occur in 94% (107/114) of gut associated 
Bacteroidetes (FIG 2.10B). A minority of sequenced Bacteroidetes from the gut encode 
biosynthesis (n=2) or transport (n=5) alone. 
Thiamine biosynthesis occurs in one of two configurations in gut associated 




which 4-amino-2-methyl-5-diphosphomethylpyrimidine (HMP-PP) is synthesized by 
ThiC and ThiD (Blue in FIG 2.10B,C) and 2-(2-carboxy-4-methylthiazol-5-yl)ethyl 
phosphate (cThz-P) is produced by ThiSFGH-TenI (Orange in FIG 2.10B,C) (15). These 
precursors are condensed into thiamine monophosphate by ThiE or YjbQ (Tan in FIG 
2.10B,C), which is then phosphorylated into the biologically active form of thiamine 
pyrophosphate by ThiL (Green in FIG 2.10B,C). A handful of gut associated 
Bacteroidetes have replaced the canonical cThz-P biosynthetic branch with a THI4-like 
thiazole synthase enzyme (Fuchsia in FIG 2.10B,C) (13/109; E.C. 2.8.1.10) (FIG 
2.10B,C). Regardless, in all 109 genomes encoding a major biosynthetic operon also 
encode a TPP riboswitch immediately upstream (28). 
None of the gut associated Bacteroidetes possess a recognizable thiamine ABC 
transport system similar to the characterized ThiQP-TbpA of Gram negative bacteria or 
YkoEDC of Gram positive bacteria (28, 41). Moreover, Bacteroidetes lack the ThiT 
thiamine transporter and the CytX and ThiW precursor transport proteins (28). Thus like 
B. thetaiotaomicron, the previously uncharacterized inner and outer membrane 
transporters (PnuT and OMthi) are widely conserved in gut Bacteroidetes with more than 
three quarters (91/114) of the genomes analyzed encoding both OMthi and pnuT (FIG 
2.10B). However, heterogeneity in the presence and genomic organization of these genes 
exists. While B. thetaiotaomicron encodes a split operon most genomes encode OMthi, 
pnuT, and tnr3 as a single operon and others have apparently lost some or all of these 
genes (e.g., B. coprocola). In most instances the TPP riboswitch is retained and 






Thiamine is an essential cofactor for all living organisms; as such its availability 
impacts human health as well as that of our microbiota. Here, we have identified 
substantial genetic diversity within and among gut bacterial phyla for acquiring thiamine 
suggesting diverse strategies are employed leading to opportunities for cooperation 
and/or competition (FIG 2.10A). Among the Bacteroidetes a ubiquitous and abundant gut 
phylum responsible for carbohydrate fermentation, fatty acid production, and immune 
function (17, 44), we identified three distinct strategies for thiamine acquisition: 
biosynthesis and transport, biosynthesis alone, and transport alone. We analyzed the 
expression profiles, dissected the genetics, and the competitive advantages of these 
strategies in B. thetaiotaomicron demonstrating the importance of both thiamine 
biosynthesis and transport. 
Our results demonstrate that the biosynthesis of thiamine is essential for growth 
and competition of B. thetaiotaomicron in environments with limited thiamine 
availability. Like many Bacteroidetes, B. thetaiotaomicron encodes a major biosynthetic 
gene operon (BioThi: BT0653-BT0647), which includes essential enzymes for both 
HMP-PP and cThz-P production and condensation (FIG 2.10B, FIG 2.1A). Our genome-
wide expression profiling identified evidence of thiamine-dependent regulation of this 
locus that we attribute to the TPP binding riboswitch preceding this operon. This 
expression response is consistent with re-analysis of microarray data from B. 
thetaiotaomicron grown both in vitro and in vivo under thiamine variable conditions (FIG 
2.2) (33). Subsequent deletion of the entire biosynthetic operon in B. thetaiotaomicron 




nM of thiamine. Both the genetic organization of the locus and a similar growth defect of 
a thiC deletion mutant are seen in S. enterica (25). Moreover, the defect in B. 
thetaiotaomicron, which can be complemented by restoring the entire biosynthetic 
operon in trans, is recapitulated during co-culture with wildtype cells. Competitions 
result in the ∆BioThi mutant being outcompeted by the wildtype cells during a multi-day 
co-culture experiment in low or no thiamine concentrations. We note that thiamine 
availability in the gut is expected to fluctuate due to factors including host genetics, diet, 
and intestinal adsorption. Measurements of thiamine in the intestinal lumen range 
between 20 – 2,000 nM (29). As such, a gut microbe’s ability to synthesize its own 
thiamine is likely most important during transient drops in thiamine availability to enable 
the microbe's own growth. We predict that gut microbes that we’ve identified that are 
wholly dependent on thiamine transport such as members of the genus Alistipes and 
many members of the Bacilli (FIG 2.10), to be adversely affected during such drops in 
thiamine availability. 
Our global transcriptomic analysis revealed differential responses of thiamine 
acquisition operons to exogenous thiamine. In conditions of excess thiamine, we’ve 
shown that B. thetaiotaomicron down-regulates the BioThi operon. However, we found 
that transcripts for the putative inner (pnuT) and outer membrane (OMthi) transporter 
genes adjacent to TPP binding riboswitches show minimal expression differences (FIG 
2.1A). These proteins were previously predicted to function in thiamine transport (28) 
and PnuT was recently shown to transport thiamine in a heterologous host (18). 
Curiously, individual deletions of these transporters have no effect on the growth of 




transport genes in tandem yielded a severe growth defect (FIG 2.3). After ruling out an 
additional role of these transporters for importing a critical precursor (FIG 2.4), we 
speculate that they may play a role in thiamine recycling or that there is an 
uncharacterized connection between biosynthesis and transport of thiamine. When we 
measured expression of the BioThi operon in the double transport mutant using RT-qPCR 
we found expression levels of thiC and thiS were down regulated (FIG 2.6A,B). This 
raises the possibility that an unknown protein regulatory mechanism may be dysregulated 
and repressing biosynthesis in the ∆∆Transport mutant. Regardless, further investigations 
are warranted to disentangle thiamine biosynthesis, transport, and their interconnected 
pathways. 
The dual transport and biosynthesis pathways appear to facilitate the ability of 
wildtype B. thetaiotaomicron to maintain a fairly stable intracellular concentration of the 
cofactor TPP (< 3-fold variation) despite radical changes in extracellular thiamine 
concentrations. However, these increases in intracellular concentrations of the thiamine 
moieties are sufficient to lead to the down-regulation of the BioThi operon in addition to 
a suite of thiamine-dependent pathways including amino acid metabolism and nucleotide 
biosynthesis. It is possible that the increased proportion of thiamine to TPP may provide 
a signal sensed by unknown regulatory mechanisms, outside of the regulatory 
riboswitches that control biosynthesis and transport genes. These additional regulatory 
factors are likely important for modulating responses to the stress of variable levels of 
exogenous thiamine.  
We observed that competitions between B. thetaiotaomicron and thiamine 




FIG 2.7) suggesting that B. thetaiotaomicron does not release thiamine into the 
environment. Confirming this hypothesis, no thiamine was detected in the supernatant of 
spent cultures of B. thetaiotaomicron grown in thiamine free medium.   This is not in line 
with previously published data in which thiamine was still detectable in the feces of a 
select group of humans were that were completely thiamine starved (21). It was inferred 
that the thiamine detectable in these patients was derived from their microbial 
communities (21). This leads us to speculate that other gut microbes including divergent 
Bacteroidetes or Proteobacteria release thiamine, as they are the most prevalent thiamine 
synthesizers. Alternatively, host-driven cell lysis (40), microbe-microbe antagonism 
and/or intoxication (43), or some gut-specific signal results in the liberation of this 
essential cofactor. 
As an essential small molecule, thiamine appears to have an important role in the 
persistence of microbes in the gut. Given the universal requirement for this cofactor and 
the diverse strategies for acquisition results in scenarios that would force competition or 
cooperation among gut microbes. Among B. thetaiotaomicron mutants encoding a single 
acquisition strategy we have observed competitive defects, similar to what has been seen 
for B12 transport (4). However, more complex communities may be crucial to enabling 
cooperation, thus modeling the dynamics of thiamine in natural or reconstructed gut 
communities will be a way forward to understand these dynamics. It thus remains 
possible that cofactors such as thiamine may be utilized to manipulate gut communities. 
Ultimately such manipulation may play a role in the combating of disease such as 






Bacterial culturing and genetic manipulation 
Routine culturing of B. thetaiotaomicron VPI-5482 occurred anaerobically at 
37°C in liquid tryptone yeast extract glucose (TYG) medium (11) or Difco brain heart 
infusion (BHI) agar with the addition of 10% defibrinated horse blood (QuadFive, 
Ryegate, MT, USA). Cultures were grown anaerobically within a vinyl anaerobic 
chamber with an input gas mix consisting of 70% nitrogen, 20% carbon dioxide, and 10% 
hydrogen (Coy Laboratory Products, Grass Lake, MI, USA). Escherichia coli S17-1 λ pir 
strains used for cloning and conjugation of suicide vectors were grown in LB medium at 
37°C aerobically. Antibiotics were added to the medium when appropriate in the 
concentrations as follows: ampicillin 100 µg/mL, gentamicin 200 µg/mL, erythromycin 
25 µg/mL, tetracycline 2 µg/mL, and 5-fluoro-2’-deoxyuridine (FUdR) 200 µg/mL. 
Markerless deletions were generated via allelic exchange and confirmed by PCR 
(4, 16). Briefly, HiFi Taq MasterMix (KAPA Biosystems, Wilmington, MA, USA) was 
used to amplify right and left flanks of thiamine associated loci by PCR, which were then 
combined using splicing by overlap extension (SOE) PCR. Purified SOE products were 
restriction digested and cloned into pExchange_tdk vector using standard methods (30). 
Sequence confirmed vectors were then conjugated from donor E. coli S17-1 λ pir strains 
into recipient B. thetaiotaomicron strains. Transconjugants were colony purified and 
screened for successful mutants by PCR (Table 2.2). Complementation and barcoded 
vectors were all constructed in pNBU2 vectors and were introduced into the genome in a 




same methods as pExchange_tdk vectors. A complete list of primers and vectors used for 
this study are provided (Table 2.4). 
 
Thiamine transcriptomic response 
A modified minimal medium was use for all thiamine growth assays (after Varel 
and Bryant (39), Scholle et al. (31)). The modified minimal medium consisted of glucose 
(27.8 mM), ammonium chloride (6. 0 mM), L-cysteine free-base (4.1 mM), sodium 
carbonate (3.8 mM), iron sulfate (0.3 mM), vitamin B12 (5.8 µM), a histidine-hematin 
solution (0.1% of 1.9 mM hematin in 0.2 M histidine), 1 M potassium phosphate buffer at 
a pH of 7.2 (2%), and a premixed mineral solution (5%). The mineral solution consisted 
of 3 M sodium chloride, 3.6 mM of calcium chloride dehydrate, 1.6 mM of magnesium 
sulfate, 1 mM of manganese chloride tetrahydrate, and 84.1 µM of cobalt chloride 
hexahydrate. Replicate cultures of wildtype B. thetaiotaomicron were grown overnight in 
5 mL minimal medium supplemented with 10,000 nM thiamine HCl (THI, > 99% pure) 
(Sigma Aldrich, St. Louis, MO, USA). Aliquots of each culture were pelleted by 
centrifugation (1 min at 13,300 x g), culture supernatants were decanted and the cells 
were washed 4 times in minimal medium with 0 nM thiamine. Cells were inoculated into 
10 mL of minimal medium with either 0 or 15 µM thiamine HCl at a final dilution of 
1:2,000 in biological duplicate. Cell growth was monitored and cells were harvested 
between OD600 0.4 and 0.6 on a UV spectrometer. Total RNA was extracted using the 
Qiagen RNeasy kit and stored at -80°C. Total RNA was DNAse treated with DNase I 
(Thermo Fisher, Waltham, MA, USA) and NEB DNase treatment protocol. DNAse 




quantitated using a Qubit 2.0 (Life Technologies, Carlsbad, CA, USA) and stored at -
80°C. 
RNA was submitted for integrity analysis, ribosomal RNA depletion, and library 
construction at the W.M. Keck Center for Comparative and Functional Genomics at the 
University of Illinois at Urbana-Champaign. 
For targeted gene expression analysis, total RNA was purified as above and used 
to generate cDNA libraries using the first strand cDNA synthesis kit (Thermo Fisher, 
Waltham, MA, USA). RT-qPCR was performed on a Biorad CFX connect instrument 
(Biorad, Hercules, CA, USA) and SYBR Fast MasterMix 2x Universal (Kapa 
Biosystems, Wilmington, MA, USA) following the manufacturer’s instructions for 
triplicate biological samples in technical triplicate. Four genes were amplified 16 
ribosomal RNA, thiC, thiS and tnr3. 16S rRNA primers were used as the control gene (4) 
and novel primers for thiC, thiS and tnr3 were designed using Primer3 (38). Standard 
curves were used to evaluate the efficiency of the amplification; all 4 genes had R2 ≥ 
0.985 and slope between -3.33 and -3.40. Relative expression changes were calculated 
using the ∆∆Cq method (2). 
 
RNA sequencing analysis 
RNAseq reads from each sample were quality filtered using a custom R script and 
fastx_clipper (http://hannonlab.cshl.edu/fastx_toolkit/index.html). Filtered RNAseq data 
were analyzed using the Rockhopper program (35) to identify differentially expressed 




thetaiotaomicron VPI-5482 genome and significantly differentially expressed genes were 
identified (≥ 2-fold change and q value ≤ 0.05). 
 
Re-analysis of microarray data 
To test for evidence of transcriptional changes in response to thiamine availability 
we re-analyzed existing microarray data from B. thetaiotaomicron growing both in vitro 
and in vivo (33). Briefly, microarrays had been hybridized with total RNA recovered 
from wildtype B. thetaiotaomicron grown to mid-log phase in biological duplicate in 
minimal medium with no thiamine added (8 h), in TYG that has excess thiamine (3.5 h) 
or from the ceca of two monoassociated gnotobiotic NMRI mice (GSE2231) (33). Raw 
GeneChip data were normalized and model-based expression values (PM-MM model) 
were compared using DNA-Chip Analyzer (v2011.05) as described (33). Mean and 
standard deviations of the normalized expression values were calculated and significantly 
differentially regulated genes were detected with t-test, p < 0.05 using FDR correction. 
 
Assaying thiamine dependent growth phenotypes 
B. thetaiotaomicron wildtype, mutant, and complemented strains were grown and 
washed in minimal medium 0 µM thiamine as above for RNAseq. Cells were normalized, 
diluted to 0.0004 OD600 and dispensed into 96 well plates with thiamine HCl, thiamine 
monophosphate HCl (TMP, > 95% pure) (Sigma Aldrich, St. Louis, MO, USA), and 
thiamine pyrophosphate chloride (TPP, > 98%) (Thermo Fisher Scientific, Waltham, 
MA, USA) at concentrations ranging from 0-10,000 nM (modified from Degnan et al. 




Multi-Mode Microplate Reader in conjunction with a BioStack3 microplate stacker 
(BioTek, Winooski, VT, USA). All phenotypic assays were averaged from three to nine 
biological replicates with three technical replicates each. All phenotypes were calculated 
as a percentage of WT growth achieved in minimal medium + 10,000 nM THI at 17.5 
hours. Pairwise student t-tests were carried out using GraphPad Prism v6 and p values ≤ 
0.05 were considered significant.  
 
In vitro competition assays 
Cells were grown for 16 hours in minimal medium supplemented with 10,000 nM 
Thiamine HCl. Cells were pelleted and washed 4 times with minimal medium. Cell 
OD600 were normalized to 0.01. Cells were inoculated 1:100 into an Axygen deep-well 
plate (Corning Inc., Corning, NY, USA) in biological triplicate for each mutant at 4 
different concentrations (0, 10, 100, and 10,000 nM) of thiamine HCl in minimal 
medium. Cultures were incubated anaerobically at 37°C for 24 hours and passaged 
1:1,000 into the same media type they were previously grown in (4, 20). Time points 
were taken for 4-5 days and saved in media +20% glycerol at -80°C. Samples were 
prepped for genomic DNA (gDNA) using the HotShot method (36) and relative 
abundance of each barcoded strain was determined using qPCR in reference to a standard 
curve on a Biorad CFX connect instrument (Biorad, Hercules, CA, USA) and SYBR Fast 
MasterMix 2x Universal (Kapa Biosystems, Wilmington, MA, USA) (4). Data were 






Quantification of thiamine in B. thetaiotaomicron and medium 
B. thetaiotaomicron was grown in either 0 nM, 10 nM, 100 nM, or 10,000 nM of 
thiamine HCl were grown to mid log (OD600 ~0.5). Cells were pelleted at 10,000-x g for 
2 minutes. Cells were washed three times with PBS buffer. Cells and media aliquots were 
submitted to the Roy J. Carver Biotechnology Center’s Metabolomics Center at the 
University of Illinois at Urbana-Champaign for quantification of thiamine, thiamine 
monophosphate, and thiamine diphosphate. Samples were analyzed with the 5500 
QTRAP LC/MS/MS system (Sciex, Framingham, MA, USA). Software Analyst 1.6.2 
was used for data acquisition and analysis. The 1200 series HPLC system (Agilent 
Technologies, Santa Clara, CA, USA) includes a degasser, an autosampler, and a binary 
pump. The LC separation was performed on a Phenomenex Polar column (4.6 x 100 mm, 
4 µm) with mobile phase A (0.1% formic acid in water) and mobile phase B (0.1% 
formic acid in acetonitrile). The flow rate was 0.4 mL/min. The linear gradient was as 
follows: 0-3 min, 95%A; 6-9 min, 0%A; 10-15 min, 95%A. The autosampler was set at 
10°C. The injection volume was 100 µL. Mass spectra were acquired under positive 
electrospray ionization (ESI) with the ion spray voltage of +5000 V. The source 
temperature was 450°C. The curtain gas, ion source gas 1, and ion source gas 2 were 33, 
50, and 65, respectively. Multiple reaction monitoring (MRM) was used for quantitation: 
thiamine m/z 265.0 m/z 122.0; thiamine monophosphate m/z 345.1 m/z 122.0; and 







Computational prediction of thiamine-associated genes 
Thiamine biosynthesis, transport, and dependent genes were identified searching 
for gene specific TIGRFAM (32) when available or PFAM (7) hidden Markov models 
with HMMR (--tc_cut) (Table 2.5) in 641 gut bacteria including 114 Bacteroidetes 
genomes available in RefSeq from the Human Microbiome Project (Table 2.6) (24, 26). 
Predicted annotations were confirmed with BLAST and PFAM hidden Markov models 
(7, 1). Homologs of B. thetaiotaomicron VPI-5482 loci were confirmed and compared 
among the other 113 Bacteroidetes genomes using a reciprocal best BLAST approach. In 
addition, Infernal 2.0 was used to detect putative TPP riboswitches adjacent to thiamine-
associated genes (RF00059) (9, 22). The presence or absence of biosynthetic and 
transporter genes were used to categorize the route of thiamine acquisition. Microbes 
capable of complete ‘biosynthesis’ have the ability to synthesize both HMP-PP (thiC or 
thi5 and thiD), cThz-P (thiGH or thi4 in addition to tenI), possesses thiamine 
condensation genes (thiE and/or yjbQ), and a thiamine kinase. Microbes categorized as 
capable of ‘recycling’ lack the ability to completely synthesize either thiazole and/or 
HMP-PP de novo, but retain the thiamine kinase enzymes. Microbes were categorized as 
capable of ‘transport’ if any gene predicted to transport thiamine was identified. Finally, 
microbes were categorized as ‘incomplete/uncertain’ if we were unable to identify any 
thiamine transporters and/or sufficient genes to carry out thiamine biosynthesis or 
recycling. Additionally, using an identical approach as described in Degnan et al. (4) a set 
of 13 core genes conserved among all three domains of life were identified in the 641 gut 
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FIG 2.1. Transcriptomic response of B. thetaiotaomicron to exogenous thiamine 
(A) Schematic of TPP riboswitch regulated operons is shown with expression fold 
changes indicated and colored according to the heat map. Asterisks (*) indicate 
individual genes that are significantly down regulated (q value ≤ 0.05) in the presence of 
thiamine. (B) Genome-wide expression response of B. thetaiotaomicron to thiamine. 
Gray circles indicate genes that are not significantly up- or down-regulated, red circles 
are genes that are significantly down regulated in the presence of thiamine and green 
circle are significantly up regulated (q value ≤ 0.05). (C) KEGG gene clusters that 
contain genes that are significantly down regulated. Numbers to the right of each KEGG 
pathway denote the number of genes down regulated in each category. Underlined 
categories indicate KEGG pathways that are significantly down regulated through GSEA 






FIG 2.2. Microarray data of thiamine biosynthesis and transport genes 
Expression of B. thetaiotaomicron genes involved in thiamine biosynthesis and transport 
during growth with known or assumed thiamine availability. Asterisks and brackets 
indicated significant expression differences between samples (FDR corrected t-test, p < 






FIG 2.3. Growth phenotypes of B. thetaiotaomicron thiamine acquisition mutant 
Thiamine acquisition operons have differential effects on the ability of B. 
thetaiotaomicron to grow in thiamine limiting conditions. (A) A representative growth 
curve of wildtype and ∆BioThi showing growth defects of ∆BioThi in a thiamine 
deficient environment (0 nM) and a thiamine replete environment (10,000 nM). Arrow 
indicates maximal growth point at ~17.5 hrs. used to calculate percent growth of WT in 
minimal medium supplemented with 10,000 nM thiamine to compare growth phenotypes 
across concentrations of thiamine in panels B-D. (B) Single mutants of the outer 
membrane transporter (∆OMthi), and inner membrane transporter (∆pnuT) loci showed 
no defect, while ∆BioThi strains were variably attenuated in thiamine concentrations less 
than 100 nM and a complement of ∆BioThi with the entire loci with the native promoter 




FIG 2.3. (cont.) 
(∆BioThi) and a single transport gene (pnuT or OMthi) have severe growth phenotypes 
below 100 nM thiamine, but can complemented with the biosynthesis locus under its 
native promoter to wildtype or near wildtype levels. (D) The double transport mutant 
(∆∆Transport) and triple locus mutant (∆∆∆) were both highly attenuated in thiamine 
concentrations less than 1,000 nM. Complement of single transporters in the ∆∆Transport 





FIG 2.4. Putative B. thetaiotaomicron thiamine transporters are specific for 
thiamine 
The specificity of the thiamine dependent phenotypes of the thiamine acquisition mutants 
were tested using media supplemented with thiamine precursors. To disentangle 
cysteine’s role as a sulfur source and reducing agent, growth analyses were carried out 
with medium supplemented (A) cysteine and thioglycolate or (B) Na2S and thioglycolate. 




FIG 2.4. (cont.) 
(E) Thiazole were also analyzed to determine if they could rescue thiamine growth 
phenotypes. In all panels thiamine was either at (+) 10,000 nM or (-) 0 nM in the and 





FIG 2.5. Growth phenotype of ∆∆Transport double transport Complement 
∆∆Transport mutant was complemented with both the inner (pnuT) and the outer 
membrane transporter (OMthi) under the natural promoter of pnuT and expressed at a 
non-native locus in the ∆∆Transport mutant. The double complement allows for a marked 
improvement in growth at low nanomolar concentrations of thiamine and partially 































FIG 2.6. (cont.) 
Expression of biosynthesis was quantitated via RT-qPCR of (A) thiC and (B) thiS in both 
wildtype and double transport mutant backgrounds of B. thetaiotaomicron at 0, 100, and 
10,000 nM concentrations of thiamine for wildtype and 100 and 10,000 nM 
concentrations of thiamine for the double transport mutant. Expression of tnr3 was also 
measured in wildtype and double transport mutant at 0 and 10,000 nM thiamine (C) in 
order to ensure that the double transport mutant did not have a polar effect on 
downstream gene. N.G. means No Growth was achieved to carry out the experiment. 
































FIG 2.7. Single competitions between wildtype and thiamine acquisition mutants 
Competitions between wildtype B. thetaiotaomicron and thiamine acquisition mutants 
(A) ∆OMthi, (B) ∆pnuT, (C), ∆BioThi, (D) ∆∆BioThi-OMthi, (E) ∆∆BioThi-pnuT, (E) 






FIG 2.7. (cont.) 
Strain abundances were quantified by qPCR and represented as a percentage of the entire 
community at 4 concentrations of thiamine (0, 10, 100, and 10,000 nM).  Error bars 












FIG 2.8. (cont.) 
Abundance of wildtype (WT) and thiamine acquisition mutants during multiday 
competitions was tracked using qPCR. Wildtype B. thetaiotaomicron was competed 
against (A) ∆BioThi, (B) ∆pnuT, (C) ∆OMthi, (D) ∆∆Transport, (E) ∆∆∆ mutants, (F) 
∆∆BioThi-OMthi, and (G) ∆∆BioThi-pnuT in 0 nM, 10 nM, 100 nM, and 10,000 nM 
thiamine. All competitions were performed in biological triplicate and error bars 






FIG 2.9. Quantification of thiamine pools in B. thetaiotaomicron  
 
 (A) Intercellular quantification of thiamine and its phosphorylated moieties indicate that 
total quantities of thiamine, TMP, and TPP increase to varying degrees as exogenous 
thiamine is increased. Values represent the average and standard error of the mean for six 
biological replicates. Letters for individual moieties indicate groups that are not 
significantly different from each other (p value ≤ 0.05, Tukey’s HSD test). (B) The 
proportions of thiamine and TMP increase as the concentration of exogenous thiamine 
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FIG 2.10. (cont.) 
 (A) Schematic phylogeny of 11 classes of cultivable gut associated bacteria and 
corresponding pie charts indicating the proportion of genomes that encodes a thiamine 
dependent enzyme and predicted thiamine acquisition strategies. Parentheses represent 
number of genome sequences in each class. (B) Presence and absence of predicted 
thiamine biosynthesis and transport genes in diverse gut Bacteroidetes are indicated. The 
phylogeny represents a maximum likelihood reconstruction gut Bacteroidetes species. 
Numbers in parentheses represent the number of individual strains analyzed and nodes 
marked with black circles indicate bootstrap values ≥ 75. The asterisk (*) indicates that 
one of the five B. uniformis genomes analyzed is missing pnuT and tnr3, but this may be 
an assembly artifact. (C) Schematic representation of thiamine biosynthesis in the 
Bacteroidetes. Arrow colors correspond to the key in (B). Gene names in grey are 








Table 2.1. Samples used for RNA sequencing 
 
  
Table S1. Samples used for RNA sequencing experiment.
Media/Replicate/Description Intial file name Raw Reads
Quality Filtered 
Reads % filtered
Reads Mapped to 
NC_004663 % mapped
Bt Minimal Media Replicate #1 8_4_GACGACAT_L002_R1_001.fastq 9,170,438 8,231,596               90% 7,712,374               94%
Bt Minimal Media Replicate #2 9_4_TACAGCAT_L002_R1_001.fastq 8,258,740 7,454,637               90% 6,830,124               92%
Bt Minimal Media plus 15 µM Thiamine Replicate #1 8_4T_TCGAAGAT_L002_R1_001.fastq 9,017,267 8,169,029               91% 7,783,046               95%




Table 2.2. Deletion loci and complements generated in this study 
 
Description 
   
 WT 
'wildtype' deletion background, ∆BT2275, FUDRR, 
intact thiamine biosynthetic and transport operons 
(Martens et al. 2008) 
Deletion mutants 
 
 ∆BioThi deletion of thiamine biosynthetic operon thiSEGCHF-tenI, BT0647-0653 (797,661 - 803,616) 
 ∆OMthi 
deletion of putative outer membrane, TonB-
dependent thiamine transporter BT2390 (2,977,834 - 
2,980,058) 
 ∆pnuT deletion of putative inner membrane thiamine transporter BT2396 (2,992,218 - 2,992,778) 
 
∆∆BioThi-OMthi deletion of BT0647-0653 and BT2390 
 
∆∆BioThi-pnuT deletion of BT0647-0653 and BT2396 
 
∆∆Transport deletion of BT2390 and BT2396 
 
∆∆∆ deletion of BT0647-0653, BT2390, and BT2396 




ΔBioThi + pBioThi BT0647-0653 complemented in trans 
 
ΔΔBioThi-OMthi +pBioThi BT0647-0653 complemented in trans 
 
ΔΔBioThi-pnuT + pBioThi BT0647-0653 complemented in trans 
 
ΔΔTransport + pOMthi BT2390 complemented in trans 





Table 2.3. Effective concentrations for 50% WT growth represented in nM of thiamine 
required 
  
Table S2. Effective concentrations for 50% WT growth represented in nM of thiamine required.
Strain
WT 0.0 - 0.0 - 0.0 -
ΔBioThi 2.8 (1.4 -  5.5) 89.7 (47.5 - 169.3) 108.9 (Wide)
ΔBioThi pBioThi 0.0 - n.t. - n.t. -
∆pnuT 0.0 - 0.0 - 0.0 -
∆Omthi 0.0 - 0.0 - 0.0 -
ΔΔBioThi-OMthi 15.8 (8.1 - 31) 91.6 (51.4 - 163) 139.9 (Wide)
ΔΔBioThi-OMthi pBioThi 0.0 - n.t. - n.t. -
ΔΔBioThi-pnuT  10.9 (9.2 - 13) 39.8 (27.4 - 58) 135.3 (90.1 - 203.5)
ΔΔBioThi-pnuT pBioThi 0.0 - n.t. - n.t. -
ΔΔTransport 30.3 (22.8 - 40.3) 141.2 (101.7 - 196.3) 221.4 (140.4 - 349.3)
ΔΔTransport pOMthi 1.9 (0.8 - 4.4) n.t. - n.t. -
ΔΔTransport ppnuT 0.1 (0 - 1.9) n.t. - n.t. -
ΔΔTransport ppnuT+Omthi 0.1 (0 - 0.2) n.t. - n.t. -
ΔΔΔ 51.9 (42.4  - 63.6) 103.9 (Wide) 566.3 (282.5 - 1135)
1n.t. = not tested, - = indeterminate, "Wide" = too broad to calculate





Table 2.4. Primers, vectors, and strains 
 
  
Table S3. Primers, vectors, and strains used in this study.
Primer, Plasmid, or Strain name Oligonucleotide sequence (5'-3')/Notes1 Citation
Locus of Primer in Bt genome 
(NC_004663)
SOE Primers
ZC129 / 5' RF BT0647-0653 XbaI atcggTCTAGAggtgcctttctttcaggcatatcgg This study 804720 - 804744
ZC130 / 3' LF BT0647-0653 BamHI gaacgGGATCCccgggtatcgctgttaaactgaacg This study 796651 - 796675
ZC131 / 5' LF BT0647-0653 SOE  cgctctttgtatttactttcaacttattaatactgataggacaatgtaagaaatatcgattcgaatattatatacaatcataaataaagaaaccgctg This study 803617 - 803662 / 797607 - 797660
ZC132 / 3' RF BT0647-0653 SOE  cagcggtttctttatttatgattgtatataatattcgaatcgatatttcttacattgtcctatcagtattaataagttgaaagtaaatacaaagagcg This study 797607 - 797660 / 803617 - 803662
ZC133 / 3' LF BT2390 BamHI tcaccGGATCCccccagtaatctgccgtattcacc This study 2976784 - 2976808
ZC134 / 3' LF BT2390 SOE ggcggcttctgtcttatctgtttgaatggttattgttacatcttgcttattaattagttctctacgc This study 2980059 - 2980097 / 2977805 - 2977833
ZC135 / 5' RF BT2390 SOE gcgtagagaactaattaataagcaagatgtaacaataaccattcaaacagataagacagaagccgcc This study 2977805 - 2977833 / 2980059 - 2980097
ZC136 / 3' RF BT2390 XbaI gatccTCTAGAgggggaatatgaaatggtacctgatcc This study 2980996 - 2981022
ZC137 / 5' LF BT2396 BamHI tcacgGGATCCgctacagtaacgaagaagtgaaaacttatttcacg This study 2991224 - 2991258
ZC138 / 3' LF BT2396 SOE gacggcttggggtatatagtgttcgtttatcatcatttccatatttgcttatttattcgttctctacgc This study 2992779 - 2992810 / 2992188 - 1992217
ZC139 / 5' RF BT2396 SOE gcgtagagaacgaataaataagcaaatatggaaatgatgataaacgaacactatataccccaagccgtc This study 2992188 - 1992217 / 2992779 - 2992810
ZC140 / 3' RF BT2396 XbaI aacgcTCTAGAgcatctttaagctctgcacgtaaacgc This study 2993749 - 2993775
Complementation Primers
Bio_F_Nat_NdeI tcgcCATATGcggataatttgatgaatctttgtttctttttcgc This study 803790 - 803823
Bio_R_XbaI aatgTCTAGAttagtccgccaatttctttaactttttgaaatg This study 797658 - 797690
OMthi_F2_BamHI cgtcGGATCCatgaaaaaaatgatgatgatggccgtc This study 2977831 - 2977857
OMthi_R2_PstI ggccCTGCAGttaaaagcggaaagagacatggcc This study 2980039 - 2980062
pnuT_F2_BamHI tacgGGATCCatggaaatgaattatctggagatattcggtacg This study 2992215 - 2992247
pnuT_R2_PstI gtagCTGCAGtcattgcatgttcattatttttttccatttgaagtag This study 2992745 - 2992781
qPCR Primers
ThiC_F gagcagctccgatggcagag This study 800577 - 800596
ThiC_R ggtccgggacacgtaccg This study 800710 - 800727
thiS_F ccattcggaacgtggaatca This study 803482 - 803501
thiS_R cctgcttctacccttacacaac This study 803559 - 803580
tnr3_F tgccaacggtgaatatcctg This study 2992816 - 2992835
tnr3_R gtctccatcgcctataatcacg This study 1882933 - 2992954
Competition Primers
NBU2_att1_F cctttgcaccgctttcaacg Martens et al. 2008 6138201 - 6138220
NBU2_att1_R tcaactaaacatgagatactagc Martens et al. 2009 6139105 - 6129127
NBU2_att2_F tatcctattctttagagcgcac Martens et al. 2010 6216940 - 6216961
NBU2_att2_R ggtgtacctggcattgaagg Martens et al. 2011 6217369 - 6217288
UNIVR cacaatatgagcaacaaggaatcc Martens et al. 2008
BC03F ttatgaccagccgcaaatgaaaag This study
BC04F ctccataaaggcgcataccgacta Degnan et al. 2014
BC06F gattacggcgtgatagattggtgt Degnan et al. 2014
BC08F cttcctgcccggctaaaaacacga Degnan et al. 2014
BC09F tcaaatccggggactgggcttaga This study
BC21F atgttcgatcatcagttcagtagc This study
SOE Plasmids










pNBU2_tet Plasmid integrates at NBU2 att1 and/or att2 sites, TetR, AmpR Martens et al. 2008
pNBU2_tet_BC03 Martens et al. 2008
pNBU2_tet_BC04 Martens et al. 2008
pNBU2_tet_BC06 Martens et al. 2008
pNBU2_tet_BC08 Martens et al. 2008
pNBU2_tet_BC09 Martens et al. 2008
pNBU2_tet_BC21 This Study
Parental Strains
E. coli S17-1 λ pir thi pro hdsR hdsM+ recA, chromosomal insertion of RP4-2(Tc::Mu Km::Tn7) , AmpS Simon et al. 1983
Bt VPI-5482 ∆tdk 'wildtype' deletion background, BT2275–, FUDRR Koropatkin et al. 2008
Deletion Strains
Bt VPI-5482 ∆tdk ∆BioThi ∆BioThi  :  deletion of BT0647-0653 This Study
Bt VPI-5482 ∆tdk ∆OMthi ∆OMthi : deletion of BT2390 This Study
Bt VPI-5482 ∆tdk ∆pnuT ∆pnuT : deletion of BT2396 This Study
Bt VPI-5482 ∆tdk ∆∆BioThi-OMthi ∆∆BioThi-OMthi : deletion of BT0647-0653 in tandem with BT2390 This Study
Bt VPI-5482 ∆tdk ∆∆BioThi-pnuT ∆∆BioThi-pnuT : deletion of BT0647-0653 in tandem with BT2396 This Study
Bt VPI-5482 ∆tdk ∆∆Transport ∆∆Transport : deletion of BT2390 in tandem with BT2396 This Study
Bt VPI-5482 ∆tdk ∆∆∆ ∆∆∆: deletion of BT0647-0653, BT2390, and BT2396 This Study
Complemented Strains
Bt VPI-5482 ∆tdk ∆BioThi att2::pNBU2_erm_NatP_BioThi This Study
Bt VPI-5482 ∆tdk ∆∆BioThi-Omthi att2::pNBU2_erm_NatP_BioThi This Study
Bt VPI-5482 ∆tdk ∆∆BioThi-pnuT att2::pNBU2_erm_NatP_BioThi This Study
Bt VPI-5482 ∆tdk ∆∆Transport att2::pNBU2_erm_NatP_Omthi This Study
Bt VPI-5482 ∆tdk ∆∆Transport att2::pNBU2_erm_NatP_pnuT This Study
Barcoded Competition Strains
Bt VPI-5482 ∆tdk att2::pNBU2_tet_BC03 This Study
Bt VPI-5482 ∆tdk ∆BioThi att2::pNBU2_tet_BC04 This Study
Bt VPI-5482 ∆tdk ∆Omthi  att2::pNBU2_tet_BC06 This Study
Bt VPI-5482 ∆tdk ∆pnuT att2::pNBU2_tet_BC08 This Study
Bt VPI-5482 ∆tdk ∆∆Transport att2::pNBU2_tet_BC09 This Study
Bt VPI-5482 ∆tdk ∆∆∆ att2::pNBU2_tet_BC21 This Study











Table S4. Search queries used to identify thiamine-dependent and thiamine acquisition genes
HMM Description Gene EC Number
Biosynthesis
PF09084 4-amino-5-hydroxymethyl-2-methylpyrimidine phosphate synthase THI5
TIGR00190 Hydroxylmethyl pryimidine synthase ThiC 4.1.99.17
TIGR00097 Hydroxylmethyl pyrimidine (phosphate) kinase ThiD 2.7.4.7
TIGR02352 Glycine oxidase ThiO 1.4.3.19
TIGR02351 Thiazole synthase ThiH 4.1.99.19
TIGR02006 Cysteine desulfurase IscS 2.8.1.7
TIGR01979 Cysteine desulfurase SufS 2.8.1.7
TIGR01683 Sulfur carrier protein ThiS
TIGR02354, 
TIGR02356 Adenyltransferase ThiF 2.7.7.73
TIGR04271, 
TIGR00342 Sulfur transferase ThiI
TIGR00204 Deoxy-D-xylulose 5-phosphate synthase Dxs 2.2.1.7
PF05690 Thiazole synthase ThiG 2.8.1.10
PF02581 Thiazole Tautomerase TenI 5.3.99.10
TIGR00292 Thiamine thiazole synthase THI4 2.8.1.10
TIGR00694 HET transport, Thiazole kinase ThiM 2.7.1.50
TIGR00693 Thiamin phosphate synthase ThiE 2.5.1.3
TIGR00149 Secondary thiamine-phosphate synthase enzyme YjbQ 2.5.1.3
TIGR01379 Thiamin phosphate kinase ThiL 2.7.4.16
TIGR02721 Thiamine kinase ThiK 2.7.1.89
TIGR01378 Thiamin pyrophosphate kinase Tpk/Tnr3/ThiN/THI80 2.7.6.2 / 2.7.4.15
PF03266 Nucleoside-triphosphatase NTPCR 3.6.1.15
PF01928 Thiamine-triphosphatase THTPA 3.6.1.28
TIGR04541 Thiaminase I / Thiamine pyridinylase I THI1 2.5.1.2
TIGR04306 Thiaminase II / aminopyrimidine aminohydrolase THI20/TenA 2.7.4.7 / 2.7.1.49 / 3.5.99.2
Transport
TIGR01528 Thiamine transporter PnuC/PnuT
Thiamine outer membrane transporter OMthi
TIGR02357 Thiamine transporter ThiT
TIGR02358 HMP-P transport CytX
TIGR02359 putative transporter of thiazole precursor ThiW
TIGR01277 thiamin ABC transporter - ATP binding subunit ThiQ
TIGR01253 thiamin ABC transporter - membrane subunit ThiP
TIGR01276 Thiamine binding protein TbpA/ThiB
TIGR00800 Thiamine transporter from Yeast THI7
TIGR00806 SLC19A2, solute carrier family 19 (thiamine transporter), member 2 THTR1
TIGR00806 SLC19A3, solute carrier family 19 (thiamine transporter), member 3 THTR2
PF00153 solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19 SLC25A19
PF05805 Interaction w/ hTHTR-2 TM4SF4
Dependent
TIGR00232 Transketolase TktA/TktB 2.2.1.1
TIGR00239 2-oxoglutarate dehydrogenase E1 component SucA 1.2.4.2
TIGR01347 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex SucB 2.3.1.61
TIGR01350 Dihydrolipoyl dehydrogenase Lpd/PdhD/DLD 1.8.1.4
PF00676 2-oxoisovalerate dehydrogenase subunit alpha BfmBAA/BCKDHA 1.2.4.4
TIGR03393 Indole-3-pyruvate decarboxylase IpdC 4.1.1.74
TIGR00118 Acetolactate synthase (ALS) ILV2/IlvI/IlvG 2.2.1.6
TIGR03846 Sulfopyruvate decarboxylase, alpha subunit ComDE 4.1.1.79
TIGR03845 Sulfopyruvate decarboxylase, beta subunit ComDE 4.1.1.79
TIGR02720 Flavoprotein pyruvate oxidase Pox 1.2.3.3
TIGR02179 Phenylglyoxylate dehydrogenase (acylating) PadI 1.2.1.58
TIGR00759 Pyruvate dehydrogenase (acetyl-transferring) PDK 1.2.4.1
TIGR03336 Indolepyruvate ferredoxin oxidoreductase IorA 1.2.7.8
TIGR02179 Oxalate oxidoreductase Oxo 1.2.7.10
TIGR02177 2-oxoacid oxidoreductase (ferredoxin) PorB 1.2.7.1









TIGR00239 2-hydroxy-3-oxoadipate synthase/2-oxoglutarate decarboxylase Kgd 4.1.1.71/2.2.1.5
TIGR03457 Sulfoacetaldehyde acetyltransferase Xsc 2.3.3.15
TIGR04377 3D-(3,5/4)-trihydroxycyclohexane-1,2-dione acylhydrolase (decyclizing) IolD 3.7.1.22
TIGR03254 Oxalyl-CoA decarboxylase Oxc 4.1.1.8
TIGR01504 Tartronate-semialdehyde synthase Gcl 4.1.1.47
TIGR03297 Phosphonopyruvate decarboxylase Ppd 4.1.1.82
PF00205 Thiamine pyrophosphate enzyme, central domain multiple
PF00456 Transketolase, thiamine diphosphate binding domain multiple
PF01855 Pyruvate flavodoxin/ferredoxin oxidoreductase, thiamine diP-bdg multiple
PF02775 Thiamine pyrophosphate enzyme, C-terminal TPP binding domain multiple
PF02776 Thiamine pyrophosphate enzyme, N-terminal TPP binding domain multiple
PF02779 Transketolase, pyrimidine binding domain multiple




Table 2.6. Genomes investigated for thiamine acquisition and dependent genes 
 
Table S5. Genomes investigated for thiamine acquisition and dependent genes.
Genome Phylum Class Order Family Genus Refseq
Bifidobacterium longum NCC2705 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NC_004307
Bifidobacterium longum DJO10A Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NC_010816
Bifidobacterium adolescentis ATCC 15703 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NC_008618
Collinsella aerofaciens ATCC 25986 Actinobacteria Actinobacteria Coriobacteriales Coriobacteriaceae Collinsella NZ_AAVN00000000
Bifidobacterium animalis subsp. lactis AD011 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NC_011835
Bifidobacterium catenulatum DSM 16992 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NZ_ABXY00000000
Bifidobacterium adolescentis L2-32 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NZ_AAXD00000000
Bifidobacterium angulatum DSM 20098 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NZ_ABYS00000000
Bifidobacterium gallicum DSM 20093 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NZ_ABXB00000000
Collinsella intestinalis DSM 13280 Actinobacteria Actinobacteria Coriobacteriales Coriobacteriaceae Collinsella NZ_ABXH00000000
Bifidobacterium breve DSM 20213 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NZ_ACCG00000000
Bifidobacterium animalis subsp. lactis HN019 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NZ_ABOT00000000
Bifidobacterium pseudocatenulatum DSM 20438 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NZ_ABXX00000000
Collinsella stercoris DSM 13279 Actinobacteria Actinobacteria Coriobacteriales Coriobacteriaceae Collinsella NZ_ABXJ00000000
Actinomyces odontolyticus ATCC 17982 Actinobacteria Actinobacteria Actinomycetales Actinomycetaceae Actinomyces NZ_AAYI00000000
Bifidobacterium dentium Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NC_Bdentium
Bifidobacterium sp. 12_1_47BFAA Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NZ_ADCN00000000
Bifidobacterium animalis subsp. lactis Bl-04 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NC_012814
Bifidobacterium animalis subsp. lactis DSM 10140 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NC_012815
Bifidobacterium bifidum NCIMB 41171 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NZ_ABQP00000000
Bifidobacterium bifidum PRL2010 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NC_014638
Bifidobacterium bifidum S17 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NC_014616
Bifidobacterium dentium ATCC 27678 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NZ_ABIX00000000
Bifidobacterium longum subsp. infantis 157F Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NC_015052
Bifidobacterium longum subsp. infantis ATCC 15697 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NC_011593
Bifidobacterium longum subsp. longum ATCC 55813 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NZ_ACHI00000000
Bifidobacterium longum subsp. infantis CCUG 52486 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NZ_ABQQ00000000
Bifidobacterium longum subsp. longum JCM 1217 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NC_015067
Bifidobacterium longum subsp. longum JDM301 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NC_014169
Corynebacterium ammoniagenes DSM 20306 Actinobacteria Actinobacteria Actinomycetales Corynebacteriaceae Corynebacterium NZ_ADNS00000000
Eggerthella sp. 1_3_56FAA Actinobacteria Actinobacteria Coriobacteriales Coriobacteriaceae Eggerthella NZ_ACWN00000000
Eggerthella sp. HGA1 Actinobacteria Actinobacteria Coriobacteriales Coriobacteriaceae Eggerthella NZ_AEXR00000000
Eggerthella sp. YY7918 Actinobacteria Actinobacteria Coriobacteriales Coriobacteriaceae Eggerthella NC_015738
Bifidobacterium animalis subsp. lactis BB-12 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NC_017214
Bifidobacterium animalis subsp. lactis V9 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NC_017217
Bifidobacterium bifidum BGN4 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NC_017999
Bifidobacterium longum subsp. longum BBMN68 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NC_014656
Collinsella tanakaei YIT 12063 Actinobacteria Actinobacteria Coriobacteriales Coriobacteriaceae Collinsella NZ_ADLS00000000
Propionibacterium sp. 5_U_42AFAA Actinobacteria Actinobacteria Actinomycetales Propionibacteriaceae Propionibacterium NZ_ACUE00000000
Bifidobacterium longum subsp. longum 2-2B Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NZ_AJTJ00000000
Bifidobacterium longum subsp. longum 44B Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NZ_AJTM00000000
Slackia piriformis YIT 12062 Actinobacteria Actinobacteria Coriobacteriales Coriobacteriaceae Slackia NZ_ADMD00000000
Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222 = DSM 20088 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NC_017219
Bifidobacterium longum subsp. longum F8 Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium NC_021008
Gordonibacter pamelaeae 7-10-1-b Actinobacteria Actinobacteria Coriobacteriales Coriobacteriaceae Gordonibacter NC_021021
Bacteroides caccae ATCC 43185 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AAVM00000000
Bacteroides thetaiotaomicron VPI-5482 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NC_004663
Bacteroides vulgatus ATCC 8482 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides 0
Bacteroides fragilis YCH46 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NC_006347
Bacteroides fragilis NCTC 9343 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NC_003228
Bacteroides ovatus ATCC 8483 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AAXF00000000
Bacteroides uniformis ATCC 8492 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AAYH00000000
Parabacteroides distasonis ATCC 8503 Bacteroidetes Bacteroidia Bacteroidales Porphyromonadaceae Parabacteroides NC_009615
Bacteroides dorei DSM 17855 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ABWZ00000000
Alistipes putredinis DSM 17216 Bacteroidetes Bacteroidia Bacteroidales Rikenellaceae Alistipes NZ_ABFK00000000
Bacteroides coprocola DSM 17136 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ABIY00000000
Bacteroides cellulosilyticus DSM 14838 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ACCH00000000
Parabacteroides merdae ATCC 43184 Bacteroidetes Bacteroidia Bacteroidales Porphyromonadaceae Parabacteroides NZ_AAXE00000000
Bacteroides stercoris ATCC 43183 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ABFZ00000000
Bacteroides intestinalis DSM 17393 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ABJL00000000
Bacteroides plebeius DSM 17135 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ABQC00000000
Bacteroides eggerthii DSM 20697 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ABVO00000000
Bacteroides finegoldii DSM 17565 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ABXI00000000
Parabacteroides johnsonii DSM 18315 Bacteroidetes Bacteroidia Bacteroidales Porphyromonadaceae Parabacteroides NZ_ABYH00000000
Bacteroides fragilis 3_1_12 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ABZX00000000
Bacteroides sp. D1 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ACAB00000000
Prevotella copri DSM 18205 Bacteroidetes Bacteroidia Bacteroidales Prevotellaceae Prevotella NZ_ACBX00000000
Bacteroides sp. D2 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ACGA00000000
Bacteroides sp. 1_1_6 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ACIC00000000
Bacteroides coprophilus DSM 18228 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ACBW00000000
Bacteroides WH2 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NC_BWH2
Bacteroides thetaiotaomicron 3731 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NC_Bthetaiotaomicron3731
Bacteroides thetaiotaomicron 7330 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NC_Bthetaiotaomicron7330
Bacteroides xylanisolvens XB1A Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NC_BxylanisolvensXB1A
Alistipes sp. HGB5 Bacteroidetes Bacteroidia Bacteroidales Rikenellaceae Alistipes NZ_AENZ00000000
Bacteroides sp. 1_1_14 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ACRP00000000
Bacteroides sp. 1_1_30 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ADCL00000000
Bacteroides sp. 2_1_16 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ACPP00000000
Bacteroides sp. 2_1_22 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ACPQ00000000
Bacteroides sp. 2_1_33B Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ACPR00000000
Bacteroides sp. 2_1_56FAA Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ACWI00000000
Bacteroides sp. 2_1_7 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ABZY00000000
Bacteroides sp. 2_2_4 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ABZZ00000000
Bacteroides sp. 20_3 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ACRQ00000000
Bacteroides sp. 3_1_19 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ADCJ00000000
Bacteroides sp. 3_1_23 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ACRS00000000
Bacteroides sp. 3_1_33FAA Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ACPS00000000
Bacteroides sp. 3_1_40A Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ACRT00000000
Bacteroides sp. 3_2_5 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ACIB00000000
Bacteroides sp. 4_1_36 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ACTC00000000
Bacteroides sp. 4_3_47FAA Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ACDR00000000
Bacteroides sp. 9_1_42FAA Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ACAA00000000
Bacteroides clarus YIT 12056 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AFBM00000000
Bacteroides sp. D20 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ACPT00000000








Bacteroides dorei 5_1_36/D4 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ACDI00000000
Bacteroides eggerthii 1_2_48FAA Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ACWG00000000
Bacteroides fluxus YIT 12057 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AFBN00000000
Bacteroides ovatus 3_8_47FAA Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ACWH00000000
Bacteroides ovatus SD CC 2a Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ADMP00000000
Bacteroides ovatus SD CMC 3f Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ADMO00000000
Bacteroides vulgatus PC510 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ADKO00000000
Bacteroides xylanisolvens SD CC 1b Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ADKP00000000
Dysgonomonas mossii DSM 22836 Bacteroidetes Bacteroidia Bacteroidales Porphyromonadaceae Dysgonomonas NZ_ADLW00000000
Odoribacter splanchnicus DSM 20712 Bacteroidetes Bacteroidia Bacteroidales Porphyromonadaceae Odoribacter NC_015160
Parabacteroides sp. D13 Bacteroidetes Bacteroidia Bacteroidales Porphyromonadaceae Parabacteroides NZ_ACPW00000000
Paraprevotella xylaniphila YIT 11841 Bacteroidetes Bacteroidia Bacteroidales Prevotellaceae Paraprevotella NZ_AFBR00000000
Porphyromonas gingivalis ATCC 33277 Bacteroidetes Bacteroidia Bacteroidales Porphyromonadaceae Porphyromonas NC_010729
Porphyromonas gingivalis TDC60 Bacteroidetes Bacteroidia Bacteroidales Porphyromonadaceae Porphyromonas NC_015571
Porphyromonas gingivalis W83 Bacteroidetes Bacteroidia Bacteroidales Porphyromonadaceae Porphyromonas NC_002950
Prevotella salivae DSM 15606 Bacteroidetes Bacteroidia Bacteroidales Prevotellaceae Prevotella NZ_AEQO00000000
Alistipes indistinctus YIT 12060 Bacteroidetes Bacteroidia Bacteroidales Rikenellaceae Alistipes NZ_ADLD00000000
Bacteroides fragilis 638R Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NC_016776
Odoribacter laneus YIT 12061 Bacteroidetes Bacteroidia Bacteroidales Porphyromonadaceae Odoribacter NZ_ADMC00000000
Paraprevotella clara YIT 11840 Bacteroidetes Bacteroidia Bacteroidales Prevotellaceae Paraprevotella NZ_AFFY00000000
Prevotella stercorea DSM 18206 Bacteroidetes Bacteroidia Bacteroidales Prevotellaceae Prevotella NZ_AFZZ00000000
Tannerella sp. 6_1_58FAA_CT1 Bacteroidetes Bacteroidia Bacteroidales Porphyromonadaceae Tannerella NZ_ACWX00000000
Alistipes finegoldii DSM 17242                                   Bacteroidetes Bacteroidia Bacteroidales Rikenellaceae Alistipes NC_018011
Alistipes shahii WAL 8301                                        Bacteroidetes Bacteroidia Bacteroidales Rikenellaceae Alistipes NC_021030
Alistipes sp. JC136                                              Bacteroidetes Bacteroidia Bacteroidales Rikenellaceae Alistipes NZ_CAEG00000000
Bacteroides caccae CL03T12C61                                    Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AGXF00000000
Bacteroides cellulosilyticus CL02T12C19                          Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AGXG00000000
Bacteroides dorei CL02T00C15                                     Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AGXH00000000
Bacteroides dorei CL02T12C06                                     Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AGXJ00000000
Bacteroides dorei CL03T12C01                                     Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AGXI00000000
Bacteroides faecis MAJ27                                         Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AGDG00000000
Bacteroides finegoldii CL09T03C10                                Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AGXW00000000
Bacteroides fragilis CL03T00C08                                  Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AGXK00000000
Bacteroides fragilis CL03T12C07                                  Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AGXL00000000
Bacteroides fragilis CL05T00C42                                  Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AGXO00000000
Bacteroides fragilis CL05T12C13                                  Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AGXP00000000
Bacteroides fragilis CL07T00C01                                  Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AGXM00000000
Bacteroides fragilis CL07T12C05                                  Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AGXN00000000
Bacteroides fragilis HMW 610                                     Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AGXQ00000000
Bacteroides fragilis HMW 615                                     Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AGXR00000000
Bacteroides fragilis HMW 616                                     Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ALOB00000000
Bacteroides helcogenes P 36-108                                  Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NC_014933
Bacteroides nordii CL02T12C05                                    Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AGXS00000000
Bacteroides oleiciplenus YIT 12058                               Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ADLF00000000
Bacteroides ovatus CL02T12C04                                    Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AGXT00000000
Bacteroides ovatus CL03T12C18                                    Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AGXU00000000
Bacteroides salanitronis DSM 18170                               Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NC_015164
Bacteroides salyersiae CL02T12C01                                Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AGXV00000000
Bacteroides sp. CF50                                             Bacteroidetes Bacteroidia Bacteroidales NC_022526
Bacteroides uniformis CL03T00C23                                 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AGXX00000000
Bacteroides uniformis CL03T12C37                                 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AGXY00000000
Bacteroides vulgatus CL09T03C04                                  Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AGXZ00000000
Bacteroides xylanisolvens CL03T12C04                             Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_AGXE00000000
Parabacteroides distasonis CL03T12C09                            Bacteroidetes Bacteroidia Bacteroidales Porphyromonadaceae Parabacteroides NZ_AGZM00000000
Parabacteroides distasonis CL09T03C24                            Bacteroidetes Bacteroidia Bacteroidales Porphyromonadaceae Parabacteroides NZ_AGZN00000000
Parabacteroides goldsteinii CL02T12C30                           Bacteroidetes Bacteroidia Bacteroidales Porphyromonadaceae Parabacteroides NZ_AGZO00000000
Parabacteroides johnsonii CL02T12C29                             Bacteroidetes Bacteroidia Bacteroidales Porphyromonadaceae Parabacteroides NZ_AGZP00000000
Parabacteroides merdae CL03T12C32                                Bacteroidetes Bacteroidia Bacteroidales Porphyromonadaceae Parabacteroides NZ_AGZQ00000000
Parabacteroides merdae CL09T00C40                                Bacteroidetes Bacteroidia Bacteroidales Porphyromonadaceae Parabacteroides NZ_AJPU00000000
Parabacteroides sp. D25                                          Bacteroidetes Bacteroidia Bacteroidales Porphyromonadaceae Parabacteroides NZ_ACUA00000000
Tannerella forsythia ATCC 43037 Bacteroidetes Bacteroidia Bacteroidales Porphyromonadaceae Tannerella NC_016610
Dysgonomonas gadei ATCC BAA-286 Bacteroidetes Bacteroidia Bacteroidales Porphyromonadaceae Dysgonomonas NZ_ADLV00000000
Bacteroides cellulosilyticus WH2 Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides NZ_ATFI00000000
Barnesiella intestinihominis YIT 11860 Bacteroidetes Bacteroidia Bacteroidales Porphyromonadaceae Barnesiella NZ_ADLE00000000
Lactobacillus reuteri DSM 20016 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NC_009513
Lactococcus lactis subsp. lactis Il1403 Firmicutes Bacilli Lactobacillales Streptococcaceae Lactococcus NC_002662
Streptococcus thermophilus LMG 18311 Firmicutes Bacilli Lactobacillales Streptococcaceae Streptococcus NC_006448
Streptococcus thermophilus CNRZ1066 Firmicutes Bacilli Lactobacillales Streptococcaceae Streptococcus NC_006449
Lactobacillus delbrueckii subsp. bulgaricus ATCC 11842 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NC_008054
Lactobacillus casei ATCC 334 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NC_008526
Lactococcus lactis subsp. cremoris SK11 Firmicutes Bacilli Lactobacillales Streptococcaceae Lactococcus NC_008527
Streptococcus thermophilus LMD-9 Firmicutes Bacilli Lactobacillales Streptococcaceae Streptococcus NC_008532
Lactococcus lactis subsp. cremoris MG1363 Firmicutes Bacilli Lactobacillales Streptococcaceae Lactococcus NC_009004
Streptococcus infantarius subsp. infantarius ATCC BAA-102 Firmicutes Bacilli Lactobacillales Streptococcaceae Streptococcus NZ_ABJK00000000
Bacillus cereus AH187 Firmicutes Bacilli Bacillales Bacillaceae Bacillus NC_011658
Bacillus cereus G9842 Firmicutes Bacilli Bacillales Bacillaceae Bacillus NC_011772
Enterococcus faecalis PC1.1 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NZ_ADKN00000000
Enterococcus faecium PC4.1 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NZ_ADMM00000000
Enterococcus faecalis TX0104 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NZ_ACGL00000000
Enterococcus faecalis TX1322 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NZ_ACGM00000000
Enterococcus faecalis TX2134 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NZ_AEBW00000000
Enterococcus faecalis V583 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NC_004668
Enterococcus faecalis X98 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NZ_ACAW00000000
Enterococcus faecium 1_141_733 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NZ_ACAZ00000000
Enterococcus faecium 1_231_501 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NZ_ACAY00000000
Enterococcus faecium Com12 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NZ_ACBC00000000
Enterococcus faecium Com15 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NZ_ACBD00000000
Enterococcus faecium DO Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NZ_AAAK00000000
Enterococcus faecium E1071 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NZ_ABQI00000000
Enterococcus faecium TX1330 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NZ_ACHL00000000
Lactobacillus acidophilus ATCC 4796 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_ACHN00000000
Lactobacillus acidophilus NCFM Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NC_006814
Lactobacillus amylolyticus DSM 11664 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_ADNY00000000
Lactobacillus antri DSM 16041 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_ACLL00000000
Lactobacillus brevis subsp. gravesensis ATCC 27305 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_ACGG00000000
Lactobacillus buchneri ATCC 11577 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_ACGH00000000
Lactobacillus casei BL23 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NC_010999
Lactobacillus crispatus 125-2-CHN Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_ACPV00000000
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Lactobacillus fermentum ATCC 14931 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_ACGI00000000
Lactobacillus fermentum IFO 3956 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NC_010610
Lactobacillus gasseri ATCC 33323 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NC_008530
Lactobacillus helveticus DSM 20075 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_ACLM00000000
Lactobacillus hilgardii ATCC 8290 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_ACGP00000000
Lactobacillus johnsonii NCC 533 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NC_005362
Lactobacillus paracasei subsp. paracasei 8700_2 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_ABQV00000000
Lactobacillus paracasei subsp. paracasei ATCC 25302 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_ACGY00000000
Lactobacillus plantarum subsp. plantarum ATCC 14917 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_ACGZ00000000
Lactobacillus plantarum JDM1 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NC_012984
Lactobacillus reuteri 100-23 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_AAPZ00000000
Lactobacillus reuteri CF48-3A Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_ACHG00000000
Lactobacillus reuteri JCM 1112 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NC_010609
Lactobacillus reuteri MM2-3 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_ACLB00000000
Lactobacillus reuteri MM4-1A Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_ACGX00000000
Lactobacillus reuteri SD2112 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NC_015697
Lactobacillus rhamnosus GG Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NC_013198
Lactobacillus rhamnosus HN001 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_ABWJ00000000
Lactobacillus rhamnosus LMS2-1 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_ACIZ00000000
Lactobacillus ruminis ATCC 25644 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_ACGS00000000
Lactobacillus salivarius ATCC 11741 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_ACGT00000000
Lactobacillus salivarius UCC118 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NC_007929
Lactobacillus ultunensis DSM 16047 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_ACGU00000000
Leuconostoc mesenteroides subsp. cremoris ATCC 19254 Firmicutes Bacilli Lactobacillales Leuconostocaceae Leuconostoc NZ_ACKV00000000
Listeria grayi DSM 20601 Firmicutes Bacilli Bacillales Listeriaceae Listeria NZ_ACCR00000000
Listeria monocytogenes F6900 Firmicutes Bacilli Bacillales Listeriaceae Listeria NZ_AARU00000000
Listeria monocytogenes Finland 1988 Firmicutes Bacilli Bacillales Listeriaceae Listeria NZ_AART00000000
Listeria monocytogenes FSL J1-175 Firmicutes Bacilli Bacillales Listeriaceae Listeria NZ_AARK00000000
Listeria monocytogenes FSL J1-194 Firmicutes Bacilli Bacillales Listeriaceae Listeria NZ_AARJ00000000
Listeria monocytogenes FSL J2-003 Firmicutes Bacilli Bacillales Listeriaceae Listeria NZ_AARM00000000
Listeria monocytogenes FSL J2-064 Firmicutes Bacilli Bacillales Listeriaceae Listeria NZ_AARO00000000
Listeria monocytogenes FSL J2-071 Firmicutes Bacilli Bacillales Listeriaceae Listeria NZ_AARN00000000
Listeria monocytogenes FSL N1-017 Firmicutes Bacilli Bacillales Listeriaceae Listeria NZ_AARP00000000
Listeria monocytogenes FSL N3-165 Firmicutes Bacilli Bacillales Listeriaceae Listeria NZ_AARQ00000000
Listeria monocytogenes FSL R2-503 Firmicutes Bacilli Bacillales Listeriaceae Listeria NZ_AARR00000000
Listeria monocytogenes FSL R2-561 Firmicutes Bacilli Bacillales Listeriaceae Listeria NZ_AARS00000000
Listeria monocytogenes HPB2262 Firmicutes Bacilli Bacillales Listeriaceae Listeria NZ_AATL00000000
Listeria monocytogenes J0161 Firmicutes Bacilli Bacillales Listeriaceae Listeria NZ_AARW00000000
Listeria monocytogenes J2818 Firmicutes Bacilli Bacillales Listeriaceae Listeria NZ_AARX00000000
Listeria monocytogenes LO28 Firmicutes Bacilli Bacillales Listeriaceae Listeria NZ_AARY00000000
Listeria monocytogenes serotype 4b str. F2365 Firmicutes Bacilli Bacillales Listeriaceae Listeria NC_002973
Listeria monocytogenes serotype 4b str. H7858 Firmicutes Bacilli Bacillales Listeriaceae Listeria NZ_AADR00000000
Paenibacillus sp. HGF5 Firmicutes Bacilli Bacillales Paenibacillaceae Paenibacillus NZ_AEXS00000000
Paenibacillus sp. HGF7 Firmicutes Bacilli Bacillales Paenibacillaceae Paenibacillus NZ_AFDH00000000
Pediococcus acidilactici 7_4 Firmicutes Bacilli Lactobacillales Lactobacillaceae Pediococcus NZ_ACXB00000000
Pediococcus acidilactici DSM 20284 Firmicutes Bacilli Lactobacillales Lactobacillaceae Pediococcus NZ_AEEG00000000
Streptococcus sp. 2_1_36FAA Firmicutes Bacilli Lactobacillales Streptococcaceae Streptococcus NZ_ACOI00000000
Streptococcus anginosus 1_2_62CV Firmicutes Bacilli Lactobacillales Streptococcaceae Streptococcus NZ_ADME00000000
Streptococcus equinus ATCC 9812 Firmicutes Bacilli Lactobacillales Streptococcaceae Streptococcus NZ_AEVB00000000
Weissella paramesenteroides ATCC 33313 Firmicutes Bacilli Lactobacillales Leuconostocaceae Weissella NZ_ACKU00000000
Bacillus sp. 7_6_55CFAA_CT2 Firmicutes Bacilli Bacillales Bacillaceae Bacillus NZ_ACWE00000000
Bacillus smithii 7_3_47FAA Firmicutes Bacilli Bacillales Bacillaceae Bacillus NZ_ACWF00000000
Enterococcus faecalis 62 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NC_017312
Enterococcus faecalis OG1RF Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NC_017316
Enterococcus saccharolyticus 30_1 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NZ_ADLY00000000
Lactobacillus sp. 7_1_47FAA Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_ACWR00000000
Lactobacillus delbrueckii subsp. bulgaricus 2038 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NC_017469
Lactobacillus fermentum CECT 5716 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NC_017465
Lactobacillus johnsonii DPC 6026 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NC_017477
Lactobacillus rhamnosus Lc 705 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NC_013199
Lactobacillus salivarius CECT 5713 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NC_017481
Listeria monocytogenes L99 Firmicutes Bacilli Bacillales Listeriaceae Listeria NC_017529
Enterococcus faecalis TX1302 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NZ_AEBK00000000
Enterococcus faecalis TX1341 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NZ_AECF00000000
Enterococcus faecalis TX1342 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NZ_AEBJ00000000
Enterococcus faecalis TX1346 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NZ_AEBI00000000
Enterococcus faecalis TX1467 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NZ_AFBS00000000
Enterococcus faecalis TX2137 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NZ_AEBQ00000000
Enterococcus faecalis TX4244 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NZ_AEBH00000000
Lactobacillus delbrueckii subsp. lactis DSM 20072 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_AEXU00000000
Lactobacillus rhamnosus ATCC 21052 Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NZ_AFZY00000000
Listeria innocua ATCC 33091 Firmicutes Bacilli Bacillales Listeriaceae Listeria NZ_AGCN00000000
Lactobacillus rhamnosus GG Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus NC_013198
Enterococcus sp. 7L76 Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus NC_021023
Blautia hydrogenotrophica DSM 10507 Firmicutes Clostridia Clostridiales IncertaeSedisXIV Blautia NZ_ACBZ00000000
Bryantella formatexigens DSM 14469 Firmicutes Clostridia Clostridiales Lachnospiraceae Bryantella NZ_ACCL00000000
Clostridium scindens ATCC 35704 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ABFY00000000
Clostridium spiroforme DSM 1552 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ABIK00000000
Dorea longicatena DSM 13814 Firmicutes Clostridia Clostridiales Lachnospiraceae Dorea NZ_AAXB00000000
Eubacterium eligens ATCC 27750 Firmicutes Clostridia Clostridiales Eubacteriaceae Eubacterium NC_012778
Eubacterium rectale ATCC 33656 Firmicutes Clostridia Clostridiales Eubacteriaceae Eubacterium NC_012781
Faecalibacterium prausnitzii A2-165 Firmicutes Clostridia Clostridiales Ruminococcaceae Faecalibacterium NZ_ACOP00000000
Faecalibacterium prausnitzii M21/2 Firmicutes Clostridia Clostridiales Ruminococcaceae Faecalibacterium NZ_ABED00000000
Ruminococcus obeum ATCC 29174 Firmicutes Clostridia Clostridiales Ruminococcaceae Ruminococcus NZ_AAVO00000000
Ruminococcus torques ATCC 27756 Firmicutes Clostridia Clostridiales Ruminococcaceae Ruminococcus NZ_AAVP00000000
Clostridium bolteae ATCC BAA-613 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ABCC00000000
Clostridium sporogenes ATCC 15579 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ABKW00000000
Clostridium asparagiforme DSM 15981 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ACCJ00000000
Ruminococcus lactaris ATCC 29176 Firmicutes Clostridia Clostridiales Ruminococcaceae Ruminococcus NZ_ABOU00000000
Anaerococcus hydrogenalis DSM 7454 Firmicutes Clostridia Clostridiales IncertaeSedisXI Anaerococcus NZ_ABXA00000000
Pseudoflavonifractor capillosus ATCC 29799 Firmicutes Clostridia Clostridiales Pseudoflavonifractor NZ_AAXG00000000
Anaerotruncus colihominis DSM 17241 Firmicutes Clostridia Clostridiales Ruminococcaceae Anaerotruncus NZ_ABGD00000000
Coprococcus comes ATCC 27758 Firmicutes Clostridia Clostridiales Lachnospiraceae Coprococcus NZ_ABVR00000000
Blautia hansenii DSM 20583 Firmicutes Clostridia Clostridiales IncertaeSedisXIV Blautia NZ_ABYU00000000
Ruminococcus gnavus ATCC 29149 Firmicutes Clostridia Clostridiales Ruminococcaceae Ruminococcus NZ_AAYG00000000
Anaerofustis stercorihominis DSM 17244 Firmicutes Clostridia Clostridiales Eubacteriaceae Anaerofustis NZ_ABIL00000000
Anaerostipes caccae DSM 14662 Firmicutes Clostridia Clostridiales Lachnospiraceae Anaerostipes NZ_ABAX00000000
Butyrivibrio crossotus DSM 2876 Firmicutes Clostridia Clostridiales Lachnospiraceae Butyrivibrio NZ_ABWN00000000
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Clostridium sp. L2-50 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_AAYW00000000
Eubacterium dolichum DSM 3991 Firmicutes Clostridia Clostridiales Eubacteriaceae Eubacterium NZ_ABAW00000000
Clostridium leptum DSM 753 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ABCB00000000
Parvimonas micra ATCC 33270 Firmicutes Clostridia IncertaeSedisXI Parvimonas NZ_ABEE00000000
Coprococcus eutactus ATCC 27759 Firmicutes Clostridia Clostridiales Lachnospiraceae Coprococcus NZ_ABEY00000000
Clostridium bartlettii DSM 16795 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ABEZ00000000
Clostridium ramosum DSM 1402 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ABFX00000000
Clostridium sp. SS2/1 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ABGC00000000
Dorea formicigenerans ATCC 27755 Firmicutes Clostridia Clostridiales Lachnospiraceae Dorea NZ_AAXA00000000
Clostridium nexile DSM 1787 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ABWO00000000
Clostridium hylemonae DSM 15053 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ABYI00000000
Roseburia intestinalis L1-82 Firmicutes Clostridia Clostridiales Lachnospiraceae Roseburia NZ_ABYJ00000000
Eubacterium biforme DSM 3989 Firmicutes Clostridia Clostridiales Eubacteriaceae Eubacterium NZ_ABYT00000000
Clostridium methylpentosum DSM 5476 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ACEC00000000
Eubacterium hallii DSM 3353 Firmicutes Clostridia Clostridiales Eubacteriaceae Eubacterium NZ_ACEP00000000
Clostridium hiranonis DSM 13275 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ABWP00000000
Subdoligranulum variabile DSM 15176 Firmicutes Clostridia Ruminococcaceae Subdoligranulum NZ_ACBY00000000
Clostridium sp. M62/1 Firmicutes Clostridia Clostridiales Lachnospiraceae Robinsoniella NZ_ACFX00000000
Clostridium symbiosum Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NC_Csymbiosum
Eubacterium rectale DSM17629 Firmicutes Clostridia Clostridiales Eubacteriaceae Eubacterium NC_Erectale_DSM17629
M23A Firmicutes Clostridia NC_M23A
Ruminococcus bromiiL263 Firmicutes Clostridia Clostridiales Ruminococcaceae Ruminococcus NC_RbromiiL263
Anaerostipes sp. 3_2_56FAA Firmicutes Clostridia Clostridiales Lachnospiraceae Anaerostipes NZ_ACWB00000000
Bacteroides pectinophilus ATCC 43243 Firmicutes Clostridia Clostridiales NZ_ABVQ00000000
Clostridiales bacterium 1_7_47FAA Firmicutes Clostridia Clostridiales NZ_ABQR00000000
Clostridium sp. 7_2_43FAA Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ACDK00000000
Clostridium sp. D5 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ADBG00000000
Clostridium difficile CD196 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NC_013315
Clostridium difficile NAP07 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ADVM00000000
Clostridium difficile NAP08 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ADNX00000000
Clostridium difficile R20291 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NC_013316
Clostridium hathewayi DSM 13479 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ACIO00000000
Clostridium sp. HGF2 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_AENW00000000
Clostridium sp. SY8519 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NC_015737
Clostridium symbiosum WAL-14673 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ADLR00000000
Eubacterium siraeum DSM 15702 Firmicutes Clostridia Clostridiales Eubacteriaceae Eubacterium NZ_ABCA00000000
Faecalibacterium cf. prausnitzii KLE1255 Firmicutes Clostridia Clostridiales Ruminococcaceae Faecalibacterium NZ_AECU00000000
Finegoldia magna ATCC 29328 Firmicutes Clostridia Clostridiales IncertaeSedisXI Finegoldia NC_010376
Lachnospiraceae bacterium 1_1_57FAA Firmicutes Clostridia Clostridiales Lachnospiraceae NZ_ACTM00000000
Lachnospiraceae bacterium 1_4_56FAA Firmicutes Clostridia Clostridiales Lachnospiraceae NZ_ACTN00000000
Lachnospiraceae bacterium 2_1_46FAA Firmicutes Clostridia Clostridiales Lachnospiraceae NZ_ADLB00000000
Lachnospiraceae bacterium 2_1_58FAA Firmicutes Clostridia Clostridiales Lachnospiraceae NZ_ACTO00000000
Lachnospiraceae bacterium 3_1_46FAA Firmicutes Clostridia Clostridiales Lachnospiraceae NZ_ACWP00000000
Lachnospiraceae bacterium 3_1_57FAA_CT1 Firmicutes Clostridia Clostridiales Lachnospiraceae NZ_ACTP00000000
Lachnospiraceae bacterium 4_1_37FAA Firmicutes Clostridia Clostridiales Lachnospiraceae NZ_ADCR00000000
Lachnospiraceae bacterium 5_1_57FAA Firmicutes Clostridia Clostridiales Lachnospiraceae NZ_ACTR00000000
Lachnospiraceae bacterium 5_1_63FAA Firmicutes Clostridia Clostridiales Lachnospiraceae NZ_ACTS00000000
Lachnospiraceae bacterium 6_1_63FAA Firmicutes Clostridia Clostridiales Lachnospiraceae NZ_ACTV00000000
Lachnospiraceae bacterium 8_1_57FAA Firmicutes Clostridia Clostridiales Lachnospiraceae NZ_ACWQ00000000
Lachnospiraceae bacterium 9_1_43BFAA Firmicutes Clostridia Clostridiales Lachnospiraceae NZ_ACTX00000000
Roseburia inulinivorans DSM 16841 Firmicutes Clostridia Clostridiales Lachnospiraceae Roseburia NZ_ACFY00000000
Ruminococcaceae bacterium D16 Firmicutes Clostridia Clostridiales Ruminococcaceae NZ_ADDX00000000
Ruminococcus sp. 5_1_39BFAA Firmicutes Clostridia Clostridiales Ruminococcaceae Ruminococcus NZ_ACII00000000
Clostridium sp. 7_3_54FAA Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ACWK00000000
Clostridium citroniae WAL-17108 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ADLJ00000000
Clostridium clostridioforme 2_1_49FAA Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ADLL00000000
Clostridium hathewayi WAL-18680 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ADLN00000000
Dorea formicigenerans 4_6_53AFAA Firmicutes Clostridia Clostridiales Lachnospiraceae Dorea NZ_ADLU00000000
Eubacterium sp. 3_1_31 Firmicutes Clostridia Clostridiales Eubacteriaceae Eubacterium NZ_ACTL00000000
Flavonifractor plautii ATCC 29863 Firmicutes Clostridia Clostridiales Flavonifractor NZ_AGCK00000000
Lachnospiraceae bacterium 7_1_58FAA Firmicutes Clostridia Clostridiales Lachnospiraceae NZ_ACTW00000000
Roseburia hominis A2-183 Firmicutes Clostridia Clostridiales Lachnospiraceae Roseburia NC_015977
Subdoligranulum sp. 4_3_54A2FAA Firmicutes Clostridia Ruminococcaceae Subdoligranulum NZ_ACWW00000000
Anaerostipes hadrus DSM 3319 Firmicutes Clostridia Clostridiales Lachnospiraceae Anaerostipes NZ_AMEY00000000
Clostridium celatum DSM 1785 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_AMEZ00000000
Clostridium difficile 70-100-2010 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_AGAC00000000
Clostridium perfringens WAL-14572 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ADLP00000000
Clostridium symbiosum WAL-14163 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NZ_ADLQ00000000
Desulfitobacterium hafniense DP7 Firmicutes Clostridia Clostridiales Peptococcaceae Desulfitobacterium NZ_AFZX00000000
Butyrivibrio fibrisolvens 16/4 Firmicutes Clostridia Clostridiales Lachnospiraceae Butyrivibrio NC_021031
[Clostridium] cf. saccharolyticum K10 Firmicutes Clostridia Clostridiales Clostridiaceae Clostridium NC_021047
Coprococcus catus GD/7 Firmicutes Clostridia Clostridiales Lachnospiraceae Coprococcus NC_021009
Coprococcus sp. ART55/1 Firmicutes Clostridia Clostridiales Lachnospiraceae Coprococcus NC_021018
[Eubacterium] cylindroides T2-87 Firmicutes Clostridia Clostridiales Eubacteriaceae Eubacterium NC_021019
Eubacterium rectale DSM 17629 Firmicutes Clostridia Clostridiales Eubacteriaceae Eubacterium NC_021010
Eubacterium rectale M104/1 Firmicutes Clostridia Clostridiales Eubacteriaceae Eubacterium NC_021044
[Eubacterium] siraeum 70/3 Firmicutes Clostridia Clostridiales Eubacteriaceae Eubacterium NC_021011
Faecalibacterium prausnitzii L2-6 Firmicutes Clostridia Clostridiales Ruminococcaceae Faecalibacterium NC_021042
Faecalibacterium prausnitzii SL3/3 Firmicutes Clostridia Clostridiales Ruminococcaceae Faecalibacterium NC_021020
Roseburia intestinalis M50/1 Firmicutes Clostridia Clostridiales Lachnospiraceae Roseburia NC_021040
Roseburia intestinalis XB6B4 Firmicutes Clostridia Clostridiales Lachnospiraceae Roseburia NC_021012
Ruminococcus champanellensis 18P13 = JCM 17042 Firmicutes Clostridia Clostridiales Ruminococcaceae Ruminococcus NC_021039
Ruminococcus sp. SR1/5 Firmicutes Clostridia Clostridiales Ruminococcaceae Ruminococcus NC_021014
[Eubacterium] siraeum V10Sc8a Firmicutes Clostridia Clostridiales Eubacteriaceae Eubacterium NC_021043
Catenibacterium mitsuokai DSM 15897 Firmicutes Erysipelotrichi Erysipelotrichales Erysipelotrichaceae Catenibacterium NZ_ACCK00000000
Holdemania filiformis DSM 12042 Firmicutes Erysipelotrichi Erysipelotrichales Erysipelotrichaceae Holdemania NZ_ACCF00000000
Coprobacillus sp. 29_1 Firmicutes Erysipelotrichi Erysipelotrichales Erysipelotrichaceae Coprobacillus NZ_ADKX00000000
Coprobacillus sp. D7 Firmicutes Erysipelotrichi Erysipelotrichales Erysipelotrichaceae Coprobacillus NZ_ACDT00000000
Erysipelotrichaceae bacterium 3_1_53 Firmicutes Erysipelotrichi Erysipelotrichales Erysipelotrichaceae NZ_ACTJ00000000
Erysipelotrichaceae bacterium 5_2_54FAA Firmicutes Erysipelotrichi Erysipelotrichales Erysipelotrichaceae NZ_ACZW00000000
Turicibacter sp. HGF1 Firmicutes Erysipelotrichi Erysipelotrichales Erysipelotrichaceae Turicibacter NZ_AEXQ00000000
Turicibacter sanguinis PC909 Firmicutes Erysipelotrichi Erysipelotrichales Erysipelotrichaceae Turicibacter NZ_ADMN00000000
Coprobacillus sp. 3_3_56FAA Firmicutes Erysipelotrichi Erysipelotrichales Erysipelotrichaceae Coprobacillus NZ_ACWL00000000
Coprobacillus sp. 8_2_54BFAA Firmicutes Erysipelotrichi Erysipelotrichales Erysipelotrichaceae Coprobacillus NZ_ACTG00000000
Erysipelotrichaceae bacterium 2_2_44A Firmicutes Erysipelotrichi Erysipelotrichales Erysipelotrichaceae NZ_ADCZ00000000
Erysipelotrichaceae bacterium 21_3 Firmicutes Erysipelotrichi Erysipelotrichales Erysipelotrichaceae NZ_ACTI00000000
Mitsuokella multacida DSM 20544 Firmicutes Negativicutes Selenomonadales Veillonellaceae Mitsuokella NZ_ABWK00000000
Acidaminococcus sp. D21 Firmicutes Negativicutes Selenomonadales Acidaminococcaceae Acidaminococcus NZ_ACGB00000000
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Veillonella sp. 3_1_44 Firmicutes Negativicutes Selenomonadales Veillonellaceae Veillonella NZ_ADCV00000000
Veillonella sp. 6_1_27 Firmicutes Negativicutes Selenomonadales Veillonellaceae Veillonella NZ_ADCW00000000
Veillonella parvula DSM 2008 Firmicutes Negativicutes Selenomonadales Veillonellaceae Veillonella NC_013520
Acidaminococcus intestini RyC-MR95 Firmicutes Negativicutes Selenomonadales Acidaminococcaceae Acidaminococcus NC_016077
Dialister succinatiphilus YIT 11850 Firmicutes Negativicutes Selenomonadales Veillonellaceae Dialister NZ_ADLT00000000
Megamonas funiformis YIT 11815 Firmicutes Negativicutes Selenomonadales Veillonellaceae Megamonas NZ_ADMB00000000
Megamonas hypermegale ART12/1 Firmicutes Negativicutes Selenomonadales Veillonellaceae Megamonas NC_021041
Fusobacterium sp. 4_1_13 Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium NZ_ACDE00000000
Fusobacterium varium ATCC 27725 Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium NZ_ACIE00000000
Fusobacterium sp. 1_1_41FAA Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium NZ_ADGG00000000
Fusobacterium sp. 11_3_2 Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium NZ_ACUO00000000
Fusobacterium sp. 2_1_31 Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium NZ_ACDC00000000
Fusobacterium sp. 21_1A Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium NZ_ADEE00000000
Fusobacterium sp. 3_1_27 Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium NZ_ADGF00000000
Fusobacterium sp. 3_1_33 Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium NZ_ACQE00000000
Fusobacterium sp. 3_1_36A2 Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium NZ_ACPU00000000
Fusobacterium sp. 3_1_5R Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium NZ_ACDD00000000
Fusobacterium sp. 7_1 Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium NZ_ACDF00000000
Fusobacterium sp. D11 Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium NZ_ACDS00000000
Fusobacterium sp. D12 Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium NZ_ACDG00000000
Fusobacterium gonidiaformans ATCC 25563 Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium NZ_ACET00000000
Fusobacterium mortiferum ATCC 9817 Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium NZ_ACDB00000000
Fusobacterium ulcerans ATCC 49185 Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium NZ_ACDH00000000
Fusobacterium sp. 12_1B Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium NZ_AGWJ00000000
Fusobacterium necrophorum subsp. funduliforme 1_1_36S Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium NZ_ADLZ00000000
Fusobacterium nucleatum subsp. animalis ATCC 51191 Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium NZ_AFQD00000000
Burkholderia oklahomensis EO147 Proteobacteria Betaproteobacteria Burkholderiales Burkholderiaceae Burkholderia NZ_ABBF00000000
Burkholderiales bacterium 1_1_47 Proteobacteria Betaproteobacteria Burkholderiales NZ_ADCQ00000000
Laribacter hongkongensis HLHK9 Proteobacteria Betaproteobacteria Neisseriales Neisseriaceae Laribacter NC_012559
Neisseria macacae ATCC 33926 Proteobacteria Betaproteobacteria Neisseriales Neisseriaceae Neisseria NZ_AFQE00000000
Oxalobacter formigenes HOxBLS Proteobacteria Betaproteobacteria Burkholderiales Oxalobacteraceae Oxalobacter NZ_ACDP00000000
Oxalobacter formigenes OXCC13 Proteobacteria Betaproteobacteria Burkholderiales Oxalobacteraceae Oxalobacter NZ_ACDQ00000000
Parasutterella excrementihominis YIT 11859 Proteobacteria Betaproteobacteria Burkholderiales Sutterellaceae Parasutterella NZ_AFBP00000000
Ralstonia sp. 5_7_47FAA Proteobacteria Betaproteobacteria Burkholderiales Burkholderiaceae Ralstonia NZ_ACUF00000000
Sutterella wadsworthensis 3_1_45B Proteobacteria Betaproteobacteria Burkholderiales Sutterellaceae Sutterella NZ_ADMF00000000
Ralstonia sp. 5_2_56FAA Proteobacteria Betaproteobacteria Burkholderiales Burkholderiaceae Ralstonia NZ_ACTT00000000
Sutterella parvirubra YIT 11816 Proteobacteria Betaproteobacteria Burkholderiales Sutterellaceae Sutterella NZ_AFBQ00000000
Sutterella wadsworthensis 2_1_59BFAA Proteobacteria Betaproteobacteria Burkholderiales Sutterellaceae Sutterella NZ_ADMG00000000
Desulfovibrio piger ATCC 29098 Proteobacteria Deltaproteobacteria Desulfovibrionales Desulfovibrionaceae Desulfovibrio NZ_ABXU00000000
Desulfovibrio piger GOR1 Proteobacteria Deltaproteobacteria Desulfovibrionales Desulfovibrionaceae Desulfovibrio NC_DpigerGOR1
Bilophila wadsworthia 3_1_6 Proteobacteria Deltaproteobacteria Desulfovibrionales Desulfovibrionaceae Bilophila NZ_ADCP00000000
Desulfovibrio sp. 3_1_syn3 Proteobacteria Deltaproteobacteria Desulfovibrionales Desulfovibrionaceae Desulfovibrio NZ_ADDR00000000
Bilophila sp. 4_1_30 Proteobacteria Deltaproteobacteria Desulfovibrionales Desulfovibrionaceae Bilophila NZ_ADCO00000000
Desulfovibrio sp. 6_1_46AFAA Proteobacteria Deltaproteobacteria Desulfovibrionales Desulfovibrionaceae Desulfovibrio NZ_ACWM00000000
Helicobacter pylori HPAG1 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_008086
Arcobacter butzleri JV22 Proteobacteria Epsilonproteobacteria Campylobacterales Campylobacteraceae Arcobacter NZ_AEPT00000000
Campylobacter coli JV20 Proteobacteria Epsilonproteobacteria Campylobacterales Campylobacteraceae Campylobacter NZ_AEER00000000
Campylobacter concisus 13826 Proteobacteria Epsilonproteobacteria Campylobacterales Campylobacteraceae Campylobacter NC_009802
Campylobacter curvus 525.92 Proteobacteria Epsilonproteobacteria Campylobacterales Campylobacteraceae Campylobacter NC_009715
Campylobacter hominis ATCC BAA-381 Proteobacteria Epsilonproteobacteria Campylobacterales Campylobacteraceae Campylobacter NC_009714
Campylobacter jejuni subsp. jejuni 81-176 Proteobacteria Epsilonproteobacteria Campylobacterales Campylobacteraceae Campylobacter NZ_AASL00000000
Campylobacter jejuni subsp. jejuni CG8486 Proteobacteria Epsilonproteobacteria Campylobacterales Campylobacteraceae Campylobacter NZ_AASY00000000
Campylobacter jejuni subsp. jejuni HB93-13 Proteobacteria Epsilonproteobacteria Campylobacterales Campylobacteraceae Campylobacter NZ_AANQ00000000
Campylobacter jejuni subsp. jejuni ICDCCJ07001 Proteobacteria Epsilonproteobacteria Campylobacterales Campylobacteraceae Campylobacter NC_014802
Campylobacter jejuni subsp. jejuni NCTC 11168 Proteobacteria Epsilonproteobacteria Campylobacterales Campylobacteraceae Campylobacter NC_002163
Campylobacter upsaliensis JV21 Proteobacteria Epsilonproteobacteria Campylobacterales Campylobacteraceae Campylobacter NZ_AEPU00000000
Campylobacter upsaliensis RM3195 Proteobacteria Epsilonproteobacteria Campylobacterales Campylobacteraceae Campylobacter NZ_AAFJ00000000
Helicobacter bilis ATCC 43879 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_ACDN00000000
Helicobacter bizzozeronii CIII-1 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_015674
Helicobacter canadensis MIT 98-5491 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_ABQS00000000
Helicobacter cinaedi CCUG 18818 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_ABQT00000000
Helicobacter pullorum MIT 98-5489 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_ABQU00000000
Helicobacter pylori 26695 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_000915
Helicobacter pylori 98-10 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_ABSX00000000
Helicobacter pylori B128 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_ABSY00000000
Helicobacter pylori B38 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_012973
Helicobacter pylori B8 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_014256
Helicobacter pylori G27 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_011333
Helicobacter pylori J99 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_000921
Helicobacter pylori P12 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_011498
Helicobacter pylori PeCan4 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_014555
Helicobacter pylori Shi470 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_010698
Helicobacter pylori SJM180 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_014560
Helicobacter winghamensis ATCC BAA-430 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_ACDO00000000
Campylobacter sp. 10_1_50 Proteobacteria Epsilonproteobacteria Campylobacterales Campylobacteraceae Campylobacter NZ_ACWJ00000000
Campylobacter jejuni subsp. jejuni M1 Proteobacteria Epsilonproteobacteria Campylobacterales Campylobacteraceae Campylobacter NC_017280
Helicobacter pylori 2017 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_017374
Helicobacter pylori 2018 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_017381
Helicobacter pylori 35A Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_017360
Helicobacter pylori 51 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_017382
Helicobacter pylori 83 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_017375
Helicobacter pylori 908 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_017357
Helicobacter pylori Cuz20 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_017358
Helicobacter pylori F16 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_017368
Helicobacter pylori F30 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_017365
Helicobacter pylori F32 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_017366
Helicobacter pylori F57 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_017367
Helicobacter pylori Gambia94/24 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_017364
Helicobacter pylori HPKX_438_AG0C1 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_ABJO00000000
Helicobacter pylori India7 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_017372
Helicobacter pylori Lithuania75 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_017362
Helicobacter pylori Sat464 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_017356
Helicobacter pylori SouthAfrica7 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_017361
Helicobacter pylori v225d Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_017355
Helicobacter pylori GAM100Ai Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_ANFP00000000
Helicobacter pylori GAM101Biv Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APCW00000000
Helicobacter pylori GAM103Bi Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APCX00000000
Helicobacter pylori GAM105Ai Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APCY00000000
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Helicobacter pylori GAM114Ai Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDA00000000
Helicobacter pylori GAM115Ai Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDB00000000
Helicobacter pylori GAM118Bi Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDD00000000
Helicobacter pylori GAM119Bi Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDE00000000
Helicobacter pylori GAM120Ai Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDF00000000
Helicobacter pylori GAM121Aii Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDG00000000
Helicobacter pylori GAM201Ai Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDC00000000
Helicobacter pylori GAM210Bi Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDH00000000
Helicobacter pylori GAM231Ai Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDI00000000
Helicobacter pylori GAM239Bi Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDJ00000000
Helicobacter pylori GAM244Ai Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDK00000000
Helicobacter pylori GAM245Ai Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDL00000000
Helicobacter pylori GAM246Ai Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDM00000000
Helicobacter pylori GAM249T Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDN00000000
Helicobacter pylori GAM250AFi Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDO00000000
Helicobacter pylori GAM250T Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDP00000000
Helicobacter pylori GAM252Bi Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDQ00000000
Helicobacter pylori GAM252T Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDR00000000
Helicobacter pylori GAM254Ai Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDS00000000
Helicobacter pylori GAM260ASi Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDT00000000
Helicobacter pylori GAM260Bi Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDU00000000
Helicobacter pylori GAM260BSi Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDV00000000
Helicobacter pylori GAM263BFi Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDW00000000
Helicobacter pylori GAM264Ai Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDX00000000
Helicobacter pylori GAM265BSii Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDY00000000
Helicobacter pylori GAM268Bii Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APDZ00000000
Helicobacter pylori GAM270ASi Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APEA00000000
Helicobacter pylori GAM42Ai Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APEB00000000
Helicobacter pylori GAM71Ai Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APEC00000000
Helicobacter pylori GAM80Ai Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APED00000000
Helicobacter pylori GAM83Bi Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APEE00000000
Helicobacter pylori GAM83T Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APEF00000000
Helicobacter pylori GAM93Bi Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APEG00000000
Helicobacter pylori GAM96Ai Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APEH00000000
Helicobacter pylori GAMchJs106B Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APEI00000000
Helicobacter pylori GAMchJs114i Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APEJ00000000
Helicobacter pylori GAMchJs117Ai Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APEK00000000
Helicobacter pylori GAMchJs124i Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APEL00000000
Helicobacter pylori GAMchJs136i Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APEM00000000
Helicobacter pylori HP116Bi Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APEN00000000
Helicobacter pylori HP250AFii Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APEO00000000
Helicobacter pylori HP250AFiii Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APEP00000000
Helicobacter pylori HP250AFiV Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APEQ00000000
Helicobacter pylori HP250ASi Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APER00000000
Helicobacter pylori HP250ASii Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APES00000000
Helicobacter pylori HP250BFi Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APET00000000
Helicobacter pylori HP250BFii Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APEU00000000
Helicobacter pylori HP250BFiii Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APEV00000000
Helicobacter pylori HP250BFiV Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APEW00000000
Helicobacter pylori HP250BSi Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APEX00000000
Helicobacter pylori HP260AFi Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APEY00000000
Helicobacter pylori HP260AFii Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APEZ00000000
Helicobacter pylori HP260ASii Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APFA00000000
Helicobacter pylori HP260BFii Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APFB00000000
Helicobacter pylori HP260Bi Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NZ_APFC00000000
Helicobacter pylori 35A Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_017360
Helicobacter pylori 83 Proteobacteria Epsilonproteobacteria Campylobacterales Helicobacteraceae Helicobacter NC_017375
Escherichia coli str. K-12 substr. MG1655 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NC_000913
Escherichia fergusonii ATCC 35469 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NC_011740
Vibrio cholerae O1 biovar eltor str. N16961 chromosome I Proteobacteria Gammaproteobacteria Vibrionales Vibrionaceae Vibrio NC_002505
Citrobacter youngae ATCC 29220 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Citrobacter NZ_ABWL00000000
Providencia alcalifaciens DSM 30120 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Providencia NZ_ABXW00000000
Providencia stuartii ATCC 25827 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Providencia NZ_ABJD00000000
Providencia rustigianii DSM 4541 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Providencia NZ_ABXV00000000
Proteus penneri ATCC 35198 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Proteus NZ_ABVP00000000
Providencia rettgeri DSM 1131 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Providencia NZ_ACCI00000000
Shigella sp. D9 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ACDL00000000
Enterobacter cancerogenus ATCC 35316 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Enterobacter NC_Ecancerogenus
Acinetobacter baumannii AB900 Proteobacteria Gammaproteobacteria Pseudomonadales Moraxellaceae Acinetobacter NZ_ABXK00000000
Acinetobacter junii SH205 Proteobacteria Gammaproteobacteria Pseudomonadales Moraxellaceae Acinetobacter NZ_ACPM00000000
Citrobacter sp. 30_2 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Citrobacter NZ_ACDJ00000000
Citrobacter koseri ATCC BAA-895 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Citrobacter NC_009792
Edwardsiella tarda ATCC 23685 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Edwardsiella NZ_ADGK00000000
Enterobacteriaceae bacterium 9_2_54FAA Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae NZ_ADCU00000000
Escherichia sp. 3_2_53FAA Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ACAC00000000
Escherichia sp. 4_1_40B Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ACDM00000000
Escherichia albertii TW07627 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ABKX00000000
Escherichia coli ATCC 8739 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NC_010468
Escherichia coli str. K-12 substr. DH10B Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NC_010473
Escherichia coli MS 107-1 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADWV00000000
Escherichia coli MS 115-1 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADTL00000000
Escherichia coli MS 116-1 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADTZ00000000
Escherichia coli MS 119-7 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADWU00000000
Escherichia coli MS 124-1 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADWT00000000
Escherichia coli MS 145-7 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADWS00000000
Escherichia coli MS 146-1 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADTN00000000
Escherichia coli MS 175-1 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADUB00000000
Escherichia coli MS 182-1 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADTM00000000
Escherichia coli MS 185-1 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADUE00000000
Escherichia coli MS 187-1 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADTQ00000000
Escherichia coli MS 196-1 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADUD00000000
Escherichia coli MS 198-1 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADTJ00000000
Escherichia coli MS 200-1 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADUC00000000
Escherichia coli MS 21-1 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADTR00000000
Escherichia coli MS 45-1 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADTO00000000
Escherichia coli MS 69-1 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADTP00000000
Escherichia coli MS 78-1 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADTY00000000
Escherichia coli MS 84-1 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADTK00000000




Table 2.6. (cont.) 
  
Escherichia coli O157_H7 str. Sakai Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NC_002695
Escherichia coli O26_H11 str. 11368 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NC_013361
Escherichia coli O55_H7 str. CB9615 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NC_013941
Escherichia coli SE11 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NC_011415
Escherichia coli UTI89 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NC_007946
Grimontia hollisae CIP 101886 Proteobacteria Gammaproteobacteria Vibrionales Vibrionaceae Grimontia NZ_ADAQ00000000
Klebsiella sp. 1_1_55 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Klebsiella NZ_ACXA00000000
Klebsiella sp. MS 92-3 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Klebsiella NZ_AFBO00000000
Succinatimonas hippei YIT 12066 Proteobacteria Gammaproteobacteria Aeromonadales Succinivibrionaceae Succinatimonas NZ_AEVO00000000
Vibrio cholerae MZO-2 Proteobacteria Gammaproteobacteria Vibrionales Vibrionaceae Vibrio NZ_AAWF00000000
Vibrio cholerae V52 Proteobacteria Gammaproteobacteria Vibrionales Vibrionaceae Vibrio NZ_AAKJ00000000
Vibrio furnissii CIP 102972 Proteobacteria Gammaproteobacteria Vibrionales Vibrionaceae Vibrio NZ_ACZP00000000
Vibrio mimicus MB451 Proteobacteria Gammaproteobacteria Vibrionales Vibrionaceae Vibrio NZ_ADAF00000000
Vibrio sp. RC341 Proteobacteria Gammaproteobacteria Vibrionales Vibrionaceae Vibrio NZ_ACZT00000000
Yersinia bercovieri ATCC 43970 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Yersinia NZ_AALC00000000
Yersinia pseudotuberculosis IP 31758 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Yersinia NC_009708
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Salmonella NC_003197
Acinetobacter radioresistens SH164 Proteobacteria Gammaproteobacteria Pseudomonadales Moraxellaceae Acinetobacter NZ_ACPO00000000
Citrobacter freundii 4_7_47CFAA Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Citrobacter NZ_ADLG00000000
Edwardsiella tarda FL6-60 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Edwardsiella NC_017309
Escherichia sp. 1_1_43 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ACID00000000
Escherichia coli 042 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NC_017626
Escherichia coli 536 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NC_008253
Escherichia coli B7A Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_AAJT00000000
Escherichia coli DH1 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NC_017625
Escherichia coli E110019 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_AAJW00000000
Escherichia coli E24377A Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NC_009786
Escherichia coli ED1a Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NC_011745
Escherichia coli F11 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_AAJU00000000
Escherichia coli HS Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NC_009800
Escherichia coli IHE3034 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NC_017628
Escherichia coli LF82 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NC_011993
Escherichia coli O157:H7 str. EC508 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ABHW00000000
Escherichia coli SE15 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NC_013654
Escherichia coli UM146 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NC_017630
Hafnia alvei ATCC 51873 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Hafnia NZ_AGCI00000000
Klebsiella sp. 4_1_44FAA Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Klebsiella NZ_ACWO00000000
Pseudomonas sp. 2_1_26 Proteobacteria Gammaproteobacteria Pseudomonadales Pseudomonadaceae Pseudomonas NZ_ACWU00000000
Vibrio furnissii NCTC 11218 chromosome 1 Proteobacteria Gammaproteobacteria Vibrionales Vibrionaceae Vibrio NC_016602
Yersinia enterocolitica subsp. palearctica Y11 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Yersinia NC_017564
Yokenella regensburgei ATCC 43003 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Yokonella NZ_AGCL00000000
Escherichia coli MS 110-3 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADTW00000000
Escherichia coli MS 117-3 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADTS00000000
Escherichia coli MS 153-1 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADTX00000000
Escherichia coli MS 16-3 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADUA00000000
Escherichia coli MS 57-2 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADUG00000000
Escherichia coli MS 60-1 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella NZ_ADUF00000000
Klebsiella pneumoniae subsp. pneumoniae WGLW3 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Klebsiella NZ_AMLN00000000
Klebsiella pneumoniae subsp. pneumoniae WGLW5 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Klebsiella NZ_AMLO00000000
Proteus mirabilis WGLW6 Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Proteus NZ_AMGT00000000
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CHAPTER 3: TRANSCRIPTIONAL AND TRANSLATIONAL ACTING TPP 
RIBOSWITCHES IDENTIFIED AMONG BACTEROIDES SPECIES  
Abstract: 
 Thiamine (vitamin B1) and its phosphorylated moieties are essential for all living 
organisms. Unfortunately, little is understood about how this cofactor impacts and shapes 
the human microbiome. Previous work has shown that both thiamine biosynthesis and 
transport are critical to the fitness of Bacteroides species. Recent studies have led to a 
better understanding of thiamine biosynthesis and transport genes in the gut. As of yet, 
little work has been done to characterize the regulation of these critical thiamine 
biosynthesis and transport operons among the prominent gut phylum Bacteroidetes. To 
this end, we have selected three representative and abundant species from the phylum 
Bacteroidetes: Bacteroides thetaiotaomicron, Bacteroides uniformis, and Bacteroides 
vulgatus in which to study thiamine based regulatory mechanisms. These regulatory 
features are highly conserved cis-acting thiamine pyrophosphate (TPP) riboswitches. TPP 
riboswitches impact the expression of thiamine biosynthesis and transport genes under 
their control. In the three selected organisms we have identified distinct transcriptomic 
profiles in response to exogenous thiamine. These profiles include distinct responses 
across thiamine biosynthesis and transport operons. We also constructed and tested 
translational fusions of the TPP riboswitches found in B. thetaiotaomicron, B. uniformis, 
and B. vulgatus in which we found pronounced regulation of transport and biosynthetic 
operons. Together these data show that Bacteroides species employ both transcriptional 
and translational acting TPP riboswitches. B. thetaiotaomicron is novel in the utilization 
	   102	  
of both transcriptional and translational acting TPP riboswitches. In addition, B. 
uniformis and B. vulgatus exclusively leverage transcriptional acting TPP 
riboswitches.  The mechanism of TPP riboswitch regulation appears to be linked to the 
distance from the first start codon in the regulon of the TPP riboswitch. Consequently, 





 Characterization of the regulatory mechanisms of TPP among gut microbes may 
help inform how gut microbiomes are formed and give insight into relative abundances of 
certain organisms in the gastrointestinal tract. Our study confirms there is regulation of 
thiamine biosynthesis and transport among Bacteroides species. In addition, our work 
shows how different organisms respond to thiamine starvation. Our data also implies 
Bacteroides species are novel in employing both transcriptional and translational acting 
TPP riboswitches in order to rapidly respond to the shifting environmental availability of 
thiamine in the gut. This work can inform how gut microbes will respond to and cope to 
changes in the availability of this essential cofactor and may help in therapeutic 
approaches to altering dysbiotic microbiomes. 
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Introduction: 
 Thiamine pyrophosphate (TPP) is the active, cofactor form of thiamine (vitamin 
B1). Thiamine is required by all living organisms to perform metabolic activities. 
Thiamine requiring pathways include central metabolism, branched chain amino acid 
biosynthesis, and nucleotide synthesis (11, 21, 32, 42). Humans primarily acquire 
thiamine from their diet and convert it to the cofactor form, TPP (17, 37). In addition to 
dietary thiamine, it is believed microbial communities in the gastrointestinal tract also 
provide thiamine to the host (38, 48). This thiamine is likely supplied by the indigenous 
gut microbes that possess ability to biosynthesize thiamine and TPP de novo (8,36). In 
contrast, studies have show that microbes common to the gastrointestinal tract sequester 
thiamine (1). The conflicting reports imply that more investigation is required to fully 
understand the role of thiamine in the gut. In addition, thiamine availability has been 
correlatively linked to the structure of microbial communities (51). Irregular host 
thiamine levels have also been linked to dysbiotic states such as Crohn’s Disease, 
Irritable Bowel Disease, and Dementia (17, 19, 33). These studies provide insight into 
how thiamine and microbial species impacts human health. However, little is known 
about how thiamine impact the prominent gut phylum Bacteroidetes. 
Work to characterize and understand thiamine biosynthesis and transport among 
many microbes such as Escherichia coli, Salmonella enterica, Bacillus subtilis, and 
Bacteroides thetaiotaomicron and the role it plays in their fitness continues (4, 8). A 
complex suite of enzymes performs thiamine biosynthesis. Despite this diversity, 
thiamine biosynthesis is performed through a conserved bifurcated pathway. TPP is 
biosynthesized by first synthesizing 4-amino-2-methyl-5-diphosphomethylpyrimidine 
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(HMP-PP) and 2-(2-carboxy-4-methylthiazol- 5-yl) ethyl phosphate (cTHz-P). HMP-PP 
and cTHz-P are condensed into thiamine monophosphate (TMP) and then phosphorylated 
to the active TPP (4). While the steps of TPP biosynthesis are conserved. The impact 
thiamine biosynthesis has on the transcriptome and metabolome of an organism is 
remarkably diverse (2, 3, 8, 30).  In addition to thiamine biosynthesis, there are many 
thiamine, thiamine monophosphate (TMP), TPP, and thiamine precursor transporters 
found across all domains of life (8, 14, 34, 35, 39, 49). These diverse thiamine transport 
and biosynthesis pathways are regulated by highly conserved TPP riboswitches. 
 Riboswitches are a highly conserved cis-encoded, cis-acting regulatory RNAs 
found in the untranslated region of the messenger RNA. These riboswitches control 
expression by binding the TPP aptamer and negatively regulating the genes under their 
control (7, 43, 50). TPP riboswitches are unique because they are the only riboswitch that 
can be found in all three domains of life (43). TPP riboswitches are so highly conserved, 
they have become key in identifying thiamine biosynthesis and transport genes (36).  In 
bacteria, TPP riboswitches are known to regulate biosynthesis and transport genes at 
either the transcriptional or translational level. Transcriptional acting TPP riboswitches 
change the secondary structure of the mRNA creating a premature terminator stem-loop 
stopping transcription. TPP riboswitches that block translation of their regulon do so by 
occluding ribosomal binding sites (50). Transcriptional or translational acting TPP 
riboswitches are canonically believed to be split between Gram positive and Gram-
negative bacteria respectively (28). It should be noted; previously characterized 
translational acting TPP riboswitches in E. coli also impact mRNA levels when 
significant portions of the coding region are added to transcriptional fusions (6). While 
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TPP riboswitch structures and functions have been studied and characterized in model 
organism (e.g. E. coli and B. subtilis) there has been surprisingly little characterization of 
these conserved regulatory elements among the abundant and prominent gut phylum, 
Bacteroidetes.  
Initial computational analysis predicts that TPP riboswitches are present and 
regulate predicted thiamin biosynthesis and transport pathways across the Bacteroidetes 
(34, 36). TPP riboswitch controlled genes in Bacteroides thetaiotaomicron, a prominent 
member of the Bacteroidetes, have recently been characterized (8, 14). These data have 
shown that both thiamine transport and biosynthesis are critical to the fitness of B. 
thetaiotaomicron. Despite understanding that thiamine acquisition is important among 
Bacteroidetes species; little work has been done to characterize how the predicted TPP 
riboswitches impact these genes. Here, we have attempted to study how TPP riboswitches 
are utilized by the Bacteroidetes. We have (i) leveraged transcriptomic data to observe 
how exogenous thiamine impacts the whole transcriptome in addition to TPP riboswitch 
controlled genes. In addition, we (ii) leveraged translational fusions on individual TPP 
riboswitches from representative and abundant Bacteroides species.  Lastly, we (iii) 
carried out in silico analysis and identification of TPP riboswitches across the 
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Results: 
Global transcriptional responses vary between Bacteroides species 
 We have previously shown B. thetaiotaomicron differentially expresses certain 
metabolic pathways when thiamine is scarce (8). To determine if this trend is consistent 
across Bacteroides species we replicated an RNA sequencing experiment that we 
performed previously on B. thetaiotaomicron in Costliow and Degnan 2017 (8). To this 
end, strand-specific RNA sequencing of cells grown in minimal medium that was 
thiamine replete (15 µM) or deplete was carried out for Bacteroides uniformis and 
Bacteroides vulgatus in comparison to our previously published RNA sequencing data 
(FIG 3.1). Samples of each species were sequenced in duplicate for both thiamine replete 
and deplete conditions. In total, 173,849,709 reads were generated (ranging between 8 
and 20 million reads per sample), quality trimmed, filtered, and analyzed utilizing 
Rockhopper (Table 3.1) (8, 23, 45). 
 Whole transcriptomic responses to exogenous thiamine were markedly different 
between B. thetaiotaomicron, B. uniformis, and B. vulgatus. As previously shown, B. 
thetaiotaomicron had 151 genes significantly (false-discovery rate [FDR], q ≤ 0.05) 
differentially expressed by ≥ 2-fold in excess thiamine (FIG 3.1A). Significantly down 
regulated genes are representative of thiamine biosynthesis, amino acid biosynthesis, 
TCA cycle enzymes, purine, and pyruvate metabolism (8). In contrast to B. 
thetaiotaomicron, transcriptomic responses observed in B. uniformis and B. vulgatus are 
more subdued in response to excess thiamine (FIG 3.1B and C). Between B. vulgatus and 
B. uniformis, only B. uniformis showed a significant response to exogenous thiamine 
(FIG 3.1B). B. uniformis down regulated 6 genes significantly, all of which are readily 
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identifiable as TPP riboswitch controlled thiamine biosynthesis genes. In addition, the 
predicted thiamine transport operon B. vulgatus did not show a transcriptional response to 
exogenous thiamine (FIG 3.1C). This lack of a response may be due in part to the unique 
genetic context of B. vulgatus and other closely related Bacteroides species. B. vulgatus 
does not have a readily identifiable outer membrane transporter to import thiamine into 
the cell. Lack of the outer membrane transporter suggests that thiamine may not be 
imported into the cell. In addition, B. vulgatus does not have a TPP riboswitch preceding 
the computationally predicted inner membrane transporter, pnuT. The absence of a TPP 
riboswitch preceding pnuT may suggest that the inner membrane transporter does not 
have specificity for thiamine. Both factors imply the lack of a significant transcriptomic 
response in B. vulgatus to exogenous thiamine is due in part to an absence of thiamine 
transport (8). 
 The different transcriptomic profiles of B. thetaiotaomicron, B. uniformis, and B. 
vulgatus in response to thiamine were unexpected. All three species are closely related 
with similar thiamine acquisition and biosynthesis genes. The divergent transcriptomic 
responses of closely related organisms that a complex level of diversity and regulation 
exist in the gut and that thiamine may play a key role in the structure of the gut 
microbiome. 
 
Thiamine biosynthesis and transport genes have divergent transcriptional responses 
 The impact of the predicted TPP riboswitches regulation on thiamine biosynthesis 
and transport genes is not understood. To better understand the role of TPP riboswitches 
we investigated the riboswitch-controlled operons mentioned above. All together 6 TPP 
riboswitch controlled operons were investigated in B. thetaiotaomicron (3), B. uniformis 
	   108	  
(2), and B. vulgatus (1) (FIG 3.2). B. thetaiotaomicron has three TPP riboswitch 
controlled operons (1 biosynthesis and 2 transport operons). Of these three operons only 
the biosynthetic operon had genes that were significantly (false-discovery rate [FDR], q ≤ 
0.05) down regulated in excess exogenous thiamine. Transport genes in B. 
thetaiotaomicron did not show significant transcriptional regulation, but that does not 
rule out that the TPP riboswitches are acting at the level of translation, the canonical 
Gram-negative TPP riboswitch mechanism (FIG 3.2A). The TPP riboswitch controlled 
operons in B. uniformis show transcriptional response to exogenous thiamine. The 
thiamine biosynthesis operon regulated by a TPP riboswitch had a 3-fold decrease in 
expression in which 6 of the 8 genes were deemed significantly so (false-discovery rate 
[FDR], q ≤ 0.05). The single three-gene thiamine transport operon also showed ~2.5 fold 
change in expression, but the changes in transcript level were not considered significant 
(q > 0.05) (FIG 3.2B). Again, B. vulgatus does not show a response to exogenous 
thiamine even at the TPP riboswitch controlled thiamine biosynthesis operon (FIG 3.2C). 
It is worth noting B. vulgatus does not have a riboswitch controlled pnu-like (inner 
membrane) or tonB (outer membrane) transporters, making it likely that there is not a 
specific thiamine transport system (8). 
To confirm the RNA sequencing profiles observed in B. thetaiotaomicron, B. 
uniformis, and B. vulgatus, RT-qPCR was performed. Probes for RT-qPCR were 
designed for a biosynthesis gene (thiC), the outer membrane tonB dependent transporter 
(OMthi), and the predicted inner membrane transporter (pnuT) for each organism they are 
present in. Among the RT-qPCR probes, the biosynthesis gene, thiC, is regulated by a 
TPP riboswitch in all three organisms tested. Consequently, OMthi and pnuT are only 
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under the control of a TPP riboswitch in B. thetaiotaomicron and B. uniformis. In 
addition, despite lacking a TPP riboswitch only the inner membrane transporter can be 
identified in B. vulgatus (FIG 3.3). The trends observed in all three organisms for RNA 
sequencing were replicated in the RT-qPCR experiments. B. thetaiotaomicron and B. 
uniformis both showed a strong transcriptional response at thiC. Respectively, thiC is 
expressed 60-fold and 2-fold higher in 0 nM thiamine as compared to its expression in 10 
µM thiamine in both B. thetaiotaomicron and B. uniformis (FIG 3.3A and B). The 
expression of the riboswitch regulated inner (pnuT) and outer (OMthi) membrane 
thiamine transporter in B. thetaiotaomicron showed a minimal change in expression 
between high and low thiamine conditions (FIG 3.3A). In contrast to B. thetaiotaomicron, 
B. uniformis shows a strong transcriptional response across the TPP riboswitch controlled 
operon that contains both OMthi and pnuT. Respectively, OMthi and pnuT are 
significantly up regulated (p < 0.05) 2.8-fold and 2.7-fold in the absence of thiamine (FIG 
3.3B). RT-qPCR also validated that B. vulgatus appears to be transcriptionally blind to 
exogenous thiamine. The expression of the riboswitch controlled thiC gene shows no 
significant response. In addition, the predicted inner membrane thiamine transporter also 
shows no response. It is worth noting, the predicted pnuT lacks a TPP riboswitch. The 
lack of a transport regulating riboswitch suggests that the predicted pnuT may be in active 
or is not specific for thiamine. 
 These transcriptional data suggest thiamine biosynthesis can be dramatically 
altered by exogenous thiamine when a readily identifiable thiamine transport system is 
present. All regulation observed is likely performed by the predicted TPP riboswitches as 
proteins that regulate these pathways have not been identified among bacteria (28). 
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Bacteroides utilize transcriptional and translational acting TPP riboswitches 
 In addition to RT-qPCR, we investigated if TPP riboswitch controlled operons 
that did not show a transcriptional response to exogenous thiamine were possibly 
regulating at the level of translation. To this end, we built translational fusions of the 
nanoluciferase gene in frame to the first three codons of genes under the control of a TPP 
riboswitch. All nanoluciferase fusions are under control of their native promoters in 
addition to the cis-acting TPP riboswitches (20, 24). Fusions for all six predicted TPP 
riboswitches in B. thetaiotaomicron (3), B. uniformis (2), and B. vulgatus (1) were tested 
across various exogenous thiamine concentrations (0 - 10,000 nM). Control vectors of the 
nanoluciferase gene without a promoter were tested in each of the bacterial backgrounds 
at 10,000 and 0 nM concentrations. These controls showed that thiamine alone did not 
significantly alter luminescence (RLU/OD630: 750-956). These fusions along with 
additional RT-qPCR analysis provided insight into the mechanism of TPP riboswitch 
regulation (FIG 3.4). In addition, the nanoluciferase fusions provided the concentrations 
of thiamine required for TPP riboswitch regulation among Bacteroides species (FIG 
3.4A-D). 
 Unsurprisingly, strong regulatory responses in line with our RNAseq and RT-
qPCR results (FIG 3.2 and 3) were observed. The nanoluciferase gene under the control 
of the thiamine biosynthesis riboswitch of B. thetaiotaomicron (Bt pTPP1-NanoLuc) 
showed significant down regulation as the concentration of thiamine increased. In 
addition, the Bt pTPP1-NanoLuc fusion showed that an exogenous concentration of 
thiamine greater than 1 nM was required significantly decrease expression (p ≤0.05, 
student's t-test) of thiamine biosynthesis in B. thetaiotaomicron (FIG 3.4A). In contrast to 
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transcriptomic data that showed no response (FIG 3.2A and 3A); significant (p ≤0.05, 
student's t-test) down regulation of transport regulating riboswitches in B. 
thetaiotaomicron (Bt pTPP2/3-NanoLuc) are reached when exogenous concentrations of 
thiamine are above 10 nM (FIG 3.4A). The above data in coordination with the 
nanoluciferase data suggest that B. thetaiotaomicron is novel in utilizing both 
transcriptional (Bt pBtTPP1-NanoLuc) and translational (Bt pTPP2/3-NanoLuc) acting 
TPP riboswitches. 
 In agreement with the aforementioned transcriptional data (FIG 3.2B and 3B), 
both TPP riboswitches in B. uniformis significantly (p ≤0.05, student's t-test) regulate the 
genes under their control (FIG 3.4B). These data suggest that both TPP riboswitches in B. 
uniformis act at the level of transcription. Consistent with trends observed in B. 
thetaiotaomicron, the TPP riboswitch that controls expression of biosynthesis (Bu 
pBuTPP1-NanoLuc) is significantly down regulated when external thiamine 
concentrations exceed 1 nM. In addition, the transport regulating riboswitch of B. 
uniformis (Bu pBuTPP2-NanoLuc) are significantly down regulated at thiamine 
concentrations above 10 nM (FIG 3.4B). 
  Also in agreement with our previous transcriptional data (FIG 3.2C and 3.3C), the 
thiamine biosynthesis regulating riboswitch in B. vulgatus (Bv pBvTPP-NanoLuc) does 
not show any change in expression across various concentrations of exogenous thiamine 
(FIG 3.4C). The lack of a response in B. vulgatus is likely due to the lack of a defined 
thiamine transport system. To ensure the TPP riboswitch in B. vulgatus was actually 
active and functional we moved pBvTPP-NanoLuc into a B. thetaiotaomicron 
background (Bt pBvTPP-NanoLuc). B. thetaiotaomicron, unlike B. vulgatus, has an 
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active and characterized transport system (8, 14). In a B. thetaiotaomicron background 
the TPP riboswitch of B. vulgatus responds to exogenous thiamine. Bt pBvTPP-NanoLuc 
is significantly down regulated at exogenous concentrations of thiamine equal to or 
greater than 1 nM (FIG 3.4D).This response is similar to both the B. thetaiotaomicron 
and B. uniformis thiamine biosynthesis regulating TPP riboswitches (FIG 3.4A and B). 
The response observed in Bt pBvTPP-NanoLuc shows that the biosynthesis regulating 
riboswitch of B. vulgatus is active. This does not however provide the mechanism of 
regulation for this riboswitch.  
To characterize the regulatory mechanism implemented by BvTPP we leveraged 
RT-qPCR of the nanoluciferase gene to rule out or confirm transcriptional regulation 
(FIG 3.4E). Transcriptional assays were carried out in minimal medium with 10,000 nM 
(+) or 0 nM (-) thiamine added.  As a control we utilized the transcriptional acting TPP 
riboswitch in B. thetaiotaomicron (Bt pBtTPP1-NanoLuc). In addition, we utilized both 
Bt pTPP2-NanoLuc and Bt pTPP3-NanoLuc as controls for riboswitches that act at the 
level of translation. The biosynthesis regulating TPP riboswitch in B. vulgatus (Bt 
pBvTPP-NanoLuc) is significantly down regulated in the presence of thiamine. Bt 
pBvTPP-NanoLuc responds similarly to the transcriptional acting B. thetaiotaomicron 
TPP riboswitch (Bt pTPP1-NanoLuc) suggesting that the TPP riboswitch in B. vulgatus 
operates at the level of transcription (FIG 3.4E).  
These data suggest Bacteroides species utilize both transcriptional and 
translational acting TPP riboswitches to maintain homeostasis of thiamine. The 
nanoluciferase assays also show that thiamine biosynthesis is down regulated at levels of 
thiamine above 1 nM of thiamine. Thiamine transport is regulated at a 10-fold higher 
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concentration of thiamine (> 10 nM) in all three of the species tested. These data define a 
clear regulatory hierarchy between thiamine biosynthesis and transport. 
 
Distances of TPP riboswitches predict regulon type and mechanism 
 The transcriptional and translational data from B. thetaiotaomicron, B. uniformis, 
and B. vulgatus pointed to a trend in how riboswitch distance from the regulon relates to 
the mechanism of regulation. To determine if this trend is conserved across the 
Bacteroidetes; we leveraged in silico analysis of 114 Bacteroidetes genomes. Among 
these 114 genomes, 219 TPP riboswitches were predicted and then categorized by the 
genes that they regulate (FIG 3.5A, Table 3.2). Among the 219 riboswitches, 122 of them 
were predicted to regulate putative thiamine biosynthetic operons. All aspects of thiamine 
biosynthesis (e.g. HMP-PP, cThz-P, and condensation) are tightly controlled by TPP 
riboswitches across Bacteroidetes species. A closer look riboswitch controlled operons 
show that closely related Bacteroides species have similarly ordered biosynthetic 
operons. More distantly related Bacteroidetes (e.g. Parabacteroides and Paraprevotella) 
species appear to have split biosynthesis operons, but have acquired a second TPP 
riboswitch in order to fully regulate the process. The other 97 TPP riboswitches regulate 
predicted thiamine transport genes, primarily operons that start with OMthi (85/97) or 
pnuT (12/97)(FIG 3.5A,Table 3.2). In contrast to the diversity observed among TPP 
riboswitch controlled thiamine biosynthesis operons; thiamine transport operon 
organization is highly conserved. TPP riboswitches regulate both the inner and outer 
membrane transporters in addition to a thiamine pyrophosphokinase (tnr3). 
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 Turning our attention to the mechanism of regulation, we identified the distance 
of the TPP riboswitches from the first gene in the regulon (Table 3.2). We then plotted 
the distances of each riboswitch from its regulon along with the predicted function of 
each operon (FIG 3.5B). The average distance of the 122 thiamine biosynthesis 
regulating are approximately 60 nucleotides (± 34 nucleotides)(Table 3.2) suggesting that 
most biosynthesis operons are regulated at the level of transcription (FIG 3.5B). 
Conversely, many TPP riboswitches regulating thiamine transport operons are closer to 
their regulon (21 ±20 nucleotides)(Table 3.2) suggesting that they might be regulating 
through ribosomal occlusion (translation) (FIG 3.5B). 
 The presence and trends observed throughout the Bacteroidetes show a clear trend 
that Bacteroidetes species are novel in utilizing both transcriptional and translational 
acting TPP riboswitches. Further characterization of this observed trend would help 
predict how this prominent class of gut microbes will respond to the availability of 




 Thiamine plays an essential role in host and microbial metabolism, as such the 
acquisition of thiamine is key for host health and microbial abundance. It is believed that 
most of thiamine in the gastrointestinal tract is made available by the host diet (37, 39), 
and that microbial prominence may be linked to gaining required levels of thiamine (8). 
Here, we have shown that Bacteroides species are novel in employing both 
transcriptional and translational acting TPP riboswitches. To this end, we utilized 
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expression analysis in the prominent and abundant gut microbes B. thetaiotaomicron, B. 
uniformis, and B. vulgatus, characterizing the mechanism employed by thiamine 
biosynthesis and transport regulating TPP riboswitches in these species. In addition, we 
utilized in silico approaches to identify if TPP riboswitches across the Bacteroidetes. The 
identification of these TPP riboswitches also helped us predict the mechanism of 
regulation used by these riboswitches. We also identified a clearly conserved regulatory 
hierarchy between biosynthesis and transport regulating TPP riboswitches. 
Our data suggest that the Bacteroides may also be utilizing different types of 
riboswitch regulation to carry out the regulation of thiamine biosynthesis and transport 
(FIG 3.2, 3.3, and 3.4). Leveraging both transcriptional and translational assays we 
determined that riboswitches that are close to their regulon (<20 bp) regulate by blocking 
translation, while riboswitches shown to be further upstream (>50 bp) are acting through 
transcriptional attenuation. These mechanisms have been shown to be canonical 
mechanisms of regulation for TPP riboswitches. However, the mechanisms of regulation 
were thought to be divided between Gram negatives (translational blocking) and Gram 
positives (transcriptional attenuation) (16, 28, 44). In B. thetaiotaomicron, B. uniformis, 
and B. vulgatus transcriptional assays have shown that thiamine biosynthesis regulating 
riboswitches affect a strong transcriptional response (FIG 3.2A, 3.2B, 3.3A, 3.3B, and 
FIG 3.4E). In addition, the transport regulating riboswitch in B. uniformis illicts a strong 
transcriptional response in response to thiamine (FIG 3.2B and FIG 3.3B). These 
riboswitches are greater than 40 nucleotides away from the start codon of their regulon, 
indicating that they may be acting through transcriptional termination by forming a stem-
loop structure. In addition to these transcriptional responses, we saw no significant 
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transcriptional regulation from riboswitches under 40 nucleotides from their start codon 
(transport regulating riboswitches) (FIG 3.2 and FIG 3.3). We then leveraged 
translational fusions (FIG 3.4) and saw regulation from all riboswitches tested. This 
suggests that riboswitches that did not show a significant transcriptional response operate 
at the level of translation. Further analysis of these riboswitches and the untranslated 
regions preceding thiamine biosynthesis and transport genes across the Bacteroidetes are 
required to characterize the mechanism regulation. These initial data imply that 
Bacteroidetes are unique in the fact that they utilize both transcriptional and translational 
acting riboswitches. 
Building on the data that the Bacteroides species tested appear to have both 
transcriptional and translational acting riboswitches and that the mechanism is linked to 
the distance from its regulon. We identified the TPP riboswitches across the 
Bacteroidetes confirming and expanding on the present data available we identified 219 
TPP riboswitches (FIG 3.5A)(8, 36). Of these 219 TPP riboswitches 122 of them are 
predicted to regulate biosynthesis genes and 97 regulated putative thiamine transport 
genes (Table 3.2). Manual inspection of the genomes in which these predicted 
riboswitches shows that they only regulate thiamine biosynthesis or transport. We then 
identified the distances of these TPP riboswitches from their regulons. Predicted 
distances of TPP riboswitches that regulate biosynthesis genes are much farther from the 
presumed regulon (FIG 3.5B) suggesting that they regulate through transcriptional 
termination. This prediction is based on data from B. thetaiotaomicron (biosynthesis), B. 
uniformis (biosynthesis and transport), and B. vulgatus (biosynthesis) that regulate 
through transcriptional termination (FIG 3.2, FIG3, and FIG 3.4E). In contrast, many 
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transport regulating riboswitches are much more proximal to the genes they regulate. 
This suggests that proximal transport regulating TPP riboswitches occlude the ribosomal 
binding site (FIG 3.5B). This data is based off of characterized translational acting 
riboswitches identified in B. thetaiotaomicron (FIG 3.3A and FIG 3.4A). Further 
characterization of these trends is warranted. Inspecting RNA stability, mapping 
individual riboswitch structure, and a better understanding of Bacteroidetes ribosomal 
binding sites would help in clarifying the precise mechanism of regulation. In addition, 
further transcriptional assays may help in narrowing down the transition from 
transcriptional to translational acting riboswitches and determine if distance is the sole 
factor in the mechanism of TPP riboswitch regulation. 
 In addition our results clearly show TPP riboswitches respond to different 
magnitudes of exogenous thiamine. In B. thetaiotaomicron and B. uniformis, the transport 
regulating riboswitches decrease the expression of the genes when the concentrations of 
thiamine are greater than 10 nM (FIG 3.4A,B). Comparatively, the biosynthetic 
regulation riboswitches in B. thetaiotaomicron, B. uniformis, and B. vulgatus are an order 
of magnitude more sensitive to exogenous thiamine. Biosynthesis regulating riboswitches 
block transcription at concentrations below 1 nM of thiamine (FIG 3.4A,B,and D). Our 
studies showed that in the wildtype background we get no response from the TPP 
riboswitch in B. vulgatus (FIG 3.1C, FIG 3.2C, and FIG 3.3C). We hypothesized that B. 
vulgatus may not respond to exogenous thiamine because it lacks a dedicated thiamine 
transport system. This hypothesis became more plausible upon further investigation of 
the genomic context of thiamine acquisition in B. vulgatus. Through in silico analysis we 
could not identify TPP riboswitch controlled inner (pnuT) or outer (OMthi) membrane 
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transporters (FIG 3.5A). As TPP riboswitches are highly conserved and appear to 
regulate thiamine biosynthesis and transport across the Bacteroidetes we suggest B. 
vulgatus relies solely on the biosynthesis of thiamine and that the predicted pnu-type 
transporter is likely a pnuC homolog that transports vitamin B3 (18). Further 
characterization of the pnu-type transport homologs across the Bacteroidetes is 
warranted. To better understand the regulation of the B. vulgatus biosynthesis TPP 
riboswitch we moved its reporter fusion into B. thetaiotaomicron that has a partially 
characterized thiamine transport system (8, 14). Under this system we see the B. vulgatus 
riboswitch now regulates similarly to the other thiamine biosynthesis controlling TPP 
riboswitches (FIG 3.4D). We then confirmed through RT-qPCR that the B. vulgatus TPP 
riboswitch acts at the level of transcription (FIG 3.4E).  Remarkably, the levels at which 
transport and biosynthesis regulating riboswitches change expression are consistent in the 
Bacteroides species tested (FIG 3.4A-D). 
 TPP riboswitches appear to have conserved mechanisms and regulatory 
concentrations of thiamine. In contrast, the global transcriptome of B. thetaiotaomicron, 
B. uniformis, and B. vulgatus are markedly different from one another (FIG 3.1). As 
shown previously, B. thetaiotaomicron down regulates multiple metabolic pathways upon 
the addition of thiamine to the environment (8). However, B. uniformis only down 
regulates its thiamine biosynthesis genes to any significant degree and B. vulgatus as 
stated above shows no response to exogenous thiamine (FIG 3.1B,C). These different 
expression profiles show each organism may have vastly different thiamine requirements 
and utilizations strategies in order to cope with variable thiamine availability in the 
human gastrointestinal tract. These differences may allow for different species to become 
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prominent at disparate thiamine concentrations. To fully understand these differences a 
meta-transcriptomic profile of a gut community in various concentrations of thiamine in 
addition to analysis of the prominence of each microbe under these conditions is needed 
to clarify the importance of thiamine in the gut. 
 The regulatory mechanisms of thiamine acquisition play an important role in the 
Bacteroidetes. The study of how thiamine impacts microbial metabolism and global 
expression is necessary for understanding how certain organisms rise to prominence in 
the gastrointestinal tract. By further characterization of thiamine acquisition and 
regulation we can begin to design therapies through utilizing compounds that target TPP 
riboswitches (8, 31) and model how to change microbial communities mitigating diseases 




Bacterial culturing and genetic manipulation 
 Culturing of Bacteroides strains B. thetaiotaomicron VPI-5482, B. uniformis 
ATCC 8492, and B. vulgatus ATCC 8482 occurred anaerobically at 37°C in liquid 
tryptone yeast extract glucose (TYG) medium (25) or a modified minimal medium with 0 
to 10 µM of thiamine hydrochloride supplemented depending on the assay and strain (8, 
40, 47) or Difco brain heart infusion (BHI) agar with the addition of 10% defibrinated 
horse blood (QuadFive, Ryegate, MT, USA). Cultures were grown anaerobically within a 
vinyl anaerobic chamber with an input gas mix consisting of 70% nitrogen, 20% carbon 
dioxide, and 10% hydrogen (Coy Laboratory Products, Grass Lake, MI, USA). E. coli 
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S17-1 λ pir strains used for cloning and conjugation of reporter vectors were grown in 
LB medium at 37°C aerobically. Antibiotics were added to the medium when appropriate 
in the concentrations as follows: ampicillin 100 µg/mL, gentamicin 200 µg/mL, and 
erythromycin 25 µg/mL. 
 Nanoluciferase reporter vectors were constructed via traditional cloning of the 
nanoluciferase gene (20,24) into the vector pNBU2 (9, 10, 22). TPP riboswitches were 
then amplified from genomic DNA by PCR using HiFi Taq MasterMix (KAPA 
Biosystems, Wilmington, MA, USA) and inserted in frame preceding the nanoluciferase 
gene in the pNBU2 vector. These vectors were then transformed into donor E. coli S17-1 
λ pir. Reporter vectors were then confirmed via PCR amplicon size as well as 
sequencing. After confirmation vectors were then conjugated into B. thetaiotaomicron 
VPI-5482, B. uniformis ATCC 8492, and B. vulgatus ATCC 8482 making a single 
insertion into the genome of each strain (9, 10, 22). A complete list of primers and 
vectors used for this study are provided (Table 3.3). 
 
Expression analysis of TPP riboswitch controlled operons 
Replicate cultures of wildtype B. uniformis and B. vulgatus were grown overnight 
in 5 mL minimal medium supplemented with a concentration of 10,000 nM thiamine HCl 
(THI, > 99% pure) (Sigma Aldrich, St. Louis, MO, USA). Aliquots of each culture were 
pelleted by centrifugation (1 min at 13,300 x g), culture supernatants were decanted and 
the cells were washed 4 times in minimal medium with 0 nM thiamine. Cells were 
inoculated into 10 mL of minimal medium with either 0 or 15 µM thiamine HCl at a final 
dilution of 1:2,000 in biological duplicate. Cell growth was monitored and cells were 
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harvested between OD600 0.4 and 0.6 on a UV spectrometer. Total RNA was extracted 
using the Qiagen RNeasy kit and stored at -80°C. Total RNA was DNAse treated with 
DNase I (Thermo Fisher, Waltham, MA, USA) and NEB DNase treatment protocol. 
DNAse treated RNAs were re-cleaned using the Qiagen RNeasy kit (Hilden, Germany) 
and quantitated using a Qubit 2.0 (Life Technologies, Carlsbad, CA, USA) and stored at -
80°C. This was the same method used for a previously published RNA sequencing 
experiment for B. thetaiotaomicron in Costliow and Degnan 2017 (8). 
RNA was submitted for integrity analysis, ribosomal RNA depletion, and library 
construction at the W.M. Keck Center for Comparative and Functional Genomics at the 
University of Illinois at Urbana-Champaign. 
For targeted gene expression analysis, total RNA was purified as above and used 
to generate cDNA libraries using the first strand cDNA synthesis kit (Thermo Fisher, 
Waltham, MA, USA). RT-qPCR was performed on a Biorad CFX connect instrument 
(Biorad, Hercules, CA, USA) and SYBR Fast MasterMix 2x Universal (Kapa 
Biosystems, Wilmington, MA, USA) following the manufacturer’s instructions for 
triplicate biological samples in technical triplicate. Five genes in three strains were 
amplified 16 ribosomal RNA, thiC, thiS, OMthi, and pnuT. 16S rRNA primers were used 
as the control gene (9) and novel primers for thiC, thiS, OMthi, and pnuT for B. 
thetaiotaomicron (8), B. uniformis, and B. vulgatus were designed using Primer3 (46). 
Standard curves were used to evaluate the efficiency of the amplification, all 5 genes had 
R2 ≥ 0.98 and slope between -3.30 and -3.40. Relative expression changes were 
calculated using the ∆∆Cq method (5). 
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Nanoluciferase reporter fusion assays 
 Reporter assays were performed through a modified and combined protocol of 
Lim et al. 2017 and Mimee et al. 2015 (20, 24). Bacteroides species with an integrated 
pNBU2 TPP riboswitch nanoluciferase reporter were grown in a modified minimal 
medium and then washed and back diluted to an OD600 of 0.004 in 1.5 mL Axygen deep 
96-well plates (Corning, Inc., Corning, NY) over a gradient of thiamine HCl (Sigma-
Aldrich, St. Louis, MO). Growth was monitored by via a BioTek Synergy HTX Multi-
Mode microplate reader (BioTek, Winooski, VT) (8).  
When cells reached mid-log phase growth (0.35-0.58 OD600) growth was stopped. 
1 mL of mid log culture was spun down in the Axygen deep well plate at 3,000-x g for 10 
minutes and medium was poured off of pellets. Cell pellets were then resuspended in 
50uL of 10x BugBuster protein extraction reagent (MilliporeSigma, Darmstadt, 
Germany). Pellets-BugBuster suspension was then incubated at room temperature while 
gently shaking for 10 minutes. Nanoluciferase extracts were then mixed 1:1 (10 µL:10 
µL) with Nano-Glo Luciferase mixture. Reporter mixture was then allowed to incubate 
for 5 minute at room temperature. Nanoluciferase luminescence was then read on BioTek 
Synergy HTX Multi-Mode microplate reader (BioTek, Winooski, VT). 
Relative Luminescence Units were then normalized to the OD600 of each 
respective pellet. Comparisons were then determined across concentrations for each TPP 
riboswitch Nanoluciferase reporter utilizing Pairwise Student’s t tests in GraphPad Prism 
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In silico identification of TPP riboswitches in Bacteroides species  
 Detection of TPP riboswitches among Bacteroidetes was done in the same manner 
as Costliow and Degnan 2017 (8). Infernal 2.0 was used to identify these riboswitches 
using the covariance model of TPP riboswitches in RFAM (RF00059)(15, 26) in 114 
Bacteroidetes genomes available of RefSeq from the Human Microbiome Project (27, 
29). In an attempt confirm that Infernal predicted riboswitches were TIGRFAM, PFAM, 
and Hidden Markov Models with HMMR were used to identify thiamine pyrophosphate 
biosynthesis and transport genes among the same 114 RefSeq Bacteroidetes genomes (13, 
29, 41).  
 To identify trend of distances between riboswitches and the genes they were 
predicted to regulated. Nucleotides distances between coordinated identified with Infernal 
2.0 and TIGRFAM, PFAM, and HMMR were taken and subtracted from one another (12, 
15, 26, 41). Annotations and genes were then manually inspected utilizing Artemis to 
confirm that genes and riboswitches were called correctly and that distances were 
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Figures: 
 
FIG 3.1. Global transcriptional response to exogenous thiamine 
RNA sequencing was carried out on (A) B. thetaiotaomicron (previously in Costliow and 
Degnan 2017), (B) B. uniformis, and (C) B. vulgatus in a defined minimal medium that 
was thiamine deplete (0 nM thiamine added) and thiamine replete conditions (15 µM 
thiamine added). Grey circles indicated genes that are neither significantly up- nor down-
regulated. Green circles indicate genes that are significantly up regulated. Red circles 
indicate genes that are significantly down regulated in the presence of excess exogenous 
thiamine.  Significance was defined by a q-value ≤ 0.05 for samples analyzed in 
Rockhopper RNA sequencing analysis tool and a change in expression of ≥ 2-fold 
between conditions. The experiment was carried out in biological duplicate. 
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FIG 3.2. Transcriptional response of TPP riboswitch controlled operons 
Operons controlled by TPP riboswitches in the RNA sequencing experiment were 
investigated. Expression changes across operons are visualized in a scale schematic of 
each operon in which asterisk (*) and bold outlines indicate significance (q-value ≤ 0.05 
and a change in expression ≥ 2-fold). Each species investigated (A) B. thetaiotaomicron, 
(B) B. uniformis, and (C) B. vulgatus has a unique structure to their riboswitch controlled 
regulons and a differential transcriptional response. The experiment was carried out in 
biological duplicate. All operons and distances are represented to horizontal scale. 
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FIG 3.3. (cont.) 
Expression of TPP riboswitch regulated biosynthesis and transport genes were confirmed 
through RT-qPCR. In (A) B. thetaiotaomicron, (B) B. uniformis, and (C) B. vulgatus 
biosynthesis expression was analyzed through the expression of the thiC gene and 
transport by the expression of the predicted OMthi and pnuT gene when present. 
Expression of each gene was compared to the expression of the gene in 10,000 nM 
exogenous thiamine (+) as opposed to medium with no added thiamine (-). Error bars 
represent the standard deviation (S.D.) of each experiment carried out in biological 
triplicate. Statistical significance for the expression of genes was determined via a 
student's t-test. Changes in expression were deemed significant when the fold change was 
≥ 2-fold and had a p-value ≤ 0.05. 
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FIG 3.4. Nanoluciferase assays of Bacteroides TPP riboswitches 
Nanoluciferase translational fusions of all six TPP riboswitches found between (A) B. 
thetaiotaomicron, (B) B. uniformis, and (C) B. vulgatus were tested. The B. vulgatus 
riboswitch was also studied in a B. thetaiotaomicron background (D) to account for the 
lack of a response to exogenous thiamine seen by B. vulgatus. In addition RT-qPCR was 
carried out on Nanoluciferase fusions in B. thetaiotaomicron in thiamine replete (+) or 
thiamine deplete (-) conditions to confirm the mechanism of regulation by predicted 
riboswitches from B. thetaiotaomicron and B. vulgatus (E). Relative light units (RLU) 
were normalized to the OD630 of the bacterial culture before the lysis of cell and 
activation of the nanoluciferase reaction. Cells were harvested in mid-log for all samples 
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FIG 3.4. (cont.) 
The expression of each riboswitch-controlled fusion was represented as the averaged 
RLU/OD630 x 1,000 from six independent biological representatives. Error bars represent 
the standard error of the mean (SEM). Letters (a, b, c, etc.) indicate groupings of that 
were significantly different from one another based off of a p-value ≤ 0.05 using a 
student’s t-test. 
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FIG 3.5. (cont.) 
Infernal and the RFAM 00059 covariance model were used to identify TPP riboswitches 
across the Bacteroidetes. (A) Predicted TPP riboswitches ORFs were then inspected to 
determine the operons directly preceded by putative TPP riboswitches. Function and 
syntenic context were assigned to all predicted riboswitch regulated operons. The 
distances of each TPP riboswitch from its predicted regulon was then recorded and 
plotted and divided into the subcategories of whether the riboswitch regulated a thiamine 
biosynthesis operon (red) or a thiamine transport operon (blue). 
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Tables: 
Table 3.1. Reads of quality trimmed and mapped RNA sequencing 
Species Treatment Replicate 
SRA 











–Thi 1 SRP116143*  9,170,438   8,231,596   7,712,374  93.7% 
 
2 SRP116143*  8,258,740   7,454,637   6,830,124  91.6% 
+Thi 1 SRP116143*  9,017,267   8,169,029   7,783,046  95.3% 




–Thi 1 SRP148918  15,534,762   13,334,281   13,036,981  97.8% 
 
2 SRP148918  15,576,078   13,358,338   12,771,513  95.6% 
+Thi 1 SRP148918  17,382,438   14,900,079   14,437,339  96.9% 
  2 SRP148918  15,505,061   13,290,981   12,756,005  96.0% 
B. 
vulgatus 
–Thi 1 SRP148917  19,391,595   13,334,281   13,036,981  97.8% 
 
2 SRP148917  18,821,066   13,358,338   12,771,513  95.6% 
+Thi 1 SRP148917  18,447,248   14,901,073   14,437,549  96.9% 
  2 SRP148917  18,300,462   13,748,120   13,183,146  95.9% 
*denotes results previously published in Costliow and Degnan 2017  
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Table 3.2. Average distance distributions of TPP riboswitches from the first  
gene of their regulon 
 
Gene 











s thiS TIGR01683 / PF02597 77 64  ± 14 
thiD TIGR00097 / PF08543 17 24 ± 34 
thi4 TIGR00292 / PF01946 16 55 ± 19 
thiE TIGR00693 / PF02581 9 106 ± 82 
thiC TIGR00190 / PF05690 3 132 ± 0 








N.A. / PF00593, 
PF07715, PF14905 85 23 ±23 
pnuT PF04973 / TIGR01528 12 3 ± 0 
    Total 97 21 ± 23 
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Table 3.3. Strains, vectors, and primers used 
 Primer, 
Plasmid, or 
Strain name Oligonucleotide sequence (5'-3')/Notes1 Citation 
qPCR Primers 















Bt_pnuT_F tgtcggaatgtggatgctg This Study 
Bt_pnuT_R acaatgcggaggtgaaatagag This Study 
Bt_OMthi_F gttctttcaacacccacaagg This Study 
Bt_OMthi_R gcatcgaatgtccagtgattg This Study 
Bu_16s_F gcagaaagagtctatctgtc This Study 
Bu_16s_R tccgttttccacttataaga This Study 
Bu_thiC_F gcacagtatgacgttgccat This Study 
Bu_thiC_R cttcgatgaaagcctgcaca This Study 
Bu_pnuT_F ctggttggactccttcacca This Study 
Bu_pnuT_R catgcccaccattgctctac This Study 
Bu_OMthi_F aacaacgccacaaagaacga This Study 
Bu_OMthi_R ttgatgtggcggtattgcag This Study 
Bv_16s_F ggcttcttactttctctcttccg This Study 
Bv_16s_R cacaccgcccgtcaagccat This Study 
Bv_thiC_F atatcacttcggccatcggt This Study 
Bv_thiC_R tgggcaatcccagatgttct This Study 
Bv_pnuT_F cagggcaccgtactatctgt This Study 
Bv_pnuT_R caccgtctaagctgctgttg This Study 
NL_F tgtgaccccgaatatgattga This Study 
NL_R cgggttaatcagacgctc This Study 
 	    
 	    TPP 
riboswitch 
Primers 
	    Bt_TPP1_F atgggatccgcgggaatcggaagaaaaatg This Study 
Bt_TPP1_R 
ttgtctagatttcattgtcctatcagtattaataagt
tg This Study 
Bt_TPP2_F tactctagagctgacttgtcatatttcaacaaactac This Study 
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Table 3.3. (cont.) 
 
Bt_TPP2_R atcggatccggcgacggccatcat This Study 
Bt_TPP3_F gagtctagacacgacaaatgaggagaagag This Study 
Bt_TPP3_R tgcggatccctccagataattcatttccatatttgc This Study 
Bu_TPP1_F aaatctagacggttccaaacgtctcttattatc This Study 
Bu_TPP1_R 
aaaggatcctctgttcattaagaaataaaacaatgga
agt This Study 
Bu_TPP2_F aaatctagacggcaataatcagcagaatgg This Study 
Bu_TPP2_R aaaggatcctctcttcatttgcaattgtttcgtttag This Study 
Bv_TPP1_F aaatctagagctgggtttcgatgtatgg This Study 
Bv_TPP1_R 
aaaggatcccagtttcatactatatcagtttatgaat
ttacttgt This Study 
 	    




Plasmids with cloned fragments integrates at NBU2 
att sites, ErmR, AmpR 
Koropatkin 
et al. 2008 
pNanoLuc 
pNBU2_erm plasmid with NanoLuciferase gene 
inserted into the MCS This Study 
pBtTPP1-
NanoLuc 
B. thetaiotaomicron TPP1 (biosynthesis) UTR and 3 
codon thiS fusion added upstream and in frame of 
Nanoluciferase gene This Study 
pBtTPP2-
NanoLuc 
B. thetaiotaomicron TPP2 (Transport) UTR and 3 
codon OMthi fusion added upstream and in frame of 
Nanoluciferase gene This Study 
pBtTPP3-
NanoLuc 
B. thetaiotaomicron TPP3 (Transport) UTR and 3 
codon pnuT fusion added upstream and in frame of 
Nanoluciferase gene This Study 
pBuTPP1-
NanoLuc 
B. uniformis TPP1 (biosynthesis) UTR and 3 codon 
thiS fusion added upstream and in frame of 
Nanoluciferase gene This Study 
pBuTPP2-
NanoLuc 
B. uniformis TPP2 (Transport) UTR and 3 codon 
OMthi fusion added upstream and in frame of 
Nanoluciferase gene This Study 
pBvTPP1-
NanoLuc 
B. vulgatus TPP (biosynthesis) UTR and 3 codon thiS 
fusion added upstream and in frame of Nanoluciferase 
gene This Study 
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Table 3.3. (cont.) 
 
Parental Strains 
  E. coli S17-1 λ 
pir 
thi pro hdsR hdsM+ recA, chromosomal insertion of 
RP4-2(Tc::Mu Km::Tn7) , AmpS 




VPI-5482 ∆tdk 'wildtype' deletion background, BT2275–, FUDRR 
Koropatkin 
et al. 2008 
B. uniformis 
ATCC 8492 ∆tdk 
'wildtype' deletion background, BACUNI03774–, 
FUDRR This Study 
B. vulgatus  
ATCC 8482 ∆tdk 'wildtype' deletion background, BVU1857–, FUDRR This Study 
 	   	  
 	   	  Fusion Strains 
	   	  B. thetaiotaomicron VPI-5482 ∆tdk pBtTPP1-NanoLuc This Study 
B. thetaiotaomicron VPI-5482 ∆tdk pBtTPP2-NanoLuc This Study 
B. thetaiotaomicron VPI-5482 ∆tdk pBtTPP3-NanoLuc This Study 
B. uniformis ATCC 8492 ∆tdk pBuTPP1-NanoLuc This Study 
B. uniformis ATCC 8492 ∆tdk pBuTPP2-NanoLuc This Study 
B. vulgatus ATCC 8482 ∆tdk pBvTPP-NanoLuc This Study 
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Chapter 4: SUMMARY AND FUTURE DIRECTIONS 
Summary: 
 This thesis exams the impact thiamine has on the prominent gut phylum, the 
Bacteroidetes. In addition, the mechanisms that regulate the level of thiamine in the 
Bacteroidetes were also characterized. These studies showed that in Bacteroides species 
both thiamine biosynthesis and transport are required to remain competitive in the gut. 
Consequently, the investigation of thiamine biosynthesis genes highlighted an unexpected 
diversity among these operons. This thesis also showed that Bacteroides 
thetaiotaomicron is novel in utilizing both transcriptional and translational acting TPP 
riboswitches. In addition, we viewed diverse transcriptional responses to thiamine across 
Bacteroides species. These studies create a foundation for future studies that will attempt 
to alter dysbiotic states through the use of essential cofactors (e.g. thiamine).  
Chapter 2 explains how gut microbes acquire thiamine. While thiamine 
biosynthesis has been well studied in model organisms, little work has been done to study 
these processes in the prominent gut phylum, the Bacteroidetes (1, 8, 12). Chapter 2 
investigated the genomes of 641 gut microbes in an attempt to identify the thiamine 
biosynthesis and transport genes found in these organisms. Our results were in line with 
other studies, and showed that gut microbes primarily utilize previously characterized 
thiamine biosynthesis genes (10). This study also showed that, among gut bacteria, the 
Bacteroidetes and γ-Proteobacteria are unique in possessing both complete biosynthesis 
and transport pathways (10). Thiamine biosynthesis operons among the gut Bacteroidetes 
however utilize a diverse set of genes to carry out this process (3, 10). In contrast, we 
confirmed that gut bacteria utilize a different thiamine transport system than the 
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previously characterized systems in Bacillus and Salmonella species (9, 16). This 
thiamine transport system, PnuT, is highly conserved throughout the Bacteroidetes (3, 5, 
9). We also showed that PnuT only imports free thiamine. This is in contrast to other 
characterized bacterial thiamine transport systems that can import the phosphorylated 
moieties of thiamine in addition to the free-form (8, 9, 16). 
  In addition, Chapter 2 utilizes B. thetaiotaomicron as a model gut microbe to 
characterize the biosynthesis and transport of thiamine among Bacteroides species. To 
this end, we showed that both thiamine biosynthesis and transport systems are critical for 
B. thetaiotaomicron. Deletion of either the biosynthesis or transport systems dramatically 
inhibit the growth of B. thetaiotaomicron. These data along with expression analyses, 
show that biosynthesis and transport systems are somehow interlinked. This connection is 
interesting and warrants further investigation into how they are linked. It would also be a 
worthwhile endeavor to characterize the flux that occurs from deleting these systems. The 
inhibited growth of thiamine biosynthesis or transport mutants in isolation directly 
correlates to a competitive defect in B. thetaiotaomicron thiamine acquisition mutants. 
Considering that thiamine biosynthesis and transport systems are conserved across the 
Bacteroidetes; we hypothesize that these results could be used to model the responses to 
thiamine for the entire phylum. 
In Chapter 3, we focused on the TPP riboswitches that precede thiamine 
biosynthesis and transport genes among the Bacteroidetes. TPP riboswitches are 
universally conserved across all domains of life (7, 17). We found that TPP riboswitches 
universally precede the thiamine biosynthesis and transport operons in the Bacteroidetes 
investigated in Chapter 2.  
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While the TPP riboswitch structure is conserved, they have been shown to 
regulate through different mechanisms. In bacteria, TPP riboswitches can act by 
attenuating transcription or by blocking translation. The mechanism of regulation was 
canonically believed to be split between Gram negative (translation) and Gram positive 
(transcription) bacteria (13, 14). Initial transcriptional analyses confirmed that some 
predicted TPP riboswitches were functional and attenuate transcription in Bacteroides 
species. 
Building on the identification of TPP riboswitches, we characterized the function 
of these regulatory elements in B. thetaiotaomicron, B. uniformis, and B. vulgatus. The 
characterization of these riboswitches showed an explicit regulatory hierarchy between 
the riboswitches that regulate transport or biosynthesis of thiamine. We found that all 
biosynthetic riboswitches decreased the expression of biosynthesis at external 
concentrations of thiamine greater than 1 nM. In addition, we found that all the transport 
regulating riboswitches decreased the expression of the regulon at external concentrations 
of thiamine higher than 10 nM. We hypothesized that these riboswitches strategically 
regulate biosynthesis and transport operons in this manner. The strategic regulation of 
both acquisition pathways may be part of the reason that the Bacteroidetes are prominent 
members of the gut microbiome.  
Consequently, our investigation of the TPP riboswitches identified that B. 
thetaiotaomicron is novel in employing both transcriptional (biosynthesis) and 
translational (transport) riboswitches. This was confirmed by leveraging translational 
fusions and transcriptional assays. Further study of the riboswitches in B. 
thetaiotaomicron suggested that the mechanism may be dictated by the distance of the 
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riboswitch from the first start codon of the regulon. Building on this trend we found that 
the distance phenomena is common across the Bacteroidetes. Commonly transport 
regulating riboswitches are much closer to their regulon. In contrast, biosynthesis 
regulating riboswitches are much farther upstream of the regulon. These data suggest that 
many of the Bacteroidetes may employ both transcriptional and translational acting 
riboswitches.  
Together the data in this thesis increases our knowledge of how vitamins impact 
the gut microbiota. The impact thiamine has on the gut microbiota then informs how the 
two work together to affect human health. Our data may eventually lead to a better 
understanding of this dynamic biome. This increased understanding may then lead to 




Are different thiamine biosynthetic strategies linked to species prominence? 
 Multiple bioinformatic studies have shown that divergent gene pathways carry out 
thiamine biosynthesis in the Bacteroidetes (3, 10). It is commonly seen that many 
Bacteroides species possess both thi5 and thiC. Both of these genes biosynthesize HMP-
PP. Possessing both thiC and thi5, suggests a fitness advantage for using multiple 
precursors to synthesize the same molecule. In contrast, thiazole synthesis appears to 
have more constraints. Among the Bacteroidetes thi4 appears to displace the canonical 
bacterial synthesis genes (thiSFGH). This suggests that the loss of thiSFGH may be 
beneficial if thi4 has been acquired. This may be beneficial because thi4 requires fewer 
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precursors to synthesize thiazole than the thiSFGH pathway. In addition, the presence of 
different suites of thiamine biosynthesis genes may lead to the differential abundances we 
observe in the gut. 
 To further investigate this topic, specific deletions and complements could be 
made in a model species, such as B. thetaiotaomicron. Selectively deleting either thi5 or 
thiC in B. thetaiotaomicron may help give us insight into why both HMP-PP synthesis 
genes are retained. Initial tests would be to determine if either deletion impacts the ability 
of B. thetaiotaomicron to grow in thiamine limited minimal medium. In addition, we can 
confirm if these mutants are now auxotrophs for different thiamine precursors. To further 
characterize the mutants, we could compete them against one another in addition to 
wildtype strains. In these competitions, fitness defects or advantages may be sussed out. 
Similar analyses can be performed for the synthesis of thiazole in B. thetaiotaomicron.  
In contrast to thiC and thi5, thiSFGH and thi4 do not coexist in any Bacteroidetes 
genomes. To study these differences a thi4 gene will have to be cloned from a closely 
related Bacteroidetes member into a B. thetaiotaomicron mutant lacking thiSFGH. After 
these strains have been constructed, we can assess the precursors that each set of genes 
require to synthesize thiamine. These assays will help us confirm the current predictions 
for how each thiazole synthesis pathway works. We can then perform competition assays 
between B. thetaiotaomicron strains containing either thi4 or thiSFGH. These 
competition assays will help us ascertain if one set of thiazole synthesis genes is truly 
more efficient than the other in the gut. 
Adding to the phenotypic and competitive assays, transcriptomic assays could be 
leveraged to see if relying on different thiamine synthesis genes impacts the global 
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transcriptome. We can then utilize metabolomic assays to investigate what the net 
metabolic flux of these different thiamine biosynthetic pathways are. Both assays would 
help inform why certain strains or pathways have higher or lower abundances in the gut. 
 
What is the link between thiamine transport and biosynthesis? 
 In Chapter 2, we showed that both the thiamine biosynthesis and transport 
systems are critical to B. thetaiotaomicron (3). While this was an unexpected phenotype, 
it is not entirely novel. It has been shown that a similar phenomena occurs in Listeria 
monocytogenes (11). Both organisms encounter shifting thiamine concentrations in the 
environments they inhabit. This shifting level of availability may be why both systems 
have been maintained, but it does not explain why both systems are essential. In B. 
thetaiotaomicron, we showed that when the entire transport system is deleted there is a 
10-100 fold down regulation of the biosynthetic operon (3). This dramatic down 
regulation suggests an uncharacterized link between the two systems. 
 In an attempt to study this link we must first determine why the biosynthetic 
operon is down regulated when transport is deleted. As there are no known protein 
regulators of thiamine biosynthesis, there must be another explanation for this down 
regulation (6, 15). One theory is that the deletion of transport creates excess free 
thiamine. Free thiamine could be increased if the tnr3 gene that recycles free thiamine to 
TPP localizes to the deleted transport proteins. If tnr3 can no longer effectively localize, 
it may lose function preventing the conversion of free thiamine to TPP. Excess free 
thiamine could then bind and down regulate thiamine biosynthesis via the TPP riboswitch 
(17). To test this theory we can use the thiamine biosynthesis riboswitch fusion utilized in 
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Chapter 3. The reporter system will conclusively tell us if the decreased expression of 
biosynthesis in the transport mutant is due to riboswitch dysregulation.  
 If this phenotype is not due to TPP riboswitch dysregulation, there may be a novel 
protein regulator of this system to consider. In order to identify this novel regulator, we 
may leverage a transposon mutagenesis library. This library would identify mutants that 
alleviate repression of the biosynthetic operon. Transposon insertions can then sequenced 
identifying what insertions improved the fitness of this mutant.  
 Together these studies may help explain the link between the two systems in the 
Bacteroidetes. Learning how these systems are linked will in turn inform how thiamine 
impacts and changes the gut microbiome as a whole. In addition, characterizing the link 
between thiamine biosynthesis and transport may lead to the development of targeted 
antibiotics and therapies. 
 
How does thiamine impact gut community structure? 
 Pairwise-competitions between B. thetaiotaomicron and thiamine acquisition 
mutants showed thiamine can dramatically impact fitness and competition (3). 
Unfortunately, pairwise competitions do not represent the dynamic community of the gut 
microbiome. To fully understand how thiamine impacts abundances of gut microbes a 
community needs to be studied. As of yet, a defined medium that supports the growth of 
many species and allows for the control of thiamine levels does not exist. To circumvent 
this issue, mouse models with a representative humanized microbiome could be used. 
Using this system we can control the thiamine intake of the mouse. We can then interpret 
how thiamine availability impacts the colonization of gut microbes. Utilizing mouse 
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models will also allow for the study of how thiamine and the microbiome impact disease 
states. These studies will lead to a better understanding of thiamine and how it impacts 
the human gut microbiome. In turn, this will lead to novel treatments of vitamin 
deficiencies and diseases in the future. 
 
Do the Bacteroidetes possess transcriptional and translational acting TPP riboswitches? 
 As identified in Chapter 3, B. thetaiotaomicron is novel in employing both 
transcriptional and translational acting TPP riboswitches. This phenomena was linked to 
the distance that the TPP riboswitch was from the start codon of the first gene in the 
regulon. In addition, this phenomena was associated with previously characterized TPP 
riboswitches in microbes (2, 4, 17). Traditionally, transcriptional and translational acting 
riboswitches are different distances from their regulon, but this trend has never been 
characterized.  
 In Chapter 3, we identified that transport and biosynthesis acting riboswitches 
were typically at different distances. This suggests that across the Bacteroidetes transport 
and biosynthesis riboswitches may be operating through different regulatory mechanisms. 
To build on this, we can leverage the nanoluciferase fusion system and transcriptional 
assays (e.g. RT-qPCR) to characterize the mechanism of TPP riboswitch regulation. 
Leveraging both of these assay will help characterize how these riboswitches are working 
and determine if the trends observed in B. thetaiotaomicron are observed in other species.  
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Cumulatively, understanding the regulation of thiamine acquisition pathways can 
create strategies for modulating the gut microbiome. In addition, we will have a better 
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